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ABSTRACT
This thesis addresses the problem of how to examine a metabolic pathway and identify
what are the key elements, specifically with respect to rate-limitation. The aim is to be
able to analyze a pathway, identify the bottlenecks and implement genetic modifications
to remove these bottlenecks. This is done by defining the system of interest and
developing a predictive model using kinetic data. The model predictions can then be
verified using fermentation data and genetic techniques to make the appropriate changes
for improved performance.
The test system chosen for this study was the TOL meta-cleavage pathway for the
degradation of benzoate. This system was chosen on the basis of the application of
pathway engineering principles to other systems. The modelling strategy and software
was developed using principles from metabolic control theory and biochemical systems
theory. By applying this to the TOL pathway using kinetic data, the control coefficients
for the pathway were obtained as well as the system parameters required for the
optimization of the pathway.
The simulated results obtained from this model must be validated by experiment. Errors
can arise both from incorrect assumptions in the model and from the fact that the
kinetic data taken from individual in vitro experiments may not be applicable to the in
vivo system. The effect of the presence of the TOL pathway on the behaviour of E.coli
1M107 during fermentation was investigated and the transient concentration data
necessary to identify the bottlenecks in the pathway measured.
This data is then used to calculate the flux control coefficients for the TOL pathway.
The predictive results were verified by the fermentation data which identified the first
two enzymes in the pathway as having significant flux control coefficients.
This final chapter also addresses the issue of flux analysis, that is, the calculation of the
fluxes in the system to determine where fluxes to unwanted by-products occur and to
indicate points of control. A graphical user interface is used to provide a user-friendly
and intuitive means of building and customising metabolic pathways which can then be
interfaced with instrumentation to provide on-line flux analysis.
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1. INTRODUCTION:
1.0 Introduction
The aim of metabolic pathway engineering is to use genetic engineering techniques to
alter the cells activity in a desirable way. This involves highly specific additions or
deletions to the cells genome to alter the proteins expressed or change the regulation of
their expression. Such changes can have complex effects on the cellular metabolism.
There are several reasons for this. The first is the way that the new genetic information
is introduced to the cell: it will either be chromosomal or plasmid-borne. Introducing
plasmids to a cell places a metabolic burden on the cell and can have other effects
which have been studied [Axe and Bailey, 1989]. It is also necessary to take into
account any feedback repression which may occur as a result of the over-production of
a metabolite. These two effects indicate the importance of considering the effects of any
modification on the pathways of the whole microorganism. This requires a systematic
approach to analysing the behaviour of metabolic pathways and the effects of
perturbations upon them. To be able to engineer a pathway for increased productivity
or to make new products requires an extensive knowledge of the mechanisms of the
pathway and it is necessary to formulate some kind of model of the system. Models can
vary in complexity from being purely phenomenological to being highly mathematically
structured but their basic purpose is to explain and predict the action of the system.
This chapter will describe how different types of knowledge about systems can be used
to engineer them for improved performance. The chapter is divided into two sections;
the first describes approaches which do not use control theories, the second gives an
account of the control theories which are applicable to metabolic systems.
Sections 1.1.1 and 1.1.2 give examples of where a knowledge-based approach has been
used in pathway engineering, both in flux optimization and in the creation of new
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pathways. Section 1.1.3 then describes the types of models and expert systems which
have been developed to describe metabolic pathways. The simplest of the mathematical
models are unstructured models. These are models which do not make use of any
biochemical or kinetic data but lump details of the metabolic system into one or more
pools which are then treated as black boxes. For example, the Monod equation for cell
growth assumes the growth of a cell to be determined by Michaelis-Menten kinetics of
a limiting substrate, X and lumps all of the other processes together so that an
expression for cell growth is
____	
(1)
While this expression can provide a good fit under some conditions, it is not universally
true, for example where more than one step affects growth rate. A second approach
treats the cell as a black box where only the inputs and outputs of substrates, products
and energy need be considered. This approach is described in Section 1.1.3.1.2 where
a set of linear conservation equations are derived from the element, electrical charge,
energy and Gibbs free energy balances. The chemistry of the process is also used in
providing the balance equations. The microorganism is specified only by its elemental
composition -for example Acinetobacter calcoaceticus is CH1O0N0•22.
This method can be used to check the validity of experimental data, to predict
maximum yields and to predict the yields of compounds difficult to measure
(Papoutsakis 1984, Papoutsakis and Meyer 1985a,b). It has however some drawbacks,
one of these being that it can give no insight into cellular regulation by individual steps
in the pathway or any of the other details of intracellular metabolism.
The structured models of the cell described in Section 1.1.3.1.3 make use to a greater
or lesser extent of the biochemical details of the cells metabolism. In simple cases this
will be the pathway stoichiometry (Aiba and Matsuoka 1984, Hoims 1986) whereas, in
highly structured models, details of initiation and termination of DNA synthesis (Shu
and Schuler 1989), initiation of sporulation (Jeong and Ataai 1990) and transcription
and translation (Peretti and Bailey 1986) may be included.
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Simple flux models discussed in Section 1.1.3.1.1 can be used to identify a correct
metabolic model (Aiba and Matsuoka 1979) or to elucidate regulatory and control
mechanisms. They require measured levels of metabolites rather than enzyme kinetic
data or data on intermediate or enzyme concentrations. However they yield no
information on the regulatory enzymes or metabolites in the pathway or the intermediate
metabolite concentrations.
It has been shown that by performing a balance over the inputs and the outputs of the
cell, the size of the system to be solved can be reduced if the number of independent
balance equations is not at its maximum (Tsai and Lee 1988, Noorman et al 1991). If
this is not the case, the metabolic pathway approach should be used as it gives more
information about the internal mechanisms of the cell.
There have been several studies comparing the approaches where the cell inputs and
outputs are balanced with those where information on the metabolic pathways is used
(Tsai and Lee 1988, Noorman et al 1991) and it has been shown that the balance
method can yield extra information and reduce the size of the system to be solved only
when the number of independent balance equations is not at its maximum. If this is not
the case, the metabolic pathway approach should be used as it gives more information
about the internal mechanisms of the cell.
The highly structured models described in Section 1.1.3.1.3 can yield a large amount
of data but require a large number of input parameters some of which may be difficult
to obtain. For example a study of sporulation in B.subtilis entailed the solution of 17
coupled differential equations (using a Cray supercomputer) requiring 210 operational
parameters (Jeong and Ataai 1990). As well as the powerful computing and numerical
techniques which are required when solving such systems, the results obtained may be
ambiguous and errors not immediately noticeable.
Even if all of the details of a metabolic system were known it is often not desirable to
construct a highly structured model. Many of the elements of a system may remain
relatively unchanged during a process - this is what allows the use of the pseudo-steady
state assumption common to many kinetic studies - and variations in them have very
little effect on the overall pathway.
Therefore what is required is to identify the elements of the metabolic system which
regulate or control the system. The cell balances its metabolic demands by controlling
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the concentration of the elements of the pathways and the rates of conversion or the
fluxes through the pathways. The control mechanisms used by the cell can act at several
different points. It can be at the transcriptional or translational level so that it is the
level of the enzyme in the cell which is controlled or it can be at the reaction level
where it is the activity of the enzyme which is altered usually by direct interaction with
the modulator. Control may also be exerted upon transport of substrates or products
across the cellular membrane, or where there is spatial organisation within the cell as
in eucaryotes, across the intracellular membranes. Even if the exact mechanisms of
control are not known it is possible to obtain quantitative descriptions of how the
control is distributed among the elements of a pathway using the theories of metabolic
control reviewed in Section 1.2.
Metabolic control theory was developed on two fronts in the early 70's, one based on
the derivation of control theorems from the examination of simple linear systems
(Heinrich and Rappoport 1974), the other based on a power-law method of expressing
reaction rates. These theories of metabolic control and others developed after them
(Savageau 1969a,b, 1970) differ in details of how the reaction rates are aggregated and
whether a rate law approximation is used implicitly or explicitly but all generate a
sensitivity analysis of the flux and metabolite concentrations. The sensitivity or control
coefficient gives a measure of the fractional change of a dependent variable caused by
a fractional change in an independent variable, i.e.
C = S(x,y) = dxix = dlnX (2)dY/Y dlnY
While optimization methods have been widely applied in chemical processes especially
with respect to costing, their use in the biological sector has so far been limited by the
uncertainty existing in the mathematical representation of biochemical processes and in
the data used in the process models. As new modelling techniques are developed they
can be combined with existing optimization methods to provide a rational method of
metabolic pathway optimization. A systematic methodology is clearly required because
of the potential size and complexity of pathways for pharmaceutical products which
include reversible steps and loops.
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The need for a rational approach to modelling metabolic systems has become greater
with the increasing ability to manipulate the conditions inside microorganisms using
genetic techniques. Such metabolic models aid the visualization of complex systems and
provide predictive results to direct experimental design. More importantly perhaps is
the way in which these techniques can be used in the metabolic pathway engineering of
cells. For example, to force a cell to make more of an existing product, to insert novel
pathways into a cell or to make novel products. Successful metabolic pathway
engineering attempts have produced impressive results such as a yield improvement of
over 50% in the production of phenylalanine (Backman et al, 1990), the synthesis of
indigo by a Pseudomonas strain (Mermod et al 1986) and the production of novel
antibiotics (Hunter and Baumberg 1989).
An overview of the modelling techniques discussed in this chapter and their inter-
relationships is shown in Figure 1.1. This figure highlights the techniques which are to
be used in this study in later chapters.
The conclusion of this chapter deals with the choice of a test system for study and the
strategy for modelling it. The system chosen was the TOL meta--cleavage pathway. The
reasons for using this were the extensive data available on its genetics and enzymology
and the availability of genetic systems which could be transformed into E. coil which is
a particularly well defined organism.
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1.1 Metabolic Pathway Engineering Without the Use of Control Theories
A prerequisite for pathway engineering is a good knowledge of the system being
altered. It is necessary to know what changes should be made and the effects of these
on the overall metabolism of the cell. Below, the pathway engineering of several
different systems is described, including those whose mechanisms are well-established
and one where pathway engineering work is just beginning. Following this, the way in
which modelling techniques can be used to provide insight into and verification of cell
mechanisms and direct cloning experiments is discussed.
1.1.1 A Knowledge-Based Approach:
1.1.1.1 Optimization of the Flux in the Phenylalanine Pathway:
The production of the amino acid phenylalanine has been extensively studied especially
due to its commercial success, but since much of this has been in the industrial sector
there has been relatively little published. However, one study by Backman et al (1990)
is a very good example of an experience-based approach to metabolic pathway
engineering.
A diagram of the phenylalanine biosynthetic pathway showing the feedback repression
mechanisms is given in Figure 1.2. Backman et al (1990) took the approach of cloning
all of the genes involved in the pathway except for the transaminases. Each of the genes
was then engineered for increased expression and the effect of such increased
expression was measured. This enabled them to determine which genes were important
in the rate of phenylalanine synthesis. As expected not all of the cloned genes increased
phenylalanine production rate and one gene even had a negative effect, decreasing
phenylalanine titres by 20%. This negative effect on flux or "wrong way behaviour" is
not unusual in biochemical systems and occurs as a result of such complex structures
as substrate cycling and metabolite conservation. (A discussion of the control analysis
of such systems is given in Section 1.2)
Having done this they then concentrated on removing the effects of regulation by
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phenylalanine from the pathway. There are two ways that this can be done: either by
changing the regulation of enzyme activity (e.g.by site-directed mutagenesis) or by
altering the regulation of gene expression. Three points at which regulation occurred
were identified as shown in Figure 1.2. The first step in the biosynthesis is catalyzed
by three isoenzymes encoded by the genes aroF, aroG, aroH and regulation of this step
occurs both at the level of control of transcription of these genes and at the level of the
enzyme activity of DAHP synthetase (by feedback inhibition). The second point of
control is in the formation of shikimate kinase which is encoded by aroL and the third
point of control occurs at the conversion of chorismate to phenylalanine where the
enzyme chorismate mutase-preprenate dehydratase (CMPD), encoded by the gene pheA
is regulated both at the level of enzyme formation and enzyme activity.
Both of the approaches mentioned above (those of changing both the enzyme activity
and gene expression) were used to maximize the flux through the pathway by removing
the mechanisms of regulation, as follows:
(i) by generating mutations in zyrR repressor protein gene:
Because several of the genes in the pathway are regulated by the repressor protein
encoded by lyrR, the mutations generated here removed repression on the formation of
the enzymes encoded by several genes, including aroF, aroG, aroL and genes involved
in the transport and transamination of phenylalanine.
(ii) by replacing the natural promoter for pheA to avoid transcriptional regulation:
The regulation of the pheA gene is sufficiently complex that it was decided to replace
the entire promoter rather than deal with each of the forms of regulation individually.
Several promoters were tried and the final choice was one that gave the highest
expression level.
(iii) by deletion of a residue from CMPD so that it was no longer subject to feedback
regulation:
In the feedback repression of CMPD by phenylalanine, a tryptophan residue is essential
so that its substitution or deletion results in the inactivation of the repression
mechanism. This is a good example of how protein engineering by site-directed
mutagenesis can by used to alter the control of metabolism.
(iv) by isolating feedback-inhibition-insensitive mutants in the gene for DAHP synthase
by means of resistance to toxic amino acid analogues.
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By using these techniques the production of phenylalanine was increased to 50 gIl.
Other efforts at maximizing the productivity of the phenylalanine pathway have resulted
in titres of up to 80 gIl and at this level the phenylalanine crystallizes out of solution.
This is one of the most successful examples (in the public domain, at least) of how
genetic engineering techniques, along with a thorough understanding of the molecular
biology and regulation of a system, can be used to engineer a metabolic pathway and
it gives an indication of the potential for over-production in biological systems.
1.1.1.2 Where To Start On A Complex System: The Penicillin Pathway:
Having discussed above one pathway which has been successfully engineered and before
going on to examine a (relatively simple) pathway on which there is enough information
to begin a pathway engineering study, it is useful to consider how we should begin to
tackle the pathway engineering of an industrially very important, but extremely complex
system such as the penicillin biosynthetic pathway.
As with any project it is necessary to define the eventual goal, even if the long-term
aim seems many years from being achieved. In pathway engineering terms, it will
usually be one of the following:
(i) increased productivity
e.g by maximizing flux through the pathway
- by changing the fermentation conditions
- by changing the host
(ii) the development and production of novel antibiotics
- by installing new pathways
- by altering the pathways present
- by changing the host
Examining the first heading, the term "productivity " is taken to include the titre of
penicillin in the broth, the efficiency of conversion of carbon source to product and
cost-effectiveness with respect to fermentation conditions and downstream processing.
A general scheme for the biosynthesis of penicillins and cephalosporins in filamentous
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fungi and Streptomyces is shown in Figure 1.3. The precursors for this pathway are L-
aminoadipic acid, L-cysteine and L-valine. This pathway has been studied in detail at
the enzymatic level so that there are data about how the individual reactions occur in
vitro. The challenge is to relate this to the action of the pathway in vivo. To do this
requires detailed knowledge of the control of the system at the transcriptional,
translational and enzymatic level.
The first hurdle which must be overcome is the complete genetic characterization of the
molecular biology of antibiotic synthesis. In all systems so far studied, antibiotic genes
have occurred in clusters. Indeed for most of the systems where all of the biosynthetic
genes have been accounted for, or where heterologous expression of antibiotic
production has been achieved, all of the antibiotic genes have been found in one cluster
often along with a gene encoding for resistance. Examples include actinorhodin,
erythromycin, cephamycin C, tetracenomycin C and oxytetracycline (Hunter and
Baumberg 1989). An exception to this was reported by Skatrud and Queener (1989)
who found that the IPNS and DAOCS genes of C. acrimonium reside on different
chromosomes.
To date the genes for three of the enzymes in the pathway have been individually
cloned: those for ACVS (Smith et al 1990a), IPNS (Samson et al 1985) and REXH
(Samson et a! 1987). In addition a cluster containing the genes encoding ACVS, IPNS
and ACT activity from P. chrysogenum has been cloned and expressed in Neurospora
crassa and Aspergillis niger (Smith et a! l990b).
The occurrence of these genes in clusters may give the impression that their
transcription and its control should be quite straightforward but this would be
misleading. The mechanisms of transcription and their controls are quite complex and
it is not even clear what controls the initiation of secondary metabolite production. Also
most gene clusters for antibiotic production are located on the chromosome rather than
on plasmids which makes cloning more difficult, except where stable transformants are
available. (The one well-documented exception to this is methylenomycin A (Hunter and
Baumberg 1989).)
Antibiotic production begins after the initial rapid growth phase and correlates with the
appearance of the enzymes of their biosynthetic pathways (the exception to this being
IPNS which is present from the beginning of the fermentation). This is an important
10
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Figure 1.2: Phenylalanine biosynthetic pathway, showing points at which feedback
repression occurs.
point as it implies that it is the repression of transcription of the genes encoding these
enzymes which occurs in the initial growth stages rather than repression of the enzyme
activity. The details of this repression have not been worked out but there is a large
amount of empirical information on the effect of fermentation conditions (Bushell
1989). In general, secondary metabolite production is enhanced by the use of carbon
and nitrogen sources which permit only slow growth. It is repressed by high phosphate
concentrations and high growth temperature. In nature it seems likely that secondary
metabolite production was connected with the formation of ariel mycelium and this has
lead to hypotheses that they play a role in cellular differentiation. One of these
hypotheses implicates guanine nucleotides in the control of antibiotic production. It has
been shown (Ochi 1984, 1987) for Bacillus subtilis and Streptomyces griseus that
sporulation is controlled by levels of one or more of GMP, GDP or GTP and ppGpp
controls the level of antibiotic production. Care must be taken when trying to extend
this result however. Factors such as the selection marker on the cloning vector used can
influence the control mechanism, for example, thiostrepton which prevents ppGpp
formation.
The transcription patterns of antibiotic synthesis pathway clusters are very complex.
They are composed of several transcriptional units: 3 in the case of methylenomycin
and at least 4 and 7 for actinorhodin and streptomycin respectively. Multiple sites of
transcription initiation are present and, in the case of antibiotic resistance genes,
multiple holoenzymes can be used to transcribe the same gene. One explanation for this
is that it gives a form of temporal control so that production occurs only at some stages
in the cells growth and not at others. Also, divergent transcription has been observed
in many antibiotic resistance gene clusters.
Catabolite repression obviously plays an important part in the regulation of antibiotic
synthesis genes. Secondary metabolism is repressed by carbon, nitrogen and phosphate
and one model for this mechanism involves a low molecular weight effector whose
concentration reflects the physiological state of the cell which modulates the activity of
a regulatory protein. One candidate for this in the streptomycetes is A-factor which
activates streptomycin production and resistance (and also sporulation) in S.griseus and
S. bikiniensis. However it has been shown that A-factor formation is itself regulated by
the product of two genes afsB and afsC in a scheme of the type shown in Figure 1.4.
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Figure 1.3: Biosynthesis of penidilhins and cephalosoprins in filamentous fungi from the
precursors L-a-aminoadipic acid, L-cysteine and L-valine.

There may be also a spatial factor as in Penicillium chiysogenum where it has been
shown that the biosynthetic machinery for peniciffin G is located in Golgi-type vesicles
whose formation corresponds to the time of synthetic activity (Kleinkauf and von
Dohren 1990).
Faced with the complexity of the above problem where should one begin with the
engineering of this pathway in order to, say, increase the flux to product? The
procedure might be as follows:
(i) Increase flux to precursors:
At the moment a standard antibiotic fermentation has a carbon source to product
conversion factor of only about 8%. It is obvious that if we wish to increase this figure
we must set about redirecting the carbon flow towards the pathways for antibiotic
synthesis. To do this we should begin with the precursors.
It is not known in detail what effect the levels of precursors of the pathway have on its
regulation but it has been shown that feeding a precursor to an antibiotic fermentation
can increase yield. This has the disadvantage that it must be transported into the cell
and the added complication that there seems to be some interaction between transport
mechanisms and antibiotic production. In the case of 3-lactam antibiotics the precursors
are L-a-aminoadipic acid, L-cysteine and L-valine. With the increasing information
available on the primary metabolism of antibiotic-producing organisms it should soon
be feasible to engineer a strain for increased precursor production. Alternatively,
traditional mutagenesis and screening techniques could be used to screen for over-
producers of the precursors.
(ii) Identify the rate-limiting enzymes:
If we can ensure that the precursors for the pathway are present in excess either by
feeding, by engineering the pathway or by screening for mutants which overproduce the
precursors, the next problem is to identify the rate-limiting enzymes in the pathway and
to increase the activity of these enzymes. There are several ways of doing this. One is
to do a flux analysis of the pathway (see Section 1.1.3.1.1) and identify the bottlenecks.
The rule of thumb that it is often the enzymes directly after these bottlenecks which are
rate-controlling can then be used (Bailey and 011is, 1986). Because of the complexity
of the control of these systems it is possible that a more detailed control analysis may
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be required and these methods are described in Section 1.2. A more ad hoc method is
to increase the expression of each of the enzymes in the pathway as was done for the
phenylalanine pathway in Section 1.1.1.1. This can be equally effective but can be
wasteful in that (a) not all of the enzymes in the pathway may have been cloned and (b)
a lot of time and effort could be put into the cloning and expression of an enzyme that
might have little or no effect on the rate through the pathway.
To complicate the issue it now seems as if the enzymes which are rate-limiting in the
antibiotic production pathways vary from organism to organism. For example an
increase in IPNS causes an increase in the production of penicillin in P. chrysogenum
(Earl 1990) whereas in C.acrimonium an increase in IPNS shows no effect but over-
expressing REXH causes a 30-80% increase in yield (Pratt 1989). Without a
mechanistic model for the control of the pathway it is difficult to explain these
differences so until our understanding of the system improves we can only be aware of
the dangers of maldng generalizations.
(iii) Minimize catabolite repression:
We know that antibiotic production is repressed by high levels of carbon, nitrogen and
phosphate. At the moment this effect is minimized by the use of low-quality feedstocks
such as corn-steep liquor and by careful feeding regimens. Because of the poor
understanding of the mechanisms of repression this will be a difficult problem to
overcome. One approach is to isolate repression-insensitive mutants (Chang et a! 1990).
These often perform poorly in other respects and so are not useful industrially but are
useful to studies of repression. A study of the fluxes through the pathway and the
control exerted by the enzymes at different levels of repression could indicate which
enzymes were influenced by what types of catabolite repression and therefore suggest
solutions.
More work is required to verify the regulation model described in Figure 1.4 but if it
is true then work could begin on increasing the expression of the proteins afsB, afsC
and afsA.
(iv) Control of initiation of antibiotic production:
Industrially it is important to be able to control and predict the stage in the fermentation
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at which antibiotic production occurs. Unfortunately there is little knowledge of the
details of the mechanism of initiation of transcription. As mentioned above ppGpp has
been implicated in this mechanism but exactly what role it plays is not clear. Because
of the connections between cellular differentiation and onset of secondary metabolite
production it is likely that developments in these two areas will proceed concurrently.
Structural models which seek to improve our understanding of such mechanisms by
simulations could prove invaluable in these areas and an example which models cellular
differentiation in B. subtilis is discussed in Section 1.1.3.1.3.
The engineering of antibiotic biosynthetic pathways for the production of novel
antibiotics requires a slightly different approach. Here we are trying to change the rules
which the organism has been programmed to follow and there are several methods
which can be applied.
(i) Use of precursor analogues:
The use of precursor analogues containing functional groups which we wish to be
present in the final product is possible because of the relaxed substrate specificity of
some of the enzymes of the pathways. For example there are many analogues of L-c-
aminoadipic acid which can be transformed by IPNS (Pratt 1989). REXH, however, is
much less promiscuous in its substrate specificity as are several of the other enzymes
in the pathway. Because of the developments in modern genetic methods we can now
alter the activity of the enzyme itself using techniques from protein engineering such
as site-directed mutagenesis [Baldwin et al, 1989].
(ii) Introduction of new DNA to create new pathways:
There are several ways to introduce non-native DNA into a microorganism.
Recombination between species has been attempted using protoplast fusion but this
requires almost totally homogenous DNA for recombination to proceed efficiently. The
introduction of heterologous DNA on autonomously replicating plasmids seems to have
more potential. Using this method the novel antibiotic dihydrogranatirhodin (shown in
Figure 1.5) was produced following the introduction of the actinorhodin gene cluster
into S.violaceoruber which normally makes granaticin or dihydrogranaticin. In a similar
way systems have been developed which can alter the backbone structure of an
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antibiotic (for an example in S.galilaeus see Hunter and Baumberg 1989) and the
potential in this area seems great.
1.1.2 Creation of New Pathways:
1.1.2.1 Production of Indigo:
A new route to the bacterial production of the dye indigo was proposed by Mermod et
al (1986) who showed that cells of E.coli K-12 containing a cloned fragment of
Pseudomonas putida TOL fragment pWWO produced indigo.
Indigo is produced by Pseudomonas sp. bacteria by the oxidation of indole to indoxyl
by molecular oxygen. It was shown that indigo is formed in E.coli cells containing
cloned genes encoding a naphthalene dioxygenase enzyme of P.putida. The proposed
pathway, shown in Figure 1.6 involves the formation of indole from tryptophan,by
tryptophanase, followed by the formation of cis-indole-2,3-dihydrodiol from indole by
naphthalene dioxygenase. Spontaneous dehydration of cis-indole-2 , 3-dihydrodiol results
in the formation of indoxyl which in turn oxidises spontaneously to form indigo. This
reaction mechanism suggested to Mermod et al that a Pseudomonas TOL plasmid-
specified hydroxylase, xylene oxidase, would form the same product.
This is rather typical of many pathway engineering efforts as it is not quite clear if this
discovery was entirely by chance (the production of indigo having a very obvious
phenotype) with the biochemical details applied afterwards to explain the phenomenon.
Obviously not all novel pathways can be so easily identified and a systematic
methodology is essential if the search for novel pathways or products is to be
optimized.
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1.1.2.2 Helping the cell to adapt to its processing environment:
This involves changing the cell so that it can cope better with the conditions under
which we wish to grow it. This is normally done by selecting for mutants with the
required properties which is essentially letting the microorganisms genetically engineer
themselves and then choosing those that have been most successful, but this method has
its limitations, depending on the availability of an efficient screening strategy.
An alternative method is to confer a desirable phenotype upon the strain using genetic
engineering methods. An example of this is the use of a haem-containing oxygen-
binding protein synthesized by a bacterium of the genus Viteroscilla to enable E.coli to
utilize oxygen more efficiently under microaerobic conditions. This work was carried
out by Khosla and Bailey (1988) and involved cloning the 2.2-kb Hindill fragment
coding the protein into E.coli JM1O1 via a pUC plasmid. The cells were shown to
express the protein by 2-D gel electrophoresis. Cells containing the gene grew to higher
cell densities than either plasmid-carrying or plasmid-free controls.
The advantage of this approach is that it frequently works. The main disadvantage is
that it is difficult to tell in advance whether or not the chosen cloning strategy will be
successful. It is very much a trial and error approach. If the system is too complex to
conceptualize but the correct cloning choices are made then that is termed intuition if
the worker is experienced, or luck if he is not. Another drawback is that while specific
experiments are admittedly the only way to prove or disprove a hypothesis they fail to
yield general insights into the structure of metabolic pathways. Also it is difficult to
know where to begin to study novel or complex systems with this approach.
For this reason we need a framework to help us to visualise metabolic systems and
predict likely outcomes. These frameworks are called models.
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1.1.3 Metabolic Models and Expert Systems
1.1.3.1 Models - From Stoichiometric to Structured
A model is a formal representation of a material system. It can be as simple as a
diagram or as complex as a system of partial differential equations but its object is to
predict, simulate or explain experimental observations of the system.
The use of models allows us to simulate metabolic systems. These simulations can
provide insight into the behaviour of such systems and a basis for control analysis. By
that we mean an analysis of what regulates the system in terms of the rate-controlling
steps and enzymes. It provides a framework upon which to fit available experimental
data as well as a means of predicting quantities in a system. Models are necessary to
provide a basis for experimental design - that is, determining which experiments are
necessary and what variables must be measured.
Before we begin modelling a system we must decide what parts of the system we wish
to include and to what degree of complexity.
Choosing which parts of a system to include will require intelligent simplification and
reduction of the complex network of reactions present in any cell. The metabolic
pathways which must be considered in the model will vary with the fermentation
conditions (for example, the carbon source will determine which catabolic pathways are
switched on) and with the genotype (whether or not any new pathways are being
expressed in the system, for example). Deciding on the degree of complexity of the
model will require careful consideration of the objectives. To carry out a control
analysis of a system will require the steady state metabolite concentrations and fluxes
as initial data, whereas an analysis of the carbon flow through the system would require
knowledge of the fluxes only.
The descriptions given below of the different areas of modelling are necessarily brief:
the intention is to point out the uses and applications of the different approaches rather
than give a detailed description of how to employ them. The relationship between the
different types of models is shown in Figure 1.1.
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1.1.3.1.1 Flux Modelling:
The minimum knowledge which we can expect to have of a system is some of its
metabolic pathways. These are well established for most microorganisms, especially for
those commonly used such as E.coli or Bacillus species. Given just this framework,
along with measurements of carbon consumption, CO2 evolution, excreted products and
biomass during a fermentation we can form a picture of the carbon flow through the
system. This method has been used by several authors for purposes varying from the
identification of a correct model (Aiba and Matsuoka 1979) to studies of the carbon
flow during growth on different substrates (Holms 1986,1987, El-Mansi and Hoims
1989, Nimmo et al 1989).
Because this method is based upon measuring the inputs and outputs and performing a
mass balance across the system, it is perhaps not surprising that most of its applications
concern the central carbon metabolism. Aiba and Matsuoka (1979) used it in their
analysis of citrate production by Candida lipolytica from glucose, where they
investigated the validity of three different models. Their base metabolic model is shown
in Figure 1.7 and of the three models which were considered, the first coordinated the
pyruvate carboxylation with the TCA cycle and disregarded the glyoxylate cycle, the
second overlooked pyruvate carboxylation and the third overlooked 2-oxogluterate
dehydrogenation.
Measurements were made of the concentrations of cell mass, protein and carbohydrate,
citrate, isocitrate, a-ketogluterate and glucose in NH4-limited chemostat culture. CO2
evolution and NH. uptake were also monitored. Writing out the carbon balance
equations for each metabolite yields the 11 branch point constraints in Table 1.1 in
terms of the carbon fluxes v 1 ,...,v12 shown in Figure 1.7.
The number of unknown carbon fluxes can be reduced from 12 to 7; v 12 , v1 , v4, v9 and
v5 can be deduced from experimental data. The number of independent relations can be
reduced to 6 (this concept of independent reactions is very important in the solution of
metabolic models and is discussed below in Sections 1.1.3.1.2) so that we must
eliminate one more unknown before attempting to solve the system. This is the basis
of the three models above. In model 1 we set v7 = 0, in model 2 v3 = 0 and in model
3 v8 = 0.
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Figure 1.7 Metabolic model showing citrate production from glucose
Table 1.1: Carbon balance equations resulting from the metabolic model above.
Metabolite Pool	 Carbon Balance Equation
G6P	 a1v	 = v1 + cr4't
PYR	 v1	 =v2+v3
AcCoA	 2/3 v2	= 1/3 v4 + 1/2 v10 + v12
CIT	 v4	 = v5 + a6Qp1
ICT	 5/6 v6	= v8 +
OCT	 2/3 V7 + 4/5 V8 	 = V9
GOX	 1/3 v7	= 1/2 v10
MAL	 v9+v10	 =vli
OAA	 4/3 v3 + vii	 = 2/3 v4
CO2	1/3 v2 + 1/6 V6 + 1/5 v8 = 1/3 + a3Q2
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The carbon fluxes can now be calculated from the experimental data and the models
compared. It was found that in models 2 and 3 negative fluxes occurred. This
contradicted what was known from the free-energy changes of these reactions which
predicted forward reaction directions. These results suggested that models 2 and 3 be
discarded. This was confirmed by measuring the enzyme activities of the pathways.
The above experimental process is a very good example of how the different pieces of
information about a system must be brought together in order to validate or invalidate
a model. It also illustrates how it is necessary to check the results of a simulation
against our knowledge of the system and how it behaves experimentally.
The same principles of mass balance and flux calculation can be use to investigate, in
qualitative terms, the control properties of a pathway. That is, what are the regulatory
mechanisms used by the cells and where in the pathway are they used. One common
regulatory mechanism is end-product repression either of the expression or the activity
of the enzyme. One general rule is that the junctions in the central pathways at which
flux is divided among several outputs are likely to be controlled by one or more of the
regulatory mechanisms available to the cell. We can calculate the flux through each
enzyme in a pathway by multiplying the throughput of each step (defined as mmol of
carbon transformed to give one gram of dry weight) by the growth rate (jL) (Holms
1986). The throughputs are obtained from experimental data on the carbon inputs and
outputs to biosynthesis, CO2 and the excreted products.We can thus determine where
such junctions occur.
This approach has been used to investigate the central metabolic pathways of E. coil, in
particular the control of carbon flux to acetate excretion (Hoims 1986, El-Mansi and
Hoims 1989) and the control of flux through the citric acid cycle and the glyoxylate
bypass (Hoims 1986, 1987).
In the study of the excretion of carbon source to acetate, it was determined from the
flux model that the key junction was at pyruvate. The fluxes through this junction will
vary with the carbon source as the organism attempts to bridge the gap between the
phosphorylated and non-phosphorylated partS of the central pathways. This provides an
indication of how we should proceed if we wish to engineer this pathway for greater
efficiency to biomass. There are two approaches which can be taken: the reduction of
the flux into the pyruvate junction by controlled feeding of glucose, the running of a
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glucose-limited culture (El-Mansi and Holms 1989) or the reduction of the flux to
acetate by altering the activity of the enzymes in that pathway (Diaz-Ricci and Regan,
1991).
The growth of E. coli on acetate provides an opportunity to investigate the control of
flux through the citric acid cycle and the glyoxylate bypass. The function of the
glyoxylate bypass is to provide carboxylic acids and phosphorylated intermediates using
only Acetyl-CoA as a source. By performing a flux analysis, it can be shown that the
control of flux through this bypass will most probably lie with the enzymes isocitrate
lyase (ICL) and isocitrate dehydrogenase (ICDH) since the synthesis of all of the
biosynthetic precursors depends on the flux through ICL. This control mechanism has
been shown to depend on reversible inactivation of ICDH by a bifunctional
kinase/phosphatase. This kinase/phosphatase responds to two types of effectors - the
intermediates which are generated by flux through ICL and ADP, AMP and NADP.
This has the effect of adjusting the flux through the citric acid cycle so that the rate of
production of ATP and NADP is equal to the demands of biosynthesis. (Hoims 1986,
1989)
This type of approach is essential when beginning to study any system, either from the
view of control analysis or pathway engineering but it is limited and in many cases may
provide no more than a starting-point from which to apply other methods of analysis.
It provides no data how control is distributed over the enzymes in a pathway before and
after a critical junction, for example. It is useful as a means of devising an optimum
feeding program so that the fluxes to the desired product are maximized (Holms et a!
1991). Genetic engineering of these pathways, however, could increase these fluxes by
orders of magnitude and for this we need to identify more precisely the enzymes with
which the control of a pathway lies. We will see how this may be done in Section 1.2.
1.1.3.1.2 Stoichiometric and Pathway Methods:
Much can be learnt about a system by examining the stoichiometric constraints across
it. These constraints include carbon, nitrogen and available electron balances. While
these types of models have been primarily used in the monitoring and control of
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bioprocesses they can also be used to validate metabolic pathway models and to model
any parts of a system which we wish to consider as a black box. These types of
stoichiometric methods are also very instructive in illustrating the difference between
independent and dependent reactions, a concept which is important in all systems of
reactions. They can also be used to determine how many flux measurements are
required in order to solve for a system.
A "beginners guide" to this kind of steady-state simulation has been written by Hofmeyr
(1986). This work brings together the conclusions of several other authors but is
convenient because of its clarity.
The first step is to write down the stoichiometric matrix. Writing the steady state in
terms of the stoichiometric matrix and its rate expressions is the basis of the solution
of many of the structured models discussed below. The stoichiometric matrix is a way
of describing the system reactions numerically. It is a matrix of m rows and r columns
where m is the number of metabolites and r is the number of reactions. The entries;
in the matrix are called the stoichiometric coefficients and represent the number of
molecules of metabolite s, participating in the stoichiometric equation of the reaction j
i.e.
ATZ = 0	 (3)
where x are the metabolites in the reaction system. Writing the balance equations for
each metabolite
vj=ajjvj	 i=1,...,m	 (4)
where X is the concentration of the metabolite x and vj is the rate of reaction j
.
 At
steady state the metabolite concentrations are time-invariant so that we have the matrix
equation
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Av=O	 (5)
This is a non-linear problem since the rate vector v is a function of substrate, product,
effector and enzyme concentrations as well as kinetic constants. This is the system
which we must attempt to solve. We begin by reducing the number of variables. This
is normally possible because of the presence of substrates which are in excess or which
are rapidly removed, either by reaction or transport processes. In addition conserved
metabolites (or rather their sum) such as NAD and NADH can be expressed as a
constant. The rows of A corresponding to these constant metabolites can now be deleted
to give a reduced matrix A' of dimensions m'x r.
If v is a linear vector, a steady state is possible only if the rows of this matrix are
linearly independent, that is, no row may be a linear combination of the other rows.
The number of linearly independent rows is given by the rank r' of the matrix. (The
rank is given by the number of rows containing non-zero elements when the matrix has
been reduced to its echelon form by Gaussian elimination.)
If m' =r' then the system is determined and a steady state can be computed. It should
be noted that this steady state is not necessarily stable or unique.
If moiety conservation occurs then m' < r' and the system will be undetermined. In this
there should be m'- r' conservation equations with which we can replace the
appropriate balance equations in the matrix. In this way we reduce the matrix so that
m' =r'. and the steady state solution can be reached.
This concept of whether the system is ill-determined recurs frequently (see Sections
1.1.3.1.3) in the study of metabolic systems and it is important to have a clear idea of
what is variable in a system and what is fixed so the problem does not become under
or over determined.
If we elaborate slightly upon the above structure its uses expand. If the m compounds
are composed of q atomic species then their molecular formulae can be described by
the equation
x = Bb	 (6)
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where B is an m x q matrix of atomic coefficients and b is a q x 1 vector of atomic
species
We can obtain n, the number of moles of species i produced in
the overall reaction from
i=1,...,m	 (7)
or in matrix form
fl =	 (8)
where n is the m x 1 column vector of flows and E the r x 1 column vector of extents
of reactions.
The maximum number of independent reactions involving m compounds composed of
the q atomic species is then given by the Gibbs rule of stoichiometry (Niranjan and San
1989, Tsai and Lee 1988) as
r = m-g+g	 (9)
where g is the number of relations observed between the columns of B. In biological
systems there are frequently only four atomic species of any importance: carbon,
oxygen, nitrogen and hydrogen so that q = 4 and g = 2 and the maximum number of
independent reactions is two less than the number of compounds in the system. It can
be shown that, if there are 1 external fluxes, then
r+1=m-q+g	 (10)
is a necessary and sufficient condition to solve the system uniquely for any values of
the m - q - 1 experimentally determined values and this proof is given in Appendix C.
Using this framework, Niranjan and San (1989) examined the conditions to delineate
among cellular mechanisms based solely on extracellular measurements. (The aim of
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this work is similar to that of Aiba and Matsuoka (1979) described in the previous
section.) They arrived at the conclusion that when r = r, there are no constraints
among the stoichiometric coefficients in the overall reactions apart from those imposed
by the elemental balances and for this case it is not possible to uniquely determine the
intercellular mechanism given only extracellular measurements. They also made the
point that no information on any mismatches between the model pathways and the actual
mechanisms could be obtained from extracellular measurements.
As an alternative to the elemental balances described by Eqn. 6 we could write a
conservation equation over the carbon and reductance degree. This is an unstructured
type of model as it treats the cell as a black box, not using any of the biochemical data
on the system. This balance of the number of available hydrogens (or available
electrons) is obtained from the oxidation of the compound to CO2 and NH3 with water
(Papoutsalds 1984, Papoutsakis et al 1985a,b).
For example, the stoichiometric balance equation for C, H, 0 and N in an anaerobic
fermentation can be written in the form
CHmO1 + aNH3
 = YcCHpOnNq + ZCHrOsNt + bH2O + cCO2
where CHmOI , CHpOnNq and CHrOINI denote the elemental compositions of the organic
substrate(s), microbial biomass and extracellular products respectively. p, n and q are
found from the elemental analysis of the biomass and m, 1, r, s and t are known from
the molecular formulae of the substrate and products.
In the available electron balance each H in excess contributes -ito the electron value
of the compound: a lack of H contributes +1 and each excess N is worth +3. The
electron values of NH 3
 and H20 are zero and the electron balance for the above
expression yields (after multiplication by 2)
21 - m = y(2n + 3q - p) + z(2s + 3t - r) + 4c
(ii)
Writing the balance for the number of available hydrogens obtained from the oxidation
of the compound to CO2 and NH3 with water we have
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4 + m-21 y(4 + p-2n-3q) + z(4 + r-2s-'3t)
(12)
Writing this balance in degrees of reductance of the compound (y), defined as the
number of equivalents of available electrons per atom of carbon in the compound
75 = YC7 + Z'Yp
(13)
Tsai and Lee (1988) have shown that this method can yield extra information and
reduce the size of the system to be solved when r < r i.e. when the number of
independent reactions is not at its maximum. Otherwise (at r = r)the usefulness of
this method is limited and it should be applied with caution.
We can apply statistical analysis to this framework to avoid the possibility of false
conclusions due to errors in the experimental data. Tsai and Lee (1988) have shown that
the maximum likelihood solution is given by
= ( A	 F' A) .	 F'	 (14)ext
where x is the maximum likelihood estimate of x and n is the measured value of n.
F is a covariance matrix which, if the measurement errors are uncorrelated and of the
same magnitude, can be expressed as
F=cI
(15)
where c is a constant representing the error.
1.1.3.1.3 Structured Models:
What differentiates highly structured models from those previously described is that the
metabolic pathway is described in as much detail as possible and each reaction in the
pathway is modelled by a kinetic expression which should contain details of any
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interactions which may occur involving other metabolites. Such models can be expanded
as is necessary, for example, to include details on transcription and translation (Peretti
and Bailey 1986) or on initiation of sporulation (Jeong and Ataai 1990). It is this aim
of describing in detail the complex interactions of the cellular mechanism which sets
this branch of modelling apart.
To set up a structured model it is first necessary to write down the metabolic pathways,
in the same way as for the flux model shown in Figure 1.7. The conservation equation
for each metabolite is expressed as an ordinary non-linear differential equation with
each reaction and interaction described by a kinetic expression. This system must then
be solved using numerical solution techniques. For simple reaction schemes, such as
those in some chemical engineering processes this is a straightforward method which
yields easily-interpreted results. However microbiological systems are sufficiently
complex that there are some difficulties which may arise.
The first of these is in deciding which elements of a metabolic system to include and
to what degree of complexity. This will mostly be determined by the hypothesis which
one is trying to prove or the control system which one is trying to elucidate. Typically,
in modelling whole cells, one would include the pathways of central carbon metabolism,
pathways to amino acid and protein synthesis and details of purine nucleotide
metabolism.
The second difficulty arises in parameter estimation. These types of models normally
require a large number of variables, most of which will have to be taken from in vitro
data. A degree of judgement is required to decide whether this data is applicable to in
vivo conditions and what, if any, adjustments should be made. This problem is
compounded by the fact that this data is frequently taken from the literature so that it
may have been obtained under different experimental conditions. The third problem
arises in the interpretation of the results. Where results do not agree with experimental
data it may be difficult to determine if the problem lies in the data, the model or in the
numerical solution.
One of the first examples of these models was developed by the Cornell group (Schuler
1991, Shu and Schuler 1989). This was a single-cell model of E.coli which responded
to changes in the carbon source (glucose) concentration and the nitrogen source
(ammonium) concentration. This model was able to predict macromolecular
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composition, cell size and shape, length of C and D periods, point of initiation and
growth rate. The parameters used were based on literature and experimental values.
This model which is of a type shown in Figure 1.8, has provided the basis for many
other studies. Schuler (1991) has expanded it to form a population model which
includes details of plasmid multimerization. Peretti and Bailey (1986) have included in
their model of glucose-limited growth of E. coil the dependence of transcription on RNA
polymerase and the mechanism of translation initiation. This type of model helps us to
predict what happens when we introduce a perturbation such as a genetic alteration or
extra-chromosomal vector into a cell.
The reaction of a cell to growth on different substrates has been studied by Shu and
Shuler (1989) who examined the growth of E.coii on a glucose/glutamine/ammonium
medium. This study revealed a lack of knowledge about the regulatory control of the
TCA cycle.
We can see another example of a structured model in Figure 1.9. This is a model for
the growth of Bacillus subtilis which also examines cellular differentiation (Jeong and
Ataai 1990). Cellular differentiation is investigated by including details of purine
nucleotide metabolism which is involved in the initiation of sporulation. This model
requires the solution of 35 coupled and non-linear differential equations involving
almost 200 parameters and its solution was carried out on a Cray supercomputer.
The difficulties inherent in solving a numerical problem of this size have long been a
deterrent in the use of structured models. There are ways of reducing the size of the
problem, however, without making too many simplifying assumptions. One of these is
by making a quasi-steady state assumption. This involves classifying the reactions in the
pathway either as slow reactions or as fast quasi-equilibrium reactions. The system is
then modelled as moving very quickly onto a quasi-steady state reaction surface as
illustrated in Figure 1.10 (Heinrich a al 1976). This method has been used by Schuster
et al (1988,1989) in their investigation of glycolysis in erythrocytes and enabled a
reduction in system size from 20 differential equations to 7. We should note that this
quasi-steady state approximation is similar to the reduction of the stoichiometric matrix
by fixing variables described in Section 1.1.3.1.2.
While there are drawbacks to this method of modelling as mentioned above, it provides
one of the few ways of applying in vitro data to in vivo systems. For systems to which
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Figure 1.9 : Structured model of Bacillus subtilis
it can be applied it can provide insight into metabolic regulation and interaction,
validate or invalidate hypotheses and predict the effect of perturbations on the system.
1.1.3.2 Expert Systems in Metabolic Pathway Engineering:
While great advances have been made in the modelling of metabolic systems by using
classical modelling methods, there is a new range of techniques coming of age which
could advance our knowledge even further. These methods use a knowledge-based
approach and are called expert systems or knowledge based expert systems.
The aim of these approaches is to embed the knowledge of an expert about a system in
the form of a series of rules. These rules are of the type that are known and intuitively
applied when interpreting data; for example that metabolite concentrations are non-
negative, reactions with a negative Gibbs free energy change are thermodynamically
favoured and so on. This approach has been used to develop a software system for
metabolic pathway synthesis by Seressiotis and Bailey (1988). This system consists of
a data base for storing enzyme and substrate descriptions which is used by a search
algorithm to identify possible ways to interconvert metabolites which contain carbon.
This approach is an expert system because of the set of rules and restrictions which are
programmed in order to guide the search routine. It can only supply the user with a set
of possible pathways, however, and experience and knowledge are required to choose
between them. In their work, Seressiotis and Bailey were able to identify a route
synthesizing L-alanine from pyruvate which does not incorporate the enzyme alanine
aminotransferase.
A similar problem was tackled by Mavrovouniotis et al (1990). Their algorithm satisfies
a set of stoichiometric constraints by recursively transforming a base-set of pathways.
It can thus be used to check the possibility of proposed pathways as well as generating
new pathways with desired characteristics. Thus they were able to show that
oxaloacetate is a necessary intermediate in all of the pathways from glucose to lysine
and that the yield of lysine over glucose cannot exceed 67% in the absence of enzymatic
recovery of CO2.
Because much of our knowledge of biochemical systems is semi-quantitative, the
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parameters.
formalization of such knowledge is important in the modelling of such systems. This
can be approached by order-of-magnitude reasoning (O[M1). Order-of-magnitude
reasoning is an artificial intelligence approach based on the formal representation of the
relative orders of magnitude of the parameters of a system, through the rigorous
definition of relations among quantities (Mavrovouniotis et a! 1989). There are seven
possible primitive O[M] relationships. O[M] provides an exact interpretation of these
relationships and this can be used along with quantitative data to produce inferences.
This method has been applied to Michaelis-Menten kinetics, inhibition of enzymatic
reactions and identification of rate-limiting steps in biochemical pathways
(Mavrovouniotis et al 1989).
Another interesting application of "new" modelling techniques to biochemical systems
is that of neural networks. These are dynamic systems composed of highly
interconnected layers of simple neuron-like processing elements. A simple neural
network is shown in Figure 1.11. The weightings between the neurons are most
commonly calculated by back-propagation using a set of training data. This approach
could be used to model any part of a cell where we do not wish to go into the detail
required by a structured model. This approach has been called a "black-frame"
approach. It is illustrated on Figure 1.12 and has been described (without using neural
networks) by Schiosser and Bailey 1990.
This is a relatively new area for metabolic modelling and much work remains to be
done before it can be easily applied to general systems. The potential of these methods
seems great however and with rapid advancements in computer speed and storage
progress should be quick.
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1.2 Review of Control Theories
1.2.0 Introduction
The preceeding sections have so far described the different levels of modeffing
complexity that can be used when addressing a metabolic pathway engineering problem,
ranging from phenomenological, through unstructured stoichiometric and structured
pathway models, to highly structured metabolic models. The function of these models
is to predict or simulate the action of the system.
None of the approaches so far described attempts to quantify the extent to which
elements in a system regulate or control the system, or to pick out the most important
regulating elements. In an unstructured model all of the elements inside the system are
lumped together as a black box whereas in a highly structured model all of the parts of
the system are given equal importance. It is often important to be able to identify and
quantify the rate-controlling elements in a pathway and it is for this reason that theories
of metabolic control have been developed.
The discussion of some of the theories which have been developed to treat the
regulation of metabolic systems will begin with metabolic control theory. THis was
initially derived for specific cases and then developed for the general case. It presents
results which are more immediately applicable in the understanding and treatment of
experimental systems This will lead on to the discussion of biochemical systems theory
and flux-oriented theory which were initially developed from more fundamental
principles.
It will be illustrated that both approaches are complementary and that the appropriate
elements of each should be used for the required purposes. The relationship between
these theories and other modelling approaches is shown in Figure 1.1.
1.2.1 Metabolic Control Theory:
1.2.1.1 Initial Developments and Their Motivations
37
Metabolic control theory was established in the mid-seventies with the publication of
the papers by Kacser and Burns (1973) and Heinrich and Rapoport (1974). The theory
was established in response to the need to quantify the control exerted on a pathway by
the enzymes and/or effectors involved in the pathway reactions. It was intended to be
a means of combining the information available from the studies of individual enzymes
(Idnetics, inhibition characteristics, effectors and so on) with that known about the
metabolic pathways and their stoichiometry. To avoid the elaborate and non-linear
mathematical models usually required to deal with such systems an attempt was made
to define the system by parameters which would describe how control of the flux in the
pathway was distributed among the enzymes in the pathway.
The approach of Kacser and Burns was to define a range of parameters which they use
to describe the effect of perturbations in system variables such as the input, enzyme and
intermediate concentrations on the flux and metabolite concentrations. The terms which
they use for these parameters are the response coefficient, the controllability coefficient
and the sensitivity coefficient. A standard nomenclature was later established
(Westerhoff et a! 1984) in which these are referred to as flux and concentration control
coefficients and sensitivity coefficients (see Table 1.2).
Table 1.2: Standard nomenclature of metabolic control theory.
Final Terminology	 Earlier Literature
elasticity coefficient of enzyme	 elasticity coefficient of Eç
E1
 towards metabolite X	 effector strength of X
intrinsic sensitivity
sensitization
sensitivity amplification
amplification factor
flux control coefficient by enzyme E1	 sensitivity coefficient
on flux J	 control strength
parameter strength
control coefficient on flux J by
	
sensitivity
pathway substrate S
X-concentration control coefficient	 element of control matrix
by enzyme Ei	 substrate sensitivity
X3-concentration control coefficient 	 logarithmic gain
by pathway substrate S
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Having defined these parameters and discussed their significance Kacser and Burns then
go on to derive a theorem which relates the flux-control coefficients in a straight-line
path by considering the changes following a perturbation. By this method they derive
the flux control coefficient summation theorem i.e.
(16)
That is, if the regulatory effect of one enzyme on the flux increases then the effect of
the other enzymes decreases. This method of proof is useful in that it provides a
conceptual means of following what is happening in the system and gives a feeling for
the physical interpretation of the result. The disadvantage is that it applies only for very
simple linear pathways and additional theorems must be derived when dealing with
elements of complex systems such as branched pathways, conserved metabolites or
substrate cycles. (see Section 1.2.1.2 below)
Kacser and Burns (1973) also derive the relationship between the flux-control
coefficients and the elasticities as expressed by a connectivity theorem
II
Cj'. e	 0	 k = 1,...,m-1	 (17)
i-i
i.e. the flux control coefficients of highly responsive enzymes are low. We can visualise
this in the following way: a reduction in the activity of an enzyme will lead to an
increase in the concentration of its substrate and a decrease in the concentration of its
product. If the enzyme has a high elasticity towards either the substrate or the product
then the change in concentration will lead to an increase in the rate of the reaction
catalyzed by the enzyme that compensates almost entirely for the initial reduction in
rate. That is, a reduction in the activity of a highly responsive enzyme has only a little
effect on the steady-state flux, implying a low flux control coefficient. Summing this
effect over the whole pathway we obtain the above result.(Westerhoff et a! 1984)
Concentration control coefficient summation and connectivity theorems can be derived
in the same way (Heinrich and Rapoport 1974, Westerhoff et a! 1984)
39
Examining the concentration control coefficient summation theorem:
(18)
i.e the sum of the concentration control coefficients on a particular metabolite by the
different enzymes equals zero, as some enzymes act to decrease the concentration of
the metabolite while others increase it.
Similarly the concentration control coefficient connectivity theorem
I'Ec.	 = jk	 (19)i-i
is analogous to the flux control coefficient connectivity theorem if; ^ S. We can state
this theorem as follows: the less responsive enzymes are towards changes in the
concentrations of their own substrates and metabolites the more stringent is the control
they can exert on a particular metabolite (Westerhoff and Chen 1984).
An example of a simple three enzyme system which illustrates the above theorems is
given in Appendix C.2.
1.2.1.2 Extension to Complex Systems:
For simple systems there are some other relationships which can be established, for
example, between the elasticity coefficients, flux control coefficients and the flux ratios
(Westerhoff et al 1984, Heinrich and Rapoport 1974,1975). However, if we wish to
apply metabolic control theory to more complex systems including features such as
branched pathways, substrate cycles and conserved metabolites, we need to adapt it
slightly. What follows will describe some of the refinements which must be made to the
basic theory in order to include features of complex systems. It is by no means a
complete list nor does it make the theory applicable to the most general system. It does
give an indication of the flexibility of the theory and how it can be adapted given a
good understanding of metabolic control theory and metabolic systems. This
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requirement is one of the drawbacks of metabolic control theory and frequently makes
its implementation difficult for the first-time user.
n,l
x k,l
-
FluxJ	
.'luxJfaJ
xi
j+1,2	 Flux J= (1-a)J
n,2
Figure 1.13: System with branched pathways, showing division of fluxes.
For the case of a system with branched pathways as shown in Figure 1.13 an additional
theorem was derived by Fell and Sauro (1985, see also Small and Fell 1989) to relate
the flux control coefficients at the branch point. This additional equation was shown to
be
-aJ(E C + J (1 -a)(E CZ1) =	 (20)
h-j,n
An equivalent equation for the concentration control coefficients was later derived
(Westerhoff and Kell 1987)
-aJ (
	
+ J (1-a) ( E CE) = 0
	 (21)
kjjs	 k-In
Similarly an extra equation for systems with substrate cycles was derived so that
solutions for such systems can be obtained (Fell and Sauro 1985)
A slightly different approach must be adopted when dealing with systems containing
conserved metabolites. An example of this is in mitochondrial metabolism where the
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total of ATP, ADP and AMP is constant. In this case we must use an effective elasticity
(Fell and Sauro 1985)
Iff,4TP = (EArp - ADP 
[ATP])	 (22)
[ADP]
where 6.ATP is the elasticity towards ATP under conditions of conservation of ATP and
ADP. A combination of the above techniques can be used to deal with the problem of
systems involving cyclic pathways with conserved metabolites (Fell and Sauro 1985).
The connectivity and summation theorems in Eqn.s 16-19 will not hold unless the
assumptions of free enzymes and pooled metabolites are valid.
Metabolic control theory has been used to investigate enzyme-enzyme interactions (Kell
and Westerhoff 1990), homologous and heterologous sites (Welch and Keleti 1990),
channelled metabolites (Keleti and Ovadi 1988) and high enzyme concentrations (Fell
and Sauro 1990). It has also been generalized to conditions of no proportionality
between activity and concentration of enzymes (Melendez-Hevia et al 1990). Thus we
see one of the principal disadvantages of metabolic control theory as it was initially
established. Because it is not sufficiently general it must be adapted and tailored to
apply it to individual cases. The adaptations required may be only slight but maldng
them requires judgement and a degree of familiarity with the theory. This has a double
disadvantage: firstly it will discourage workers in fields ranging from biochemical
engineering to molecular biology who are not familiar with metabolic control theory
from using it and secondly it makes the writing of software packages utilizing the
approach more difficult both from the point of view of program structure and the use
of numerical methods.
This problem was alleviated with the extension of the theory to the general case and the
description of the system by matrix algebra.
1.2.1.3 Formalization and Development of a Matrix Algebra
In order to solve the difficulties stated above a two-pronged approach was adopted. The
first element of this was the generalization (and, necessarily, formalization) of metabolic
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control theory (Reder 1988)and the second was thedescriptio nof the system by matrix
algebra (Small and Fell 1989, Westerhoff et al 1984, Fell and Sauro 1985).
To generalize metabolic control theory it was necessary to take a "structural" approach.
This approach takes the stoichiometric reaction without any expression of the reaction
rate as the structure of the model (Reder 1988). Firstly a reaction matrix N similar to
that in Section 1.1.3.1.2 is set up. This simplifies the problem, using a notation already
established in the field.
Having set up this model system Reder uses decomposition of the matrix N to establish
a set of independent reactions denoted by the matrix N i.e.
N = LNR
(23)
where N is the m x r reaction matrix and NR is the m0 x r independent reaction matrix
(m is the number of species, r is the number of reactions and m 0 is the rank of N).
L is an m x m0 matrix of the form
10	 ..0
01	 0
L= ......
0.	 .	 .01
L
where L. is an (rn-rn0) x rn0 matrix
This model system and this matrix of independent reactions is then used to express the
ideas of metabolic control theory. A steady state flux function J and a set of rate
vectors V are defined and the relationship between a steady state control matrix F, a
steady state flux control matrix C and the system variables is established.
The above control matrices differ from those used by other authors in that the
coefficients are "simple" and not logarithmic derivatives. The reason given (Reder,
1988) is that the logarithmic steady state flux control matrix has fewer general structural
linear relationships between its rows and its columns (for example the summation and
connectivity relationships) than has the simple steady state flux control matrix.
The structural properties including summation and connectivity relationships of these
simple steady state control matrices are then outlined, using a rigorous mathematical
(24)
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method. The model differential system described below is similar to that in Equation
3 in Section 1.1.3.1.2 but not at steady state. The form of these relationships is detailed
in Appendix C.3.
This treatment is very useful in that it formalizes and makes general a theory which had
previously been accused of being set up in an ad hoc manner (Savageau et al 1986). By
stating specifically all assumptions made and using rigid proofs it further validates what
was earlier proven in a more intuitive manner. Unfortunately the terminology and
methods used are a little inaccessible to those without some background in mathematics.
Before it can be used by the average researcher in biotechnology or biochemistry some
"translation" is required. This translation could perhaps be in the form of a user-
friendly computer program which would convert an input system into the reaction
matrix and then deliver the control matrices. We should note that if this method is to
be used then some kind of normalization must be chosen in place of the logarithmic
normalization used by the other methods.
Even before the formalization of metabolic control theory (Reder 1988) it had been
shown that for ease of manipulation and obtaining numerical solutions a matrix
representation was required. This was first done to facilitate the expression of flux
control coefficients in terms of the elasticities (Fell and Sauro 1985) as will be
discussed in the following section. An extension to this theory allowed the calculation
of the concentration control coefficients in a similar manner (Sauro et al 1987) and
determined the response of the flux at the branch points in a pathway. Also in the same
paper, Sauro et al outlined a set of rules or heuristics for setting up the matrix notation
of metabolic control theory applied to a system.
Another work published independently at about the same time proposed a similar set
of matrix equations relating the flux and concentration control coefficients in branched
pathways to the elasticity coefficients (Westerhoff and Kell 1987)
More useful perhaps is a review of the validity of these matrix methods as applied to
complex pathway structures. (Small and Fell 1989). Here the structural approach to
metabolic control theory of Reder (1988) is retrospectively applied to the above matrix
expressions to test for their validity in complex and general cases. In this way, quite
complicated structures such as multiply branched pathways or branched structures with
reconvergence can be expressed in matrix notation.
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Because of these developments the criticism that metabolic control theory must be
developed in an ad hoc manner for different systems and revalidated for each one is
becoming less justified. The theory has now been proven generally and the time is now
fast approaching when it will be amenable to numerical representation and analysis
regardless of the complexity of the system under consideration.
Other approaches avoided these initial difficulties by using a power-law approximation
for metabolic rates. These were called biochemical systems theory and flux-oriented
theory and are discussed in Section 1.2.2.
1.2.1.5 Other Applications
The aim of this section on metabolic control theory is to show how the basic principles
can be extended and used to treat many different systems involving transient responses,
thermodynamic effects and microbial growth.
The techniques of metabolic pathway engineering have been used in the analysis of
transition times by Easterby (1990) and Melendez-Hevia (1990) among others. The aim
of these works is to analyze the establishment of a new steady state from a given steady
state and the systems response to perturbations while in such a steady state. To this end
a temporal control coefficient (Easterby 1990) or transition control coefficient
(Melendez-Hevia 1990) was defined:
- E 3t	 (25)
where r is the transition time for a steady state established from rest defined by
r =E[S)/J	 (26)
where [Si] is the concentration of metabolite j and J is the steady state flux to product.
Summation and connectivity relationships similar to those in Section 1.2.1.3 have been
proven so that the temporal control coefficient can be calculated from the elasticities of
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a system in the same way as for flux control coefficients (Tones et al, 1994).
The analysis of this transition behaviour is a departure from the other work in metabolic
control theory which studies systems at steady states. This kind of work could be very
useful in determining which are the parameters that contribute to the instability of a
system (Mizraji ci al 1988). For example it could be used to quantify relationships
which have previously been studied only qualitatively, such as that between the pulse
of NADH and the onset of oscillations in glycolysis (Riol-Cimas and Melendez-Hevia
1988, Goldbeter and Nicolis 1976).
Some interesting studies have used metabolic control theory to explain the way that
variations in enzyme activity segregate in a population (Keightly 1989). Kacser and
Burns (1981) have also used it to offer an explanation for the general recessivity of null
mutants in diploid organisms which goes as follows: since the flux control coefficient
of most enzymes is low, a decrease in their concentration tends to have little effect on
the pathway flux so that many rounds of mutations are normally required to produce
productive strains.
There has also been a great deal of interest shown in the ways that metabolic control
theory can be used to analyze the thermodynamics of metabolic systems. Since living
systems are not in equilibrium (the only means by which an organism can attain
equilibrium is through death, which is an interesting philosophical point) it is necessary
to use non-equilibrium thermodynamics, an area pioneered by Prigogine (1967) and
recently reviewed by Rutgers ci a! (1991).
Kell at a! (1989) have published a review of how microbial growth can be studied by
control analysis. In this they discuss the role which metabolic control theory can play
in modelling microbial growth and how it compares with other theories such as
biochemical systems theory and non-equilibrium thermodynamics.
We can see from the above how broad the range of applications of metabolic control
theory can be and with improvements in experimental and computational techniques,
this range will expand even further.
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1.2.2 Biochemical Systems and Flux-Oriented Theory
1.2.2.1 Derivation of the Power-Law Formalism
One of the earliest attempts to establish an underlying formalism which could be used
to describe metabolic systems was made by Savageau in 1969. [Savageau 1969a,b, 1970]
In these papers a power-law approximation technique is proposed as a description of the
dynamic equations governing biochemical systems. This approximation (or formalism,
as it is later referred to) was chosen because it seemed to retain the essential non-linear
features of such systems, while being amenable to mathematical analysis.
The power-law formalism is analogous to the linear formalism, being based on the first
two terms of the Taylor series, but in logarithmic space. We can write the Taylors
series for the rate of reaction u, about an operating point 0 as
Inu1(X1,..j,1) = nui(Xic,...,Xno)
ä[In u(X10,...X,,0)]
a[lnx,]	
(InX,-ln4)	 (27)
where X1 ,. . . ,X denote the variables that affect the process such as the concentrations
of reactants,enzymes or effectors. Regrouping terms, we can rewrite Eqn. 27 as
Inu1(X1,...,X,.) = Ina + g1nX1 + •.. + glnX,,	 (28)
such that the rate can be expressed as a product of power-law functions[Voit and
Savageau 1982a, Savageau et a! 1987a].
II
= a1fl fu	 (29)
i-i
where
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K
-g
= u10fl x,
i-i
= a(lnu)Ia(lnX) = (audax,xx,Ju,&
	
(31)
The expression in Eqn. 29 can be recognised as that normally used to describe chemical
kinetics where the g exponents are termed the kinetic orders and the a, coefficients the
rate constants. The values of these parameters can be obtained in two ways: either by
direct calculation if the rate laws and kinetic constants are known, or from flux data,
by plotting in log-log coordinates the reaction rate versus substrate (say) concentration
over a range of substrate concentrations close to the operating point. The slope gives
the value of g and the value of a can be obtained from the intercept with the y-
axis.[Voit and Savageau 1982b]
This mode of parameter calculation has the advantage that the power-law parameters
can be calculated from flux data rather than kinetic data although if such data is
available it can be used in conjunction with flux data to build a complete picture. It
should be remembered that it may not be possible to vary a single concentration inside
a cell independently, so that kinetic data may occasionally be essential.
The above formalism underlies most of the control theories proposed for simulating
biochemical systems and it is important to remember the principal assumption made in
deriving it i.e. that it is only exact for regions close to the operating point and the
approximation may not hold for conditions very far from the operating point. [Savageau
1973]
1.2.2.2 Different Levels of Aggregation
1.2.2.2.1 The S-System Variant Used in Biochemical Systems Theory
Having developed this formalism there are several ways in which it can be used to
model a biochemical system. The first of these is termed the generalized mass action
variant (GMA). This applies the above formalism at the level of individual enzyme
(30)
48
catalyzed reactions [Savageau 1969b]. This has been used by some workers but has not
been developed extensively and seems to have limited potential.
At one level up from this, methods differ primarily in the level and type of aggregation
of fluxes. The first of these which we will discuss is the S-system variant as applied to
the system or part of a system shown in Figure 1.14. This variant has been so named
for "its usefulness in simulating the synergistic and saturable properties of biological
processes" (Sorribas et al, 1989a). The essential feature of this variant is in the
aggregation of those fluxes which tend to increase a given substrate into one net rate
law and those which tend to decrease it into another. The power-law formalism
explicitly represents each of these net rate laws so that for each substrate (or pool of
substrates) X1 we can write the equation
dX/dt = a. 11 x - 134fl x7'	 i = 1,...,n.	 (32)
i-i	 i-i
There is one equation for each of the n dependent variables and the product is over
n+m where m is the number of independent variables.cw and 3 are the rate constants
for the net increase and net decrease of X respectively and g and h are the kinetic
orders for the net increase and decrease respectively of X with respect to variation in
xi.
Even within this variant there is more than one way of aggregating the fluxes in a
system. Using as an example the system shown in Figure 1.15 there are two principle
strategies which have been termed "reversible" and "irreversible" [Sorribas et al
1989b,c].
The reversible strategy involves aggregation of the fluxes with the same sense towards
a given metabolite (see Figure 1.15) while the irreversible strategy involves the
aggregation of the forward and reverse fluxes through each reaction. Both approaches
have been compared and contrasted and while all S-system representations of a given
biochemical system exhibit the same steady-state behaviour for the dependent
concentrations it has been shown that the reversible strategy is superior with respect to
accuracy in predicting steady-state flux and transient responses and in terms of
robustness [Sorribas et a! 1989c].
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Figure 1.14: Reference system involving enzyme-enzyme interaction
and channeling of metabolic flux [Sorribas et al 1989aJ.
(i) Reversible strategy:
X 1 % 	 xi+1
dX/dt = V, -
V1 = vf 1+ v
v_i =v11+v(
(ii) Irreversible strategy:
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1xi
dX1/dt=V1-V1
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v_I = V -
Figure 1.15: Reversible and irreversible strategies
1.2.1.2.2 A Matrix Representation of the S-System Variant.
Having decided on a particular mode of aggregation, in this case the reversible mode
we can examine the properties of the steady-state solutions. In steady-state the time
derivatives are equal to zero and we can write Eqn. 32 in matrix notation as
Ay = b
	 (33)
where
Yg = IflX1
b = 1n(P/a)	 (34)
=	 -
One of the reasons why this representation is so useful is that it can be immediately
determined if the system under consideration has a positive steady-state solution. The
condition for this is
	
rankk = n
	 (35)
which, if the system has no external variables can be expressed as
	
IAI^O	 (36)
We can seek an explicit solution of the form
	
= Ly + Mb
	 (37)
where y, and y are vectors whose elements are logarithms of the internal and external
variables and L and M are matrices obtained from the inversion of Eqn. 33.
From this solution we can obtain the fluxes in the system
	
lnV=lna+Gy
	 (38)
where V1 is the net rate of synthesis of X1, a, is the corresponding rate constants and
the matrix G is composed of the g kinetic orders.
This solution provides a direct answer to how the dependent variables and fluxes vary
with the independent variables but it is useful to calculate the sensitivities of the system
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S(X1,a1 =
S(X1,13J) =
to determine what the rate-controlling parameters are.
The elements of the mxn matrix L are defined as logarithmic gain factors [Soribas et
al 1989a]. These relate the fractional change in any dependent variable to the fractional
change in the independent variable responsible for the change i.e.
L 
=	 (39)
ain 1	 äy1
The elements of the nxn matrix M are the sensitivities of the dependent variables with
respect to the rate constants. That is, they relate the fractional change in a dependent
variable to the fractional change in one of the rate constants.
äInX, =
aInc 1	 a,,1	 (40)
alnx, =
a1n131	 a,,1
S(X,p) = -S(X,a) = M	 (41)
We can also define a sensitivity with respect to the kinetic orders i.e.
S(y1,g) =	 I
ag y
We can view S(y1,g) as a weighted average of the sensitivities of the individual Lb 's and
M ' s.
These parameters have also been referred to as control coefficients and an alternative
nomenclature has been established (see Table 1.2 [Westerhoff et al 1984]) so that
confusion can arise. The relationship between sensitivities and control coefficients can
be seen more clearly in Appendix C.5 where the derivation of the control theorems
described in Section 1.2.1.1 are derived from the power-law formalism.
This approach has been applied to a system involving enzyme-enzyme interactions but
(42)
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only to the extent that it compares results derived from BST with those derived from
Michaelis-Menten rate laws and two other control theories, metabolic control theory and
flux-oriented theory which will be discussed below.
1.2.2.3 Flux-Oriented Theory:
The approach taken by Crabtree and Newsholme differs from that outlined above in its
emphasis on the fluxes in the system rather than the intermediate metabolites. For that
reason it has been named "Flux-Oriented Theory". The reason for concentrating on this
aspect of a biochemical system seems to stem from the authors desire to improve our
conceptual understanding of how the fluxes and metabolite levels in a system affect each
other and change over a given time-period.
This theory was developed independently from the work done by Savageau et al but
uses the same explicit form of the power-law formalism (called the law of mass action).
In the paper in which the bulk of their theory is introduced [Crabtree and Newsholme
1985], the concepts of flux-generating steps i.e. reactions which generate the steady-
state flux and flux-transmitting steps, which are the intermediate reactions normally
treated as being close to equilibrium. They defme a regulatory step as one which
communicates with all of the reactions of a pathway and discuss how such regulatory
steps are rate-limiting in systems such as the control of postabsorbtive blood glucose
levels.
In order to analyze quantitatively such systems they use the response of a given system
variable to a given regulator, a quantity which they term the sensitivity s, i.e. the
sensitivity of the response Y to the stimulus X is
x(dY/Y)_dInY	 (4(dX/X) dlnX
Integrating we find
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Y = k(X)'	 (44)
which is a power equation of the kind used in BST by Savageau et al. We should note
here that the sensitivities defined in Eqn. 43 used in FOT by Crabtree are not the same
as those defined in Eqn.s 39 - 42 used in BST by Savageau. They differ in that they are
total differentials as opposed to partial differentials and are in fact similar to the kinetic
orders g in Eqn. 31. This means that they are global parameters instead of local
parameters and that they include the effect of all of the variables in the system rather
than just one. We can see this if we write out the full expression for the total
differential of Y with respect to X 1 when there are X 1 ,... ,X. variables in the system.
dlnY = aInX1 aIn' + aIflX2 lnY +
	
+ 8IflX aiy
	 (45)
dlnX1	ölnX1 alnX1	älnX1 älnX2	 alnx1 alnx
These s, values are called intrinsic sensitivities and can be combined using a product
rule for series reactions or an addition rule for parallel reactions to constitute a net
sensitivity to describe all or part of a system.
Using this method, Crabtree et a! have analyzed the effect of substrate cycling, of
systems close to equilibrium and of conserved pools. in this type of analysis the
principal aim is to determine how the fluxes affect the sensitivities and vice-versa rather
than the steady-state levels of each of the intermediates.
1.2.2.3.1 Treatment of a Substrate Cycle Using Flux-Oriented Theory
An example of this approach can be seen in the treatment of the sensitivity conferred
by a substrate cycle. In this system the intrinsic sensitivity for effects of the forward
reaction in the cycle is (1 +C/J) where C is the rate of cycling and J is the net flux
across the cycle [Crabtree and Newsholme 1985].
FOT can be used to determine the conditions under which cycling will increase the
sensitivity of the flux J to the regulator X. It can be shown that cycling will increase
the sensitivity of the flux J to the regulator X only if the sensitivity of the reaction
catalyzed by E3 to P is greater than the sensitivity of the reverse cycle to P, that is, if
P has a greater effect on the forward reaction than the backward reaction to S. A proof
for this is given in Appendix C.2.
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1.2.2.3.2 Developments and a Matrix Algebra:
This method was later elaborated upon [Crabtree and Newsholme 1988] in order to
relate it more closely to the control coefficients used in metabolic control theory. This
work displayed a shift in emphasis away from the intrinsic sensitivities and towards the
net sensitivities, the s''s. (These are in fact the control coefficients discussed in Section
1.2.1 which have been studied in depth by Westerhoff et a! among many others.) In this
work the slightly unusual notation of X1 is used (to signify an infmitesimal relative
change in X) and this makes it rather difficult to make direct comparisons with other
approaches i.e.
r	 (46)
X = dX/X = d(LnX)
so that for the case of substrate cycling we could write
r	 T	 T	 T	 (47)
- a1 S1 - b1 P = c1X1
Usually we would have more than one of these equations so that it becomes more
convenient to arrange them into a matrix form in order to solve them.
T	 T	 r	 7	 (48)
J = aS + bP + cX
J
1 -a -b s
	
cX
= .	 (49)
P
and so on.
Crabtree and Newsholme (1988) have also showed how this method may be used for
more complex branched systems.
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1.2.2.4 Comparison of Biochemical Systems Theory and Flux-Oriented Theory:
The treatment of the above system as compared to the BST method gives an indication
of how one can concentrate on different elements of a system and provide different
insights into it even though the underlying formalism is the same.
Sorribas et al have studied this in their comparison of flux-oriented theory and
biochemical systems theory although they may have gone too far in their attempts to
tailor other theories to the objectives and methods of biochemical systems theory.
However they outline some important points at which FOT and BST separate.
The first of these differences is only one of notation but is important both in terms of
a conceptual view of the system and its numerical analysis. BST denotes all of its
dependent variables by X, i =1,... ,n and its independent variables by
X1,i=n+1,...,n+m whereas FOT differentiates in its nomenclature between substrates,
intermediates, products and enzymes. Both of these notational systems have their
advantages and disadvantages. From the point of view of the numerical analysis of a
large system the notation used by BST is preferable since in large systems the products
of one pathway may be the intermediates, substrates and/or effectors of other pathways
and it could be difficult to make the distinctions made by FOT. However the notation
in BST is difficult to work with conceptually and it becomes difficult to see how the
physical system behaves according to the mathematics.
The second difference is in the aggregation of fluxes. BST strictly aggregates all of
those fluxes which go to increase the concentration of a variable into one power-law
rate and those which go to decrease the concentration of that variable into another
power-law rate. FOT on the other hand stays closer to the traditional biochemical
notation of treating each enzyme-catalyzed reaction as an individual rate. The
advantages and disadvantages of this approach are similar to those above in that the
BST is numerically more convenient but conceptually more difficult. One must be
careful not to abandon conceptual mechanisms for the sake of numerical ease. It must
be remembered that the aim of modelling a system is not merely to provide a simulation
against which to match experimental data but also to provide us with a framework for
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the conceptualization of 'very complex systems.
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1.2.3 Implicit Use of the Power-Law Formalism
1.2.3.1 Sensitivity-Based Approaches
Because many workers have been more concerned with predicting the variables whose
change will have the greatest effect on a system they have dealt more with the
sensitivities of the system rather than the actual values of the variables. As a result their
use of a power-law formalism is not obvious although the results achieved are the same
as those derived using techniques from biochemical systems theory. This can make it
difficult to make direct comparisons between different theories and several authors have
attempted to clarify these links.
Each has used the technique of writing down the conservation equations and then
differentiating with respect to a given parameter. In the work of Cascante et al
(1989a,b) the conservation equations are in the form
=f(S,cc,t)	 (50)
dX1
I = - = v = g1(S,cc,t)	 (51)
dt
Differentiating with respect to a parameter we obtain
(52)
dtôcg1 	 ôSôa1	 8a
and in steady state this implies
= 6f 1 ôf	 (53)
The authors claim that this contains the same information as Eqn. 33 above which was
derived from biochemical systems theory but this is true only if we take & to indicate
the partial differential (a less ambiguous notation would be &)
Sorribas et al adopt the same approach applied to a specific system involving enzyme-
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enzyme interactions. In their work they write down the steady-state equations before
differentiating them (see Eqn.s 43 - 47) in Sorribas et a!, 1989a and Figure 1.16) so
that for the two equations describing the conservation of the interacting enzymes X9 and
X0 and their product X3
x9=x7—x3	 (54)
xo=x8—x3	 (55)
we have, after taldng the derivative of the log of the expression
=(__	 (56)
8 X6 X9	 6 X3 X9 6 X6 X3
(57)
6 X6 X0	 6 X3 X0) 6 X6 X3
which (using the notation from Eqn. 39) can be written as
L96 
= 19.3 '3.6
	 (58)
L06 = f L36	 (59)
Each of the steady-state equations can be differentiated in the same way to give the
same results as those obtained from biochemical systems theory (see [Sorribas et al
1989b] for details).
1.2.2.2 Development of a Matrix Algebra:
Whereas Sorribas et al (1989a,b,c) consider just one specific case, Cascante et a!
(1989a,b) develop a matrix algebra both for a general unbranched system and for
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complex systems such as those involving conserved cycles and branched chains. They
consider an unbranched pathway which consists of n-i internal metabolites S 1, h external
effectors and n enzymes. In steady state each of the local velocities v are equal to the
flux I through the system so that for each Vk we can write the control coefficient for one
enzyme E as
j_
I	 ÔEJVJ
851
(60)
=	 _
8vk	
:	 +
IVkAÔS1	 8S*1 	(¼8I) (Vk
(Note that here ô obviously indicates the partial differential). If we define a sensitivity
coefficient as
El= ____
6S/S
we can write Eqn. 60 as
(c
c , =	 + (4)	 (62)
In this literature the sensitivity coefficients above have also been called "elasticity
coefficients" because they describe the elasticity of the system to changes. If a change
in Si causes little or no change in v then the response is inelastic whereas if a large
change in v occurs then the response is elastic.
Extending this to the set of enzymes j =1,.. ,n
(61)
60
1A =.
1
1
	
ES1	
•
	
II	 I;
(66)
c'
= 1k	 k
	
:	 + (E4 ,..., E4)
c1
	
c
(63)
Rearranging
CE
c::
(1 -E,...,-E
c1
c
_iEk	 Ek
-	 Es,..., E
'-'si,-1
(64)
and extending this to the n velocities (k=1,. ..,n) we obtain the equation
AXB=C	 (65)
where A, B and C are three nxn matrices as follows
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C1
(67)
El
ER
(68)
(69)
(70)
(71)
(72)
c::...
B=
El
c =
ER
LE
If the rate equations are homogenous with respect to the system enzyme concentrations
(that is , if the rate laws are proportional to the enzyme concentrations and are
independent of each other) then
Ii fk=iI
= 1 0 fk^iJ
-	 c=I
I=AxB
B = A1
Using this matrix notation the connectivity and summation theorems proven for linear
systems in 1.2.1.1 can be shown to hold for general systems (see Appendix C.5 for
proofs).
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1.2.4 Determination of Control Coefficients and Elasticities
A crucial criterion of the usefulness of metabolic control theory and its applicability to
real systems is the ease with which the required parameters i.e. the elasticities and the
control coefficients can be obtained. These should be available without having to resort
to extensive kinetic or genetic studies of the whole system as this would defeat one of
the purposes of metabolic control theory, that is, to direct a cloning procedure so that
the flux can be maximized with the minimum number of genetic alterations.
It is the control coefficients which provide the most useful information. They are
parameters of the system, rather than of an individual enzyme taldng into account the
total change in the variable concerned allowing for effects in changes through all the
other variables.
This differentiation between the control coefficients as system properties and the
elasticities as local properties distinguishes metabolic control theory from biochemical
systems theory and also from other sensitivity-based approaches (Kohn et al 1979, Kohn
and Chiang 1982). It has been emphasized by some authors (Kell and Westerhoff 1986)
but has been ignored by others. Indeed the notation used to indicate the control
coefficients fluctuates between the total differential d, the infinitesimal change ô and the
partial differential 0. If a coherent literature on metabolic control theory is to be
established it will be necessary to standardise these definitions.
Since the control coefficients provide the information on the distribution of control in
a system we shall examine various methods of determining them. Indeed we shall see
that a principal use of the elasticities is as a means of calculating the control
coefficients. The most common ways of determining the control coefficients are by
direct calculation, by the use of specific inhibitors, by genetic means or via the
elasticities.
1.2.4.1 Direct Calculation:
Many of the early studies identified rate-controlling enzymes by the criterion of the
deviation of the mass action ratio from the equilibrium constant (Heinrich et al 1977).
It was taken as a general rule that enzymes which catalyze reactions far from
equilibrium regulate the concentrations of the metabolites. It was shown however that
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the deviation of the mass action ratio (I') from the equilibrium constant (K m) is
independent of the flux, being a function only of the kinetic parameters of the enzymes
concerned and not of the kinetic parameters of any of the preceding enzymes (Heinrich
and Rapoport 1974). Because of this, this criterion cannot be used to determine the
enzyme(s) which regulate the flux through a pathway, but the ratio r/Icq has frequently
been used in the expressions for control coefficients, which are derived by direct
differentiation.
Table 1.3:
Rate Law
Competitive inhibition:
S/Km
V = Vr 1+S/Km4I/Ki
Expression for effector strength
I/K1
1 +S/K +1/K1
Non-competitive inhibition:
S/Km
V = V	 (1+1/K1) (14S/Km)
I/K1
1+1/K1
Allosteric inhibition:
S/Km
V=
 Vw.ax (1+S/Km) (1L(1+I/KI))
(1+S/Km) '
(nI/K1) L (1+I/K1)
(14S/Km)'
(1+1/K1) (1L(1+I/Ki))
(1+S/Km)
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Heinrich et al (1977) present expressions for the elasticities (or,in the terminology then
used, effector strengths - see Table 1.2) for competitive, non-competitive and allosteric
inhibition and give expressions for the control coefficients of a linear enzymatic chain
in terms of the relaxation times and the equilibrium constants of the enzymes. (These
are presented in Appendix C.6.) For a similar pathway, S0 ' S 1 S2, Green et al
(1984) give the ratio of the control coefficients in terms of the combined mass action
ratio r ( = S2/S0 ) and the combined equilibrium constant K (see Appendix C). Derr
(1986) presents similar results including the effect of an inhibitor for a similar set of
systems.
All of the above results were derived by direct differentiation of the kinetic rate
expressions. For more than three steps in a pathway the use of such analytical solutions
for the control coefficients becomes difficult. Because of this we must resort to one of
the other methods described below.
1.2.4.2 Use of Specific Inhibitors:
This can be regarded as a removal of enzyme from the system. Enzyme-specific
inhibitors have frequently been used to determine rate-controlling enzymes on the basis
that if, on titrating with the inhibitor, a hyperbolic curve was obtained then the enzyme
was rate-controlling whereas if a sigmoidal curve was obtained then it was not. This
criterion can be misleading however and is not quantitative (Groen et al 1984).
Given an inhibition curve as in Figure 1.16, we can use the expressions in Appendix
C.6 to calculate the control coefficients for different types of inhibitors. We can thus
see why the shape of the inhibition curve alone is not sufficient to provide even
qualitative information on the control exerted by the enzyme since the concentration and
nature of the inhibitor must also be taken into account.
This last point was demonstrated by Green et a! (1984) in examining the control
properties of the adenine nucleotide translocator with respect to oxidative
phosphorylation. Because these had been debated in the literature Green took the
approach of estimating the control strength of the adenine nucleotide translocator at
different rates of oxidative phosphorylation. By titrating rat-liver mitochondria with the
inhibitor carboxytractyloside and isolated rat-liver cells with atractyloside they
calculated a minimal control strength of 0.34 for the adenine nucleotide translocator.
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Figure 1.16: Estimation of flux control coefficient of an enzyme by titration with a
specific inhibitor. The slope of the line given by yields the term
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which is used in the expressions in App.C.6 to calculate the control coefficients.
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Figure 1.17: The effect of changes in the tryotophan dioxygenase activity on the
elasticity coefficient € and the flux control coefficients CT. This shows a non-linear
relationship between the control coefficients and tryptophan 2,3-dioxygenase for
tryptophan metabo1i flux.
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In this study the rate of transport of the inhibitor across the membrane was taken into
consideration as well as the competitive nature of the inhibitor. A similar study of
gluconeogenesis was undertaken, by inhibiting phosphoenolpyruvate carboxylase with
3-mercaptopicolinate. In this case a control strength of only 0.08 was calculated,
indicating that the PEP carboxylase exerts minimal control on gluconeogenesis. This
result contradicted the conclusions of Rognstad (1979) and Ackerboom (1979) who had
used the hyperbolic shape of the inhibition curve as a criterion for control.
The use of inhibitors has its restrictions however. Specific and non-competitive
inhibitors are not very abundant although the approach of applying monoclonal
antibodies against individual enzymes in permeabiized cells could be used (Kell and
Westerhoff 1986). In the use of competitive, non-competitive or mixed-type inhibitors,
knowledge of the kinetics and of metabolite concentrations is usually required (as for
the adenine nucleotide translocator (Groen et a! 1984)). In the case of all but
irreversible inhibitors we must know the distribution of the inhibitor across any
membranes in the system. In the case of irreversible inhibitors, any significant binding
of the inhibitor to other proteins will lead to an underestimation of the control strength.
Where these restrictions do not apply enzyme-specific inhibitors can provide a
convenient method for determination of the control coefficients of a pathway.
1.2.4.3 Addition of Enzyme:
Another method of calculating the control coefficients is by monitoring the change in
flux following an increase in enzyme activity or concentration. As with enzyme-specific
inhibitors this method cannot be applied to all systems (for example, in the case of
membrane-bound enzymes) but when it is applicable it works very effectively.
One of the earliest examples of the calculation of control coefficients by the increase
of enzyme activity is the study of bacteriorhodopsin liposome by Westerhoff and Arents
(1984). Using an illumination range where the catalytic activity of the bacteriorhodopsin
was proportional to the light intensity, they increased the activity of the
bacteriorhodopsin by varying the light intensity. They also varied the charge-
compensating ion movement by titration with valinomycin and increased proton leakage
by adding an uncoupler chiorprimazine. The control coefficients thus found were: 0.9
67
for the bacteriorhodopsin, 1.0 for the charge-compensating ion movement and -1.1 for
the proton leakage reaction, the sum of the control coefficients was therefore 0.8 which
is a reasonable verification of the flux control coefficient summation theorem (see
Section 1.2.1).
Saltar et al (1986) studied the effect of changes in tryptophan dioxygenase activity on
the magnitude of the external elasticity coefficient and the flux control coefficients
during tryptophan flux in hepatocytes, the results of which are shown in Figure 1.17.
We see that as the magnitude of the flux control coefficient for tryptophan dioxygenase
decreases with increasing dioxygenase so the magnitude of the tryptophan transport
coefficient increases, so that the sum of the two is approximately 1.0 over the range of
activity shown. This indicates that the other enzymes of the tryptophan catabolic
pathway contribute little to the control of flux over this activity range (Kacser and
Porteous 1987).
A similar test of the summation was reported by Rapoport et al (1976). Here an equal
concentration of purified enzyme was added to ultrasonicated erythrocyte hemolysate
in which the ATP level and glycolytic flux had been constant for one hour and the flux
control coefficients were as follows: pyruvate kinase 0.0, glyceraldehyde phosphate
dehydrogenase -0.08, phosphofructokinase 0.42 and hexokinase 0.33, adding up to
0.67.
It is interesting to compare these results with those from a study by Torres er al (1986)
of the same system in vitro. This study was carried out using rat liver extract which
converts glucose into glycerol-3-phosphate. The enzymes fructose biphosphate aldolase,
triosephosphate isomerase and glyceraldehyde-3-phosphate dehydrogenase were added
to the mixture so that all of the control rested in the first three enzymes of the pathway:
hexokinase, glucose-6-phosphate isomerase and phosphofructokinase. The results are
given in Table 1.4 with the corresponding figures from Rapoport et al (1984) for
comparison.
The difference in the above results should alert us to one of the major drawbacks in
attempting to establish control coefficients by this method, that is, that we cannot be
sure how close our experimental conditions are to that of the in vivo system. If the
conditions are too different then we may obtain misleading results, as above. It is
important to match experimental conditions such as enzyme activity, metabolite
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concentration and redox charge as closely as possible to those known to exist in vivo.
Table 1.4: Comparison of glycolysis flux control coefficients from two different studies.
Enzyme	 CJE (Tones et al) CJE (Rapoport et al)
Hexoidnase	 0.77 +1- 0.025
	
0.69-0.73
glucose-6-phosphate isomerase	 0.0	 0.0
Phosphofructokinase	 0.24 +1- 0.01
	
0.3 1-0.27
Fructose 1,6-biphosphate aldolase 0.0
Triose phosphate isomerase 	 0.0
Glycerol-3-phosphate 	 0.0
dehydrogenase
1.2.4.4 Genetic Methods:
The problems listed above can be avoided if there exists a means of varying the enzyme
concentration from inside the cell. This is the ideal way of establishing the control
distribution since the same intracellular and extracellular conditions can be used for
analysis as will be used in larger fermentations.
The obvious means of achieving this is by using an adjustable expression vector, for
example one containing the tac promoter which can be switched on to varying degrees
by different levels of IPTG. An example of this has been given by Walsh and Koshland
(1985) who put citrate synthase under the control of such a promoter in order to study
the extent to which it controls the overall rate of carbon flow through the Krebs cycle.
The conclusion that they arrived at was that citrate synthase has little controlling effect
during growth on glucose but during growth on acetate almost all the control rests with
it i.e. its flux control coefficient is almost 1.0.
An earlier study by Flint et a! (1980,1981) used this approach by creating
heterokaryons of Neurospora crassa expressing different amounts of the enzyme of
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interest.
There are several pitfalls to be encountered in this method of determining control
coefficients. Pleiotropic effects must be avoided and the control should be a null allele
of the enzyme of interest. This requires that the genetics of the system must be well-
established before this approach can be used, but as more and more knowledge is being
obtained about a wide range of systems so should the popularity and applicability of this
method increase.
1.2.4.5 Via Elasticities:
As stated above, elasticities are local properties, measuring the degree to which an
effector changes the rate of an enzyme while all of the other variables are held constant.
Because of this it is possible to measure the elasticities experimentally by incubating the
enzyme in conditions as close as possible to those existing in vivo (in terms of
concentrations of metabolites, pH and temperature) and then measuring the change in
rate upon addition of a small amount of the effector (Kell and Westerhoff 1986). While
this does not always ensure that the elasticity obtained will be the same as that in vivo
(because of the possible absence of allosteric effects in vitro, for example) it has been
used successfully in the past (Torres et a! 1986).
If the rate expression for the enzyme is known, then the elasticity can be calculated by
differentiation of this expression with respect to the effector considered. This yields
expressions such as those in Appendix C.6 (Heinrich et a! 1977) and these expressions
can be used to make rough estimates, even if the enzyme properties are only roughly
known. A study of the flux control coefficient varies following different rate equations
has been presented by Canela et a! (1989).
We can use the elasticities thus obtained to yield values for the control coefficients by
means of the relationships established in the control theorems (Eqn.s 57 - 60). Groen
et a! (1984) have demonstrated this for a simple two-enzyme pathway of the type
E1E2
so "Si - S2
where the relationship has proved to be
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_____ 1Cl = ______
1 - v16/ V26	 (73)
__ 1C2 - _______ __________
1 - 2E31/ ViE;	 (74)
It is more useful to consider the general case however and since algebraic manipulations
of this kind would be tedious we must use matrix methods.
These methods, previously mentioned in Section 1.2.1.3, have been established for both
simple (Fell and Sauro 1985) and complex pathways (Sauro et al 1987, Westerhoff and
Kell 1987, Derr 1986, Fell and Sauro 1985).
The limitations of this method of determining control coefficients, as with the previous
forms of matrix representation, are in its lack of generality. To combat this several
alternatives to the basic metabolic control theory as established by Kacser and Burns
(1973) and Heinrich and Rapoport (1974) have been proposed. We have already
mentioned the formalization of the theory by Reder (1986). An equally rigorous method
for calculating flux and concentration control coefficients has been derived by Giersch
(1988a,b,c) by applying the theorem on implicit functions to the equations defining the
steady-state metabolite concentrations (a stoichiometric matrix of the kind described in
Section 1.1.3.1). The parallels between this work and that of Reder are obvious.
A different approach based on a non-algebraic diagrammatic method has been proposed
by Hofmeyr (1989). In this work "control patterns" showing how a small change in an
enzyme activity affects a flux or metabolic pool are drawn directly on the diagram of
the metabolic pathway according to certain rules. This method is similar to the King-
Altmann method used in enzyme kinetics (Lam 1981). As proposed by Hofmeyr, this
method can be used to calculate the control coefficients of systems containing any
combination of linear chains, branched pathways, metabolic loops and conserved cycles.
It is necessary to work around such features as enzyme-enzyme interactions or
channelled pathways, for example by lumping them into one "conversion unit".
A similar topological approach in which the control structure of the pathway is
represented by a weighted, directed graph and the control coefficients evaluated in a
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heuristic manner from the elasticities is presented by Sen (1990).
These methods have the advantage that they can yield a deeper understanding of the
interaction between the local and systemic control properties of metabolic pathways but
they are labour intensive and not easily amenable to computer simulation.
It is not always necessary to determine the control coefficients and elasticities for each
enzyme in the pathway. Often, topological "functional groups" can be identified and
lumped together. This kind of "top-down" approach has been adopted by Brown et a!
(1990). In this work, pathways are conceptually divided in two about an intermediate
metabolite and the overall coefficients of the two parts are derived from the overall
elasticities of the two parts of the pathway. This approach can be of great help in
making the analysis of large systems tractable.
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1.3 Conclusions
Reviewing the range of literature on metabolic pathway engineering and the applicable
modelling techniques, there are several conclusions which can be drawn.
With all systems some sort of model is proposed. It may be purely phenomenological
with no mathematical content as in the case of the engineering of the phenylalanine
pathway where the knowledge of the mechanisms of regulation of the system was
sufficient to enable engineering of the pathway for maximum phenylalanine production.
For example, knowing that it is a tryptophan residue of CMPD which is essential in its
feedback repression by phenylalanine enables the removal of this repression by deletion
or substitution of the tryptophan residue.
Details of such mechanisms are essential for pathway engineering - we must know
where repression occurs before we can remove it - and with a full knowledge of the
regulation of a system it may be unnecessary to formulate any other model. Not all
systems are so well-documented however and the type of model which can be useful
depends on how much data is available on a system as well as on what information we
wish to obtain.
The black box system of balancing inputs and outputs over the cell requires only a
knowledge of the conservation equations and the elemental composition of the cell. A
fermentation equation can then be derived from which can be predicted product yields
and also outputs that cannot be directly measured (Papoutsakis 1984, Papoutsakis and
Meyer 1985).
If stoichiometric data on the metabolic pathways of the cell is available then we can
calculate the fluxes inside the cell and this information can be used in several ways. For
example the stoichiometric information on the Candida lypolytica system was used to
determine which of three metabolic models was the correct one (Aiba and Matsuoka
1979). Flux analysis can also be used to examine carbon flux inside the cell and flux
to waste products as well as identifying the junctions at which this flux is controlled
(Holms 1986, El-Mansi and Holms 1989).
To quantify the control of flux in a pathway as well as identifying the points at which
it occurs, several approaches have been developed. All are based on the concept of
sensitivity analysis but they differ in details such as the generality of application,
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notational convention, the lumping of the reactions and concentrations in the system and
determination of the parameters of the system.
How generally applicable a particular theory is depends on its mathematical rigour. The
first metabolic control theories were developed on an almost ad hoc basis and applied
to linear systems only whereas more recent theories have been formally developed and
apply to totally general systems.
Those theories which are most mathematically rigourous (Reder 1988) tend to be least
used in application but this may have more to do with their comparatively recent
development rather than any practical difficulties. One advantage of considering simple
systems is that the metabolic control theorems which can be derived can be explained
in physical terms which give an insight into the distribution of control over flux and
concentration in a metabolic system.
Another way in which theories differ is in the type of aggregation used. It has been
shown (Voit and Savageau 1987) that aggregation into composite rate laws for net
increase or net decrease of each system constituent almost always improves the accuracy
of the model. This type of aggregation, however, leads to results on the levels of the
metabolite pools rather than individual reaction rates, which may be of more interest
to the biochemist.
In determining the parameters of the system, either kinetic or fermentation data can be
used in most approaches. If there is full kinetic data on the system (for example as part
of a highly structured model) then control theories can be used along with the
simulation to predict the distribution of control throughout the system but there may be
discrepancies between the results obtained from the in vitro data and the in vivo system.
If fermentation data is used then the control parameters calculated are those pertaining
to the in vivo system under those conditions. This suggests that while kinetic data for
individual enzymes may be used to provide initial predictions, it is necessary to use
fermentation data to validate these predictions.
The modelling approaches which will be used in this pathway engineering study are
highlighted in Figure 1.1 and are detailed in the following chapter and in Chapter 5.
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1.3.1 Choice of Test System, the TOL meta-Cleavage Pathway
The TOL meta-cleavage pathway shown in Figure 1.18 was chosen as a test system for
several reasons. Firstly, it is of industrial significance owing to its bioremediation
capabilities for degrading a range of aromatics and also for its uses in
biotransformations for the production of chiral intermediates. Because of these
properties, the molecular biology and biochemistry has been extensively studied. What
follows is a review of some of the main features of the TOL pathway with respect to
its relationship to homologous aromatic degradation pathways, its genetics, the pathway
biochemistry, its regulation and how the pathway has been engineered for improved
performance.
The TOL system used in this study is the meta-cleavage pathway for the degradation
of benzoate to pyruvate and acetaldehyde. It is encoded on the TOL plasmid pWWO
which is native to Pseudomonas putida. This series of enzymic reactions is one of a
family of aromatic degradation systems and degrades substituted benzoates to Krebs
cycle intermediates. These aromatic degradation systems are a crucial step in the entry
of organic compounds into the carbon cycle. There is an extremely large number of
organic molecules which have been created by geological processes and microorganisms
have developed a wide range of catabolic pathways in order to use these compounds
as growth substrates (Harayama and Timmis, 1989). This is in contrast to the number
of organic compounds resulting from biosynthetic pathways, which is relatively limited
and so requires only a small number of catabolic pathways for degradation. One
essential feature of aromatic degradation pathways is the channelling of structurally
different compounds into a small number of catabolic pathways via a central
intermediate.
The aromatic ring is very stable and the strategy used by most microorganisms for
opening it is by addition of two hydroxyl groups. Once the ring has been doubly
hydroxylated it can then be opened by either meta- or ortho-cleavage.
There are five central intermediates: catechol, protocatechuate, homeprotocatachuate,
gentisate and homegentisate. The enzyme involved is either a mono- or dioxygenase
depending on presence of initial hydroxyl groups. Dioxygenases have a common
structure which is that of 4 subunits catalysing reactions. Dehydroxylation occurs
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followed by formation of cis-diols. There are two types of fission and two principle
catabolic routes. While there is a common strategy among microorganisms for the
degradation of aromatic compounds, two means of keeping distinct pathways for
different substrates exist: tight substrate specificity and specificity of enzyme induction.
Structurally diverse compounds are channelled into a limited number of pathways,
yielding a limited number of ring-cleavage substrates which are generally ortho- or
para-dihydroxy intermediates. This destabilizes the chemically stable resonant structure
of the aromatic ring and enables its subsequent opening. There are two types of fission:
ortho- and meta-fission. Both dioxygenases are multimeric proteins, the meta- contains
non-haem ferrous irons as prosthetic groups whereas the ortho- contains non-haem
ferric irons. After ring-cleavage there are two principle catabolic groups towards the
Krebs cycle: ortho-cleavage (or 3-ketoadipate) which degrades unsubstituted and
haloaromatic compounds to succinate and acetyl CoA and meta-cleavage which degrades
alkylaromatics to pyruvate and acetaldehyde.
The pathways are often encoded on conjugative plasmids but some are chromosomal
(e.g. the -ketoadipate). If the TOL plasmid is carried by P.putida then the -
ketoadipate pathway is not induced (the 13-ketoadipate pathway is induced by cis,cis-
muconate, formed by ortho-cleavage of catechol which does not occur).
Catabolic genes are clustered and organised into operons. The order within the operon
is identical for isofunctional enzymes and there is strong homology between pathways.
However the relative orientation of the two operons and the size of the intervening
DNA between the operons vary.
Regulation of TOL and NAH pathways is through modulation of rates of transcription.
Substrates of the pathway are inducers of transcription action in conjunction with two
regulatory proteins encoded by xylR (upper pathway) and xylS (lower pathway). XyIR
requires a sigma factor encoded by ntrA and two other factors involved in transcription
of nitrogen-regulated promoters can substitute for xylR and stimulate transcription from
Pu.
To date, three methods have been used to design microorganisms for increased substrate
specificity. These are chemostat selection, in vivo genetic transfers (i.e. transfer of
DNA via natural genetic processes such as transformation and especially conjugation,
for example, natural mutation isolated a TOL xylSxylE mutant able to grow on 4-
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ethylbenzoate) and in vitro genetics e.g. creation of a strain capable of degrading
mixtures of 3-chlorobenzoate/4-methylbenzoate and 4-chlorobenzoate/4-methlybenzoate
by cloning xy1IXYZL and an Alcaligenes isomerase [Harayama and Timmis, 1989].
1.3.1.1 Historical and evolutionary
In the early 1950s a Pseudomonas strain which could degrade aromatic compounds was
isolated (Hosowalca, 1952). It was designated Pseudomonas putida (arvilla) mt-2. The
carbon source used for its selection was m-toluate and benzoate was also reported as
a carbon source.
Evidence that the capability for aromatic degradation could be plasmid-encoded was
reported independently by three sources in the early 1970s (Nakazawa and Yokota,
1973; Williams and Murray, 1974; Wong and Dunn, 1974) on the basis of a high
frequency of conjugal transfer of the ability to utilize specific aromatic compounds and
the high frequency of loss of that ability. The plasmid was shown to enable the host to
grow on 20 substrates (Table 1.6) and was named pWWO (Worsey et al, 1978). Other
plasmids with the same degradation capability have since been discovered, such as
pDK1 and pWW53, and all are known as TOL plasmids. However it is the TOL
pWWO which is the most studied and which is the source for the meta-pathway used
in this study. Initial substrate specificity work an Pseudomonas arvilla mt-2 was carried
out by Murray et a!, 1972.
1.3.1.2 Relation to Other Aromatic Degradation Pathways
A comparison of gene sequences from TOL PWWO from P.putida and those from
isofunctional pathways in Acetinobacter calcoaceticus, the naphthalene degradative
pathway on pVIlO5 (P.putida CF600) and NAH7 from P.putida PpG7 suggests that
xy1XYZL genes diverged from those of Alcaligenes 100 to 200 million years ago while
the xy1TEGFJQKIH diverged from other isofunctional genes 20 to 50 million years. In
codons where amino acids were not conserved the substitution rate in the third base was
higher than that in synonymous codons and from this it was deduced that both single
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and multiple nucleotide substitutions contributed to amino acid-substituting mutations
and hence to enzyme evolution [Harayama and Rekik, 19931.
34% of the TOL plasmid shows homology with NAH and SAL DNA. The plasmid
pHMT1 12, carried by P.putida ML2, carries genes for the dioxygenase and
dehydrogenase involved in the catabolism of benzoate via the ortho-cleavage pathway.
These are expressed by the fragment bedC1C2BAD in E.coli and this fragment has been
restriction-mapped [Tan and Fong, 1993].
1.3.1.3 Genetics
The cloning of Pseudomonas genes in E. coli has been described and reviewed by
Nakazawa and Inouye, 1986 and by Mermod et al, 1986. Early molecular and
functional analysis of the TOL plasmid by transposon mutagenesis determined that the
pathway was clustered into two operons, separately regulated by two genes, xylR and
xylS [Franklin Ct al, 1981].
The complete TOL pathway is encoded on a 115 kb transmissible extrachromosomal
element, with the genes for the upper and lower parts of the pathway clustered into
regulatory blocks and separated by a 10 kb DNA segment. The enzymes encoded by
the upper pathway are xylene oxidase (XO), benzyl alcohol dehydrogenase (BADH) and
benzaldehyde dehydrogenase (BZDH). The gene order is shown in Figure 1.18.
XO has a relaxed substrate specificity for which a mechanism has been proposed
[Harayama et al, 1986a] and enzyme synthesis is positively regulated by xylR. There
is 1.7 kb of DNA between the promoter and the iylC gene whose function has not been
identified. xylC encodes the 57 kDa BZDH and xylM and xylA encode 35 and 40 kDa
proteins which are subunits of XO. BADH is a 40 kDa protein encoded by xylB and the
last gene xylD encodes a 52 kDa protein of unknown function. An isofunctional system,
benABCD, has been cloned from Acetinobacter calcoaceticus into E.coli. benABC
encodes a 53, 19 and 38 kDa protein which comprise the NADH-cytochrome C
reductase and terminal oxygenase components of a benzoate- 1 ,2-dioxygenase system.
benD encodes the cis-diol dehydrogenase which is a dimer with two identical 31 Kda
subunits [Neidle er al, 1987].
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The meta-cleavage pathway consists of 13 genes and extends over 10 kb. Transposon
mutagenesis was used to order and locate eight of the meta-cleavage genes. Some
mutations caused what seemed to be non-specific reductions in the activities of several
enzymes [Harayama et a!, 1984].
There are many similarities between the TOL pathway and the isofunctional pathway
in Acetinobacter calcoaceticus. From the evolutionary relationship between the toluate
1,2-dioxygenase and benzoate 1,2-dioxygenase, the functions of the xyIXYZ products
were inferred: the xylX and xlyY products being two components of an oxygenase and
the xylZ product being an NADH-cytochrome c reductase. OEH and 40D were also
found to be associated in vivo [Harayama and Rekik, 1990].
Genetic analysis of TO was carried out by complementation analysis using Tn 1000
derivatives and nitrosoguanidine-induced derivatives (both defective in TO) and E.coli
recA. Four cistrons were identified: the first two comprising xylX, encoding a 57 Kda
protein and the third, xylY encoding a 20 Kda protein [Harayama et al, 1986b].
The Pseudomonas putida Fl todC1C2BADE genes were sequenced and cloned into
E.coli for over-production of their products. Significant homology was observed with
isofunctional enzymes from P.putida 136R-3 and also with those for biphenyl
degradation from P. pseudoalcaligenes KF707 [Zylstra and GIbson, 1989].
The gene order for a meta-cleavage pathway from Pseudomonas CF600 capable of
utilising phenol, cresol and 3,4-dimethyiphenol was determined. There are 15 genes
clustered in one operon and these are dmpKLMNOPQBCDEFGHI. Enzyme activity
assays were used to correlate dmpE, G, H and I with known meta-cleavage enzymes
and dmpF was found to encode acetaldehyde dehydrogenase acylating activity [Shingler
et al, 1992]. The activities of the acetaldehyde dehydrogenase (acylating) and the
preceding enzyme in the pathway, 4-hydroxy-2-ketovalerate have been shown to be
tightly associated. (4-oxalocrotonate decarboxylase and 2-oxopent-4-enoate from the
TOL pathway are also tightly bound. dmpF and dmpG show no sequence homologies.)
This metabolic channelling minimizes the toxicity of the aldehyde and maximizes its
flux through the reaction, by preventing competing reactions, such as that with ADH
[Powlowski et al, 1993].
xylE has been sequenced and its product catechol-2,3-dioxygenase has been purified and
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its amino acid sequence determined. It is made up of four identical subunits each
containing 1 g atom of iron essential for the activity [Nakai et a!, 1983a, Nakai Ct al,
1983b].
The nucleotide sequence of the promoter region of xyIDEGF has been determined, as
has the sequence of the xylR and xylS promoter genes [Inouye et al, 1984, Inouye et
a!, 1986, Inouye et a!, 1988].
1.3.1.4 Biochemistry
This section deals with the biochemistry of the principal enzymes involved in the
meta-cleavage pathway reactions. These are as follows:
* toluate 1,2-dioxygenase:
TO consists of a flavoprotein, a [2Fe-2S] ferrodoxin (ferrodoxinT01-) and an
iron-sulphur protein (ISPT0L). The flavoprotein component of TO (46 kDa) has been
purified to homogeneity and shown to accept two electrons from NADH and transfers
them to ferrodoxinTol [Subramanian et al, 1981]. The iron-sulphur protein (ISPT0I) is
composed of two subunits, with molecular weights of 52.5 kDa and 20.8 kDa
[Subramanian et a!, 1979].The study of the oxidation of indole and indan to 1-indenol
and 1-indanol shows that the TO from P.putida is capable of benzylic monoxidation as
well as dioxygenation. This is also true of naphthalene and may be a characteristic of
bacterial multicompenent dioxygenases [Wackett et a!, 1988].
An investigation of the monohydroxylation of phenol and 2,5-dichlorophenol by TO
indicates that only one atom of oxygen is incorporated into the catechol [Spain et a!,
1989]. Naphthalene dioxygenase is a multienzyme system consisting of three
components: an iron-containing flavoprotein to transfer electrons directly from NADH
to cytochrome c, a terminal dioxygenase component which is an iron-sulphur protein
(ISP) and a ferodoxin. The terminal dioxygenase has been purified and shown to
consist of two subunits with molecular weights of 50 kda and 20 kda, indicating an a2
quaternary structure [Ensley and Gibson, 1983]. A 10-fold increase in expression of a
2,3-dihydroxybiphenyl dioxygenase in E.coli, P.putida and P.aeruginosa as compared
to the parental strain P.putida SU83 has been obtained. This was due to the orientation
and transcription read-through from the resistance promoter [Andreyeva et a!, 1993].
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* 1 ,2-dihydroxycyclohexa-3 ,5-diene- 1-carboxylate dehydrogenase:
DHCDH was shown to be made up of four identical subunits, each of weight 24 kDa.
The proposed mechanism of the reaction is dehydrogenation of DHB to an unstable
$-ketoacid which decarboxylates to form catechol. K. 1, values for the reaction were
determined to be 0.2 for DHB and 0.15 for NAD [Reiner, 1972].
* 2-hydroxymuconic semialdehyde hydrolase (HMSH):
The meta-cleavage pathway displays a relaxed substrate specificity which is not found
in the /3-ketoadipate pathway, which cannot metabolise compounds which give rise to
alicylcatechol intermediates. While most of the meta-cleavage pathway enzymes have
a broad substrate specificity, the enzymes on the divergent branches of the pathway are
exceptions and are substrate specific. In theory there are two possible mechanisms for
the degradation of 2-hydroxymuconic semialdehyde, one involving 2-hydroxymuconic
semialdehyde hydrolase and the other involving 2-hydroxymuconic semialdehyde
dehydrogenase. HMSH is most active against 3 substituted catechols and catechol and
4-methylcatechol are almost exclusively reacted upon by the dehydrogenase.
HMSH is encoded by the xylF gene which has been mapped to within a region of about
1kb (Inouye et al 1981). It has been purified to homogeneity and shown to have an M
of 65000. It comprises two subunits of equal size which are assumed to be identical
(Duggleby and Williams, 1986). The amino acid composition indicates each subunit as
consisting of nearly 300 residues, indicating a structural gene of about 0.9 kb which is
in agreement with genetic work.
Only linear chain alkylcatechols and 4-chiorocatechol can be degraded by this enzyme
and the reaction proceeds with varying levels of activity which occurs as a result of
different V, rather than Km (see Table 1.5).
* 2-hydroxymuconic semialdehyde dehydrogenase
2-hydroxymuconic semialdehyde dehydrogenase is the other side of the branch in the
pathway. With benzoate and p-toluate as substrates for the pathway, its activity is much
greater than that of the dehydratase branch and as a result benzoate and p toluate are
degraded preferentially by this branch (Harayama et al, 1987). m-toluate is degraded
exclusively by the hydratase branch. This branch is energetically favourable as one
NADH is produced for each benzoate degraded. The role of the divergent branches was
investigated in 1987 and it showed m-toluate to be dissimilated exclusively by the
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hydrolytic branch and p-toluate and benzoate by the dehydrogenase branch. Pathway
selection is made by HMSD.
Table 1.4: Kinetic parameters for HMSH with various substrates:
Substrate
catechol
3-methylcatechol
4-methylcatechol
3-ethylcatechol
4-ethylcatechol
3-propylcatechol
Km
(mmol)
30
36
10
15
22
5.0
Vmax
(mmol/hr)
6.9
100
3.2
34
6.7
2.4
4-propylcatechol 	 23	 0.5
3-allylcatechol	 37	 30
4-chlorocatechol	 122	 2.3
* 4-oxalocrotonate tautomerase
Isomerization of oxalocrotonate occurs spontaneously in vitro but must be enzyme-
eatalysed in vivo by 4-oxalocrotonate tautomerase. This enzyme catalyzes the
enolization of oxalocrotonate from its keto form. This is a reaction which occurs
spontaneously in vitro, but whose rate is very low in vivo (Harayama et al, 1987). It
is a tetramer of four subunits of 7.5 Kda.
* 4-oxalocrotonate decarboxylase
Relitively little work has been done on this enzyme to date.
* 2-hydroxpent-2 ,4-dienoate hydratase
This enzyme has been purified almost to homogeneity and has been shown to have a
molecular weight of 287,000 . Treatment with SDS suggests that it comprises 10
subunits of molecular weight 28,000. 2-hydroxpent-2,4-dienoate hydratase exhibits a
narrow substrate specificity and is stereospecific, hydrogenating only the cis isomer. A
mechanism has been proposed for this reaction, based upon the requirement for an
enolizable carbonyl group and the stimulation in activity caused by Mg 2 (Collinsworth
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a5
et a!, 1973).
* 4-hydroxy-2-oxovalerate aldolase
A similar mechanism for the aldolase reaction based upon the requirement for an
enolizable carbonyl group and the stimulation in activity caused by Mg 2 (Collinsworth
et al, 1973) has been proposed.
1.3.1.5 Regulation
Regulation of TOL and NAH pathways is through modulation of rates of initiation of
transcription. Substrates of the pathway are inducers of transcription action in
conjunction with two regulatory proteins encoded by xylR (upper pathway) and xylS
(lower pathway). xylR requires a sigma factor encoded by ntrA and two other factors
involved in transcription of nitrogen regulated promoters can substitute for xytR and
stimulate transcription from Pu [Harayama and Timmis, 1986].
CH3	COOH0
ire 1.19: This figure shows the gene order of the upper and lower pathways of the TOL plasmid and
egulatoiy mechanisms of the xlyR and xylS genes.. The solid arrows indicate positive regulation
the required effectors while the open arrow denotes repression.
Figure 1.19 shows the current model for the regulatory cascade which controls the
transcription of the TOL genes [Harayama and Timmis, 1989]. Transcription of the
upper operon originates from the Pu promoter and is initiated by the xylR protein when
it is activated by pathway substrates such as m-xylene and toluene and other structural
analogues in combination with the ok-containing form of RNA polymerase. The xylR
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product seems to regulate its own transcription (indicated by the open arrow in Figure
1.19). Transcription of the lower pathway is initiated when an excess of xylS or xylS
bound to its effectors which are substrates of the meta-cleavage pathway activates the
promoter Pm.
The promoters Pu and Ps are oM and IHF-dependent. A directly repeated sequence
5'-TGCAA PuAAPu-PyGGNTA-3', separated by a 6 bp inter-repeat region and
overlapping the -35 region of the Pm promoter has been identified as the binding site
of the xylS protein [Kessler et a!, 1993].
The site of xylR interaction has been identified as an inverted sequence repeat
homologous to that recognised by xylR in the upper pathway promoter Pu and lying in
the region between -133 bp and -207 bp. The xylR protein appears to recognise and
bind cooperatively to two halves of the motif in the Ps promoter upstream region.
While IHF was found to bind to Ps, it is not essential for its activation (this has been
found in other T-rich, oMdependent promoters [Holtel et a!, 1992]. Additional work
on the xylR promoter region, studying the positional requirements for the three protein
binding sites of Pu [URS for Xy1R, IHF site for IHF and the -12 to -24 region for the
oM-E complex] by means of point mutations. Two full helix turns did not reduce
activity whereas three resulted in a 90% drop [Abril and Ramos, 1993].
A regulatory sequence has been located upstream of the xylS promoter (between 145
and 188 bp upstream of the transcription start site) by deletion analysis. This is a
common feature with other oM dependent promoters characterized to date which all
require activator proteins binding to sequences approximately 100 bp upstream of the
promoter. This UPS consists of two functional regions and contains a palindromic
sequence, suggesting binding in an oligomeric form of the XyIR protein. The DNA loop
structure proposed for activation of the upper pathway operon [Inouye et a!, 1990]
seems to be applicable to the activation of xylS by the Xy1R protein in the presence of
an effector. It has been postulated that the IHF induces DNA binding and thus
facilitates and stabilizes the loop structure in the region between the UPS and the
promoter of xylR. There is no IHF binding site between the UPS and the promoter of
xylS and IHF mutants show no difference in xylS activity so it appears that a factor
other than IHF stabilizes the loop structure [Gomada et a!, 1992].
Several xylS mutants have been isolated which recognise as effectors benzoate
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analogues that are not effectors for the wild-type Xy1S protein and the characteristics
of these have suggested that the effector binding pocket of the Xy1S protein may be
composed of two or more non-contiguous segments of its primary structure [Ramos et
al, 1990]. Activation by its effectors of the Xy1S protein is dependent on intramolecular
interactions between the C- and N-terminal regions. These domain interactions have
been deduced from intraallelic dominance in double mutants on P.putida [Michan et a!,
1992a]. Arg-41 has been identified as a critical residue in xylS for effector stimulation
of transcriptional activity [Michan et al, 1992b].
A locus on the P.putida chromosome can substitute for xylS in initiation of gene
expression from the 0P2 lower-pathway operator-promoter region in the presence of
benzoate which acts as an inducer. A putative benzoate regulatory gene, benR, has been
identified. xylS also substitutes for benR in regulating expression of cloned
chromosomal genes. While homology exists between benABC and xy1XYZ, none exists
between benR and xylS [Jeffrey et al, 1992].
Xy1S protein mutants have been isolated which constitutively switch on the Pm
promoter. These have mutations at their C-terminal ends which are adjacent to
a-helix-a-helix domains likely to be involved in DNA binding [Zhou et a!, 1990].
1.3.1.2 Engineering Microorganisms for Improved Performance
One way of prolonging the life of cultures capable of biocontrol and plant
growth-promotion as well as degrading xenobiotics is to enable them to utilize a nutrient
which is then supplied to the environment. This has been done by enabling P.putida
R20 (an antagonist of Pythium ultimum and so reduces rot of sugar beet seed) to grow
on salicylate, by the addition of NAH7 [Colbert et al, 1993].
A bioreactor for the degradation of benzene, toluene and xylene was developed using
silicone tubing for controlled release of substrate and a mathematical analysis carried
out [Choi et al, 1992, Lee et a!. 1993].
Trichioroethylene was degraded by E.coli JM1O9 containing the genes todC1C2BA. A
linear rate of degradation was observed whereas in a P.putida Fl mutant, the initial rate
was much higher and decreased over time [Zylstra et a!, 1989].
The cis-diols produced as intermediates by the TOL degradation pathway can be used
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as building blocks for polyphenylene synthesis or as reactants for the organic synthesis
of fine chemicals. The production of cis-diols by TO in P.putida and E. coli was studied
using '4C-labelled benzoate. and it was shown that the presence of a methyl group in
the ortho-position relative to the carboxyl strongly interferes with TO activity. Also, the
accumulation of cis-diol was much higher in P.purida that in E. coli [Wubbolts and
Timmis, 1990].
Trichioroethylene can be degraded by several aerobic bacteria, some of which have
toluene degradation abilities. The products of oxidation of TCE by TO have been shown
to be toxic to P.putida F! by the alkylation of cellular molecules, though the
microorganism can recover by the turnover and resynthesis of these molecules [Wackett
and Householder, 1989].
Several bacterial dioxygenases are capable of the oxygenation of indole to cis-indole
-2,3-dihydrodiol. In the case of XO this occurs by direct hydroxylation at C-3. This
product spontaneously dehydrates to form indoxyl which in turn oxidises to form
indigo. (Indole is formed from tryptophan by tryptophanase) [Mermod et a!, 1986].
Genes encoding toluene dioxygenase, toluene cis-glycol and catechol-2,3-dioxygenase
from P.putida NC1B 11767 were cloned into E.coli HB1O1 and were observed to
produce indigo and a variety of other coloured products [Stephens et a!, 1989].
When organisms which can degrade a range of aromatic compound are exposed to
mixtures of chloro- and methyl-aromatics, both orth- and meta- pathways are induced
to degrade the mixture (chioro- via ortho- and methyl via meta). This leads to
non-productive misrouting of the substituted catechols produced. This can be overcome
either by restructuring existing pathways or by the constructing of new pathways via
the combination of different enzymes from different organisms to give the desired
properties. By combining five discrete pathway segments with the desired enzymatic
activities a strain was developed which was capable of degrading mixtures of 3CB,
4CB, 4MB, 4CP and 4MP without non-productive misrouting of intermediates [Rojo
et a!, 1987].
Pseudomonas sp. T-12 can degrade many 3-fluoro-substituted benzoates with either
defluorinated catechol and inorganic fluoride products or catechol products with the
fluorine substituent. The steric size of the C-i substituent was found to affect the ratio
of defluorinated to fluorinated catechols formed and a mechanism for the reaction
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involving TO has been proposed [Renganathan, 1989].
Reasons why substituted aromatics or xenobiotics may not be degraded by an organism
are: toxicity, failure to be taken up by the bacteria, failure to act as an effector of
regulators of transcription of catabolic operons, and failure to be degraded by the
pathway enzymes.
The reason why 4EB is not degraded by the TOL plasmid is due to its failure to induce
transcription of the pathway enzymes and the fact that one of the pathway intermediates
inactivates C230. (These two points were identified as crucial to expanding the
substrate specificity of the TOL pathway) Mutants were selected to overcome these
deficiencies and then combined to redesign the pathway [Ramos et al, 1987].
The meta-cleavage pathway has been cloned into Rhodobacter sphaeroides, and the
enzymes were expressed at a high level. However the cells were unable to grow with
m-toluate as sole carbon source, probably due to an inhibitory effect of one of the
intermediates [Calero et al, 1989].
Cloned genes can be used to extend the range of substrates which can be degraded by
an organism. By cloning the genes, xylD, iylL and nahG into Pseudomonas sp. B13 its
catabolic range was expanded to include 4-CB, 3-CB, and 3,5-CB, salicylate, 3-, 4-
and 5-salicylate [Lehrbach et al, 1984]. The activity of the upper pathway enzymes XO,
BADH and BZDH were tested with chlorotoluenes as substrates. Using this
information, a hybrid strain was constructed by introducing TOL into the 3-CB-
degrading strain B13 or JH320. Steric effects were observed for all three enzymes with
substituents in the ortho position bigger than fluorine [Brinkmann and Reinekke, 1992].
Also, the upper pathway enzymes will accept nitroaromatics as substrates though xylR
does not recognise them as effectors [Delgado et a!, 1992].
Several issues involved in using genetically engineered microorganisms for combatting
pollution in the environment were identified: survival of the organism, stable
maintenance of genome, transfer of genetic material to other microorganisms, spread
beyond the target environment and effect on the ecosystem. Two Pseudomonas strains,
one with the ortho-cleavage pathway for 3CB and 4MB and one with a TOL pathway
for 4EB were introduced into an activated sludge microcosm. These protected the
indigenous sludge microorganisms from shock loading of these substrates. Horizontal
in situ of plasmid DNA was readily observed [Nu/lien et al, 1992].
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1.3.1.7 Stability of TOL plasmid.
On batch and continuous cultures of P.putida on toluene, complete inhibition of growth
is observed at greater than 1.4 gIl of toluene. Chemostat cultures can be maintained at
steady state for several months [Vecht et al, 1988]. The kinetics of plasmid loss of
P.putida MT15 in potassium-limited chemostat culture were shown to be dependent on
the growth rate advantage endowed by the plasmid i.e under glucose limitation there
was a stable mixed culture while with excess glucose, 100% plasmid loss was exhibited
[Stephens and Dalton, 1988].
TOL plasmid in chemostat culture under succinate-, sulphate-, ammonia- and phosphate-
limitation and at different dilution rates has been studied. There was a persistence of
TOL+ plasmid-containing cells under phosphate-limiting conditions and it was found
that dilution rate had a strong influence under carbon- and energy limitation. Mutants
were found containing partially deleted plasmid leading to theories about other functions
of the TOL plasmid [Duetz and Van Andel, 1991].
During growth of TOL+ P.putida in pH controlled culture, TOL- strains had a 15%
growth advantage which led to their taldng over the culture. The reason for this was
proposed to be an inhibitory intermediate of the meta-cleavage pathway such as
hydroxymuconic semialdehyde.
Table 1.6: List of TOL substrates:
toluene
m-xylene( 1 ,3-dimethylbenzene)
p-xylene( 1 ,4-dimethylbenzene)
pseudocumene(1 ,2,4-trimethylbenzene)
3-ethyltoluene
benzyl alcohol
m-methylbenzyl alcohol (3-methylbenzyl
alcohol)
p-methylbenzyl alcohol (4-methylbenzyl
alcohol)
3 ,4-dimethylbenzyl alcohol
3-ethylbenzyl alcohol
benzaldehyde
m-tolualdehyd e
(3-methylbenzaldehyde)
p-tolualdehyd e
(4-methylbenzaldehyde)
3 ,4-dimethylbenzaldehyde
3-ethylbenzaldehyde
benzoate
m-toluate (3-methylbenzoate)
p-toluate (4-methylbenzoate)
3 ,4-dimethylbenzoate
3-ethylbenzoate
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2. SIMULATION AND OPTIMIZATION OF METABOLIC PATHWAYS
2.0 Introduction
In this chapter, a procedure is outlined for simulating and optimizing a metabolic
reaction network. A range of software has been developed for the implementation of
this approach with respect to general metabolic systems and this is briefly described.
Section 2.1.1 describes how the reaction system matrix is set up and the checks which
must be made to validate it and the system steady state. Section 2.2 models the action
of the system about this steady state using a technique called biochemical systems
theory. This theory uses a power-law function to model the system reactions rather than
the more usual linear or Michaelis-Menten expressions. This formalism was chosen
because it seemed to retain the essential non-linear features of metabolic systems while
being amenable to mathematical analysis [Savageau, 1969a,b, 1970]. Section 2.3
presents the formulation and solution of the optimization problem presented by the
system. The method for calculating the control coefficients of a metabolic system from
transient concentration data is described in Section 2.4 and methods for sensitivity
analysis developed in Section 2.5. These methods have been used in a modelling
strategy which is outlined in Figure 2.1. Section 2.6 presents the results of the above
methods and software when applied to the TOL meta-cleavage pathway.
2.1. Metabolic Modelling
2.1.0 Introduction
An essential feature of a model is that it establishes a mathematical framework for
experimental data. This can be of several forms depending on the function of the
model: it can be one that simply arranges experimental data in a logical way so that the
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2. 1 : Flow-chart for the modelling system used.
Ift
important correlations are emphasised, or it can be one which enables the use of data
from individual in vitro studies in examination of the overall system behaviour. In any
case the model must address two issues: the behaviour of the individual enzymic
reactions, and the interrelation of all of the reactions in the system. The individual
enzymic reactions can be modelled using different levels of complexity. They can be
described mechanistically using expressions of the King-Altman variety, or more simply
with a pseudo-steady state model using an expression such as the Michaelis-Menten
equation.
Before any system can be modelled it is necessary to define the system boundaries and
state which are the exchangeable and non-exchangeable parameters. This helps outline
what the modelling assumptions are to be. It is essential to be clear if and when
assumptions about a metabolic system are made so if there are discrepancies between
the model predictions and experiment, the assumptions can be reviewed. In this case,
the system under investigation is the TOL meta-cleavage pathway, whose biochemistry
and genetics and regulation are described in Section 1.3.1. The 13 genes of the lower
pathway under a tac promoter are transformed into E.coli JM1O7 as described later in
Section 3.1. The exchangeable parameters are benzoate (X1), pyruvate (X2),
acetaldehyde (X3) and formate (X4). To ease later calculations these are numbered first,
followed by the exchangeable metabolites, as described in Section 1.2.1.3. The
numbering system is shown in Figure 2.2. It is assumed that the cofactor requirement
is not limiting as it is balanced over the pathway. It is also assumed that secretion is not
limiting. In addition, no mechanism for toxicity of either the substrate, the intermediate
or the products is included in the model.
2.1.1 Theory
The next step in modelling is to express the reaction system in numerical terms. This
is done by writing down the metabolic reaction matrix for the system, which contains
the stoichiometric coefficients of all of the components in every reaction. (This is the
same as the stoichiometric matrix described in Section 1.1.3.1.2.) In this matrix the
column j represents the reaction j and we write in this column at row i:
+a if the reaction j produces moles of metabolite i
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-a	 if the reaction j consumes a moles of metabolite I
0	 if the reaction j neither produces or consumes metabolite I
The structure of the system reaction matrix for a system with r reactions and m
metabolites is shown in Figure 2.3 along with the metabolic reaction matrix R for the
TOL degradation pathway.
The m metabolites can be divided into m' non-exchangeable compounds (those which
remain inside the system) and m - m' exchangeable compounds so that R is an m x (r
+ m - m) matrix. The system rate vector v has dimensions (r + m - m') x 1 and we
can write the set of conservation relations as
R.v = 0	 (75)
The metabolic reaction matrix R and the rate vector u can be partitioned, separating
the net conversion rates and the metabolic reaction rates. We write the m x 1 vector of
net conversion rates as VA:
N'.v 
=
	 (76)
where N' is m x r and v is r x 1. Considering only the non-exchangeable compounds
we can write
N.y = 0
	 (77)
where N is m' x r.
Not all of these reactions are necessarily independent and we can extract from N a
subset of its rows which is a basis of the whole set of its rows i.e. the rows of the basis
set are independent and every row of N is a linear combination of the basis rows.
Assuming that the first in0 rows form the basis N (as it is always possible to renumber
the rows) N can be decomposed as follows
N = KNR	 (78)
where the m' x m0 matrix K has the form
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1	 0	 ...	 ...	 ...	 0
	
oi	 o	 ...	 ...	 0
	
K=I o...	 ...	 0	 1	 0
	
O...	 ...	 ...	 0	 1
K0
(79)
andKoisa(m'-ma)xmomatrix.
The above decomposition illustrates one of the tests that must be made on a system
before further analysis - that of independence. There are five such checks which should
be made. These are independence, consistency, observability (Noorman et a! 1991),
existence of a steady state and stability of a steady state (Reder 1988).
The independency test can be stated as follows
rank(R) = m	 (80)
or
rank(N)	 (81)
If rank(R) < in then this indicates the presence of identical component relations. If
rank(N) < in' the presence of one or more dependent reactions is indicated. There are
several ways of forming an independent set. Either the components or reactions
responsible can be eliminated or the elements and reactions can be concentrated into an
independent set. For example when considering the redox state of the cell we can
replace NAD 4 and NADH2 by the couple NAD/NADH2 in systems where they are
conserved and similarly for ATP, ADP and AMP which determine the energy balance
within a cell.
The system must also be tested for consistency, that is, whether the mathematical
relations are compatible. This involves finding the number of degrees of freedom of the
system. This is the difference between the number of a priori unknown rates (m - m'
+ r) and the number of independent relations specified by R (in0) and gives the number
of rates that must be calculated to allow the calculation of all of the others i.e.
no. of degrees of freedom, dr = r - m'
(82)
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If m' ^ r then the system is either over-specified or exactly specified. In this case it
is likely that a metabolic reaction is missing so that the system metabolic pathways need
to be re-examined (Noorman ci al 1991, Hofmeyr 1986).
The observability test ensures that the number of rates measured is sufficient for
determination of the state of the system. The vector of measured rates VAtm must have
the same dimension as the number of degrees of freedom d. The metabolic reaction
rates can be calculated by partitioning the matrix N' to separate the measured rates from
the calculated rates:
(N)M.v =	 (83)
(f/J)CV =
The criteria for observability is that
rank(N) = r	 (84)
i.e. r linearly independent relations are required to determine the u1 ,..., U reaction
rates.
Metabolic control theories consider the perturbations of the system around a steady state
and it is necessary to consider the existence and the nature of this steady state. To do
this we need to calculate the Jacobian of the system N. y. It can be shown that the
system will reach a new steady state upon perturbation if the matrix NRVXvK is
invertible (Reder 1988). Vu is the r-row and rn-column matrix of the partial derivatives
of the rates with respect to the X metabolites. The steady state is stable if the real parts
of all of the eigenvalues of (NRVXvK) are negative (Reder 1986).
Having simulated and examined this steady state we need a linear way of modelling the
action of the system around it, with respect to changes in the system parameters.
Because of the non-linear form of most enzymatic rate laws metabolic models are not
numerically tractable if we wish to perform more sophisticated analyses especially for
larger systems. By transforming into logarithmic coordinates it is possible to obtain a
linear expression for metabolic systems.
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2.2 Simulation
2.2.1 Theory
To simulate a metabolic system, the power-law approximation which forms the basis
of biochemical systems theory as described in Section 1.2.2 will be used. The power-
law formalism is analogous to a linear model, being based on the first two terms of the
Taylor series, but in logarithmic space. The use of log coordinates was suggested by
the fact that the rational functions which provide a good representation for rate laws in
vitro can be approximated over a wide range by a straight line on a log-log plot
[Savageau and Voit, 1982; Savageau et al, 1987a]. A rate expression similar to the law
of mass action for chemical reactions is obtained by writing the Taylor series for the
rate of reaction v1 for each of the reactions in the pathway about an operating point and
transforming back into Cartesian coordinates so that the rate can be expressed as a
product of power-law functions [Voit and Savageau, 1982; Savageau et al 1987a].
Is
v.(X1,...,X) = [I 	(85)
i-i
where
II
-gil
a, = v oll X,.
i-i
= a(Inv)/a(InX) = (avdaXJ)(xftiv,.))
	
(87)
Using this formalism to model a metabolic system we apply the S-system variant (see
Section 1.2.2.2.1) [Savageau, 1991]. The essential feature of this variant is in the
aggregation of those fluxes which tend to increase a given substrate into one net rate
law and those which tend to decrease into another [Sorribas and Savageau, 1989c]. The
power-law formalism explicitly represents each of these net rate laws so that for each
substrate (or pool of substrates) X we can write the equation
(86)
Here the B, and h are respectively the kinetic orders and rate constants for the rate laws
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dX/dt = V1 - V_1	
(88)'S
=a 1ftx-p 1 xj"	 i=1,...,n.
1=1	 1-1
decreasing X1. There is one equation for each of the m' dependent variables and the
product is over n where n-rn' is the number of independent variables.
As described in Section 1.2.1.2.2 Eqn.s 33-38, the time derivatives can be set to zero
for steady state and the system can be written in matrix notation and partitioned to solve
for an explicit solution.
From this solution can be calculated the sensitivities of the system S(X, Xi), S(X1, oç)
and S(X1, g) (see Eqn.s 39-42 for definitions) to determine the rate-controlling
parameters. These sensitivities indicate the presence of any bottlenecks in the process
and what variables must be altered to remove them in that they relate the fractional
change in any dependent variable to the fractional change in the independent variable
responsible for the change. These sensitivities are equivalent to flux and concentration
control coefficients in metabolic control theory.
2.2.2 A program for the Simulation of Metabolic Systems, MetaSim:
1. Simulation of system using kinetic data.
The aim of this program is to simulate the steady-state action of the system using
kinetic rate laws and parameters for the reaction rates. The rate of change of the
concentration of each component is described by rate laws for each reaction associated
with it. A quasi-steady state is then assumed, which sets the rate of change of the
intermediate concentrations equal to zero, and the resulting set of relations are solved
for the steady state intermediate concentrations. One and two substrate Michaelis-
Menten kinetics are assumed. The form of these laws is as follows: for the one
substrate reaction:
k1 [El [11
r =v=	 (89)x	
Km+[X]
For a two substrate reaction
The metabolites in the system are grouped into m' non-exchangeable components -
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	dX1 - dX2 - -	 k1[E]
	
- -- - - -- - -
	 K1	 K2	 ('2 K12 +K1 K)	 (90)1 +-+-+
[X1]	 [X2]	 2 [X1] [Xi]
those which are retained within the system and rn-rn' exchangeable components - those
which are exchanged with the environment, and are numbered X 1 ,...	 ..,Xm.
The system reactions are numbered r 1 ,.. . ,r,. The reaction scheme is described
numerically by a stoichiometric matrix. In this matrix the column j represents the
reaction j and we write in this column at row i:
if reaction j produces a moles of metabolite i
-a
	 if reaction j consumes a moles of metaboite i
0
	
if reaction j neither produces nor consumes metabolite i
The form of the stoichiometric matrix can be seen in Figure 2.3 which illustrates the
stoichiometric matrix for the TOL pathway. The use of a rigorous nomenclature ensures
that systems of any complexity can be dealt with once the above numbering scheme is
used.
The file InputData.m contains all of the input information for the subsequent modules.
The kinetic data is contained in a matrix k, where k is the jth kinetic parameter of the
ith reaction. The order of the kinetic parameters is as follows:
For a one substrate reaction:	 Km
For a two substrate reaction	 k1	 K1	 K2	 K12 K21
[Note: While the method of ordering and numbering of the reactions and metabolites
is fixed, the choice of kinetics and kinetic parameter numbering is not. The kinetic
expressions appear in the functions kinexp in the module ModelSolve.m. Any form of
kinetic expression can be used here and the kinetic parameters should be numbered to
correspond to these functions.]
The enzyme concentrations are entered in the array enzyme. The exchangeable
metabolite concentrations are contained in the array xdep, and initial guesses for the
non-exchangeable concentrations in the array xindep.
The file ModelSolve.m solves for the steady state values of the non-exchangeable
metabolites. It is comprised of three functions: RateExp, EqnSet and Findroot.
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RateExp contains the kinetic expressions kinexp and uses the stoichiometric matrix r
and the matrix of kinetic parameters k to return the array of rate expressions for each
reaction in the system (v).
EqnSet displays the full set of equations describing the rate of change of each
metabolite in the system. It is by setting the rate of change of the non-exchangable
metabolites equal to zero that the steady state values are found.
Findroot solves the set of equations obtained from EqnSet using input values for the
exchangable metabolite and enzyme concentrations and initial guesses for the non-
exchangable metabolite concentrations (xdep, enzyme and xindep, respectively). This
set of simultaneous equations is solved using the Mathematica subroutine FindRoot.
FindRoot searches for a numerical solution to a system of equations using either
Newtons method or a variant of the secant method. The steady state values are returned
in output.
findroot returns the non-exchangable metabolite concentrations for one set of kinetic
parameters and enzyme and exchangable metabolite concentrations but what is more
often required are the concentration profiles obtained when one of the input parameters
is varied. The function FindRoots plots the concentration profiles obtained when either
the input concentrations, the enzyme concentrations or the kinetic parameters are
varied. To investigate the effects of changing an input parameter, it is sufficient to enter
the range (and step size) over which it is to be varied in place of the usual single value.
the change in the data entry format allows the subroutine to recognise which parameter
is to be varied and Findroot is applied at each value. The concentration proffles are
returned in plotted in a file called plot!.
While this approach works well for small and medium sized metabolic systems, for
large or complex systems the matrices involved become difficult to solve and it is
important to have close initial guesses. For this reason such solution techniques must
be applied with care to large systems.
The purpose of the module PowerLaw.m is to calculate simulate the metabolic system
on the basis of a power-law formalism. It has been shown that this type of model is
suitable for describing the characteristics of metabolic systems and it can be posed in
a linear form which greatly simplifies the numerical analysis.
The first function of the module, KinParam, uses the array of rate expressions V from
RateExp and the steady state values in output to calculate the power law parameters a,
B, g and h.
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Recall that the system can be described by an expression of the form
dXi_ccft Xs4I _ I.3 Ü Xh4 	 i=1,...,rn0.	 (91)
dt	 i-i
SSCaIc uses these parameters to solve the matrix equation
Ay = b
	 (92)
where
= lnX1
= ht(f3jc)	 (93)
=	 -
PL performs the same function here as FindRoots in ModelSolve.m, in that it applies
SSCaIc repeatedly over a range of one of the input parameters to return profiles of the
concentrations and rates in files named xplot and I'plot.
Full listing and documentation of this software is given in Appendix D.
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2.3 Optimization
2.3.0 Introduction
While optimization techniques have been used as a tool in chemical engineering process
design for many years, their applications in the bioprocess industries have so far been
limited. There are several reasons for this. The primary reason is that the most common
solution techniques have been developed for well-defined linear problems and there are
few bioprocess which fall into this category. However as solution techniques improve
and as understanding of bioprocess improves, the number of cases in which
optimization techniques can provide useful insights and data is increasing.
The goal of optimization is to find the values of the variables in the process that yield
the best value of the performance criterion. In the formulation of an optimization
problem it is necessary to identify firstly the objective finction, which represents the
performance criterion which is to be optimized and this must be expressed in terms of
the key variables of the process being analysed, and secondly the process model, which
describes the interrelation of the key variables and provides the constraints for the
solution.
By describing a process in mathematical terms a variety of computational techniques can
be used to identify the best solution from the set of possible solutions. However these
must be used intelligently if the results are to be meaningful. This requires insight as
to the appropriate objective function to be used and good judgement in the interpretation
of the results.
The essential features of an optimization problem are: one or more objective functions
to be optimized, equality constraints and inequality constraints. The latter two arise
from the model describing the behaviour of the system. An optimal solution is one
which satisfies these constraints (i.e. is a feasible solution) and which also supplies the
optimal value to the objective function). In most cases the optimal solution is a unique
one. If there are no residual degrees of freedom among the constraints then there exists
only one solution and there is no need to search for an optimum.
When solving an optimization problem there are several steps which should be
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followed.
1) List all of the variables of importance in the system
2) Identify the objective function and define it in terms of the system variables.
3) Develop the expressions which will form the system model. Identify the independent
and dependent variables to determine the number of degrees of freedom.
4) Apply a suitable optimization technique to the mathematical model of the system.
5) Examine the sensitivity of the model, that is, the effect on the result of changes in
the input parameters.
In this section we describe how this approach can be applied to a metabolic system in
conjunction with the modelling techniques described previously.
2.3.1 Theory
The previous sections have described how a metabolic system can be described in
power-law terms so that it becomes linear in logarithmic coordinates. Having expressed
the problem in a linear form it is possible to apply standard optimization techniques.
In the case of metabolic pathways the objective function will usually be either a flux or
a metabolite. That is, we will wish to maximize or minimize either the rate at which
a metabolite is produced or its level in the cell. The constraints on this system are
imposed by the pseudo-steady state assumption applied to the non-exchangeable
elements of the system. The problem is a constrained linear optimization problem and
of the many linear programming techniques available the chosen solution method is by
a NAG library subroutine EO4MBF.
A general way of expressing a linear programming problem is
minimize f(x)	 T	 (94)
x
subject to
a'x=b1	 iE	 (95)
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arx^b	 1€!	 (96)
Eqn.(95) is the set of equality constraints and Eqn.(96) is the set of inequality
constraints. When considering a metabolic pathway, the objective function will be either
a metabolite or a flux i.e.
fix) = 1nx0,,	 (97)
or
fix) = ln V01 = 1ncç, +	 g0Mi1nXj	 (98)
subject to the equality constraint given by Eqn.(95) and the inequality constraints; >
0 i=l,...,n. The equality constraints arise from the linear description of the problem,
Ax=b, and the inequality constraints form the physical limitations of the system.
2.3.2 A Package for Optimizing Metabolic Pathways MetaOpt
This software is based upon the same subroutines as that for simulating metabolic
pathways, MetaSim, and makes use of the power law form employed by that package
to express the system in linear form and apply linear optimization techniques. In this
way, the optimum set of parameters for a particular objective function can be
determined. Full listing and documentation is given in Appendix D.
The parameters to be optimized are the intermediate and the enzyme concentrations.
These are subject to a set of inequality and equality constraints. The inequality
constraints are in the form of upper and lower bounds and these ensure that the solution
is physically reasonable. The lower bound specifies that the concentrations should not
be less than zero. The upper bound will depend on a range of factors determined by the
particular system: upper bounds on intermediate concentrations may be specified by
their levels of toxicity to the cell while upper bounds on enzyme concentrations will
depend on the maximum expression level of the enzymes in the organism under process
conditions.
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The software which performs this optimization is called MetaOpt. It is similar to the
package MetaSim described in Section 2.2.2 in that it calculates the steady state
operating point of a metabolic system from its kinetic parameters and then determines
the power law parameters for the system from this operating point. Instead of
simulating the system about this operating point, it uses the linear form of the power
law expression in logarithmic coordinates as the equality constraints for the optimization
routine.
The package MetaOpt contains the functions Fmdroot, RateExp, KinParam, and
SSCa1c which are as described in Section 2.2.2 and the additional function Opt. The
arguements required by Opt are the same as those required by PL (k, aa, hit, ext,
enziine) with the addition of the objective function c. The upper and lower bounds
specified in the program as upper and lower can be specified or the default values of
upper = 100. and lower = -10. can be used.
The optimization routine used here is the NAG library subroutine eO4mbf (see
Appendix D for details and parameter listing) and was chosen because of its robustness
and ease of use. MetaOpt writes the objective function, the system matrix A, the upper
and lower bounds and the starting point (which is the operating point) to a data file
modsol.r. The Fortran subroutine is then compiled and executed from within MetaOpt
and the results from the output data file optsol.r read in and plotted.
2.4 Fermentation Data
2.4.0 Introduction
The previous sections have described the simulation and optimization of a metabolic
system using kinetic data. This approach is useful in that it can provide initial data on
a system from in vitro data on the individual reactions. It may also give insight into the
behaviour of reactions which for practical reasons cannot be monitored in vivo.
However, results obtained from this method may be misleading if the kinetic
experiments have been carried out under very different conditions from those expected
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in vivo or if elements of the system behave significantly differently in vitro than in vivo.
For these reasons, it is necessary to validate results acquired from kinetic data with data
from the system in vivo. There are several ways of achieving this, in general based on
the variation of levels of enzyme and intermediate expression.
In this section the analysis of in vivo data for the determination of control coefficients
is described.
2.4.1 Theory
The dynamic approach uses measurements of the concentration profiles of metabolites
following a perturbation to the system to measure the flux control coefficients. Because
the transient metabolite concentrations do not vary freely but are constrained [Reder,
1986] the relationships between these concentrations can be used to evaluate the flux
control coefficients [Delgado and Liao, 1992].
The transient metabolite concentrations can be correlated with time by the following
expression
ii+1
E a,(x1(t) - x.(0)) = t	 (99)
where x(t) are the metabolite concentrations at time t for n metabolites and a, are the
correlation coefficients which are evaluated from linear regression. The flux control
coefficients can then be calculated from
ECE'CE,...,CE] = [a 1 a2,...,cc 1]AJ	 (100)
Here, A is the stoichiometric matrix shown in Figure 2.3, and J is the steady-state flux.
This is derived from a linearization of the kinetics as follows:
L-1
r=EaXj+b1	 (101)f-i
or generally:
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(102)
= E aY, + b.
where Y0 =s, Y=X, j=1,2,...,L-1, YL=P
Y	 3)Efl =__LaU	 = (103)
o=
	 (104)
for fixed s and p.
0 =	 (105)
since X are independent of i and rj = r at steady s.
0 = ECl'a(ItX
with multiplication by a constant.
o =	 C' a AX, = E C a iX = E C'r
ii	 S	 I	 I
(106)
(107)
where = X(t) - X(t=O) which is the transient response. Hence C1r can be obtained
by least squares from measurement of the interval rates (or X) at an arbitrary number
of time values t>0.
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2.4.2 Description of In Vivo Data Program, InVivo
The most important part of this program is the routine for linear regression supplied by
the NAG subroutine GO2DAF. This routine performs a general multiple linear
regression and computes parameter estimates, standard errors, residuals and influence
statistics (see Appendix D for a description and listing of the subroutine parameters).
The input data required for this program module is an array of time-varying metabolite
concentrations, the stoichiometric matrix, and the system fluxes. The concentration data
is read into the file res.d and the FORTRAN program residual.f is compiled and the
object file a.out executed by InVivo. The calculated parameters, a, are then read back
into Mathematica and the control coefficients calculated using the flux array J and the
stoichiometric matrix R.
2.5 Sensitivity Analysis
2.5.0 Introduction
An essential consideration of any system model is how it responds to small
perturbations in its input data. The measure of this response is termed the sensitivity
of the system. It is essential that the sensitivity of a system be such that it can cope with
experimental errors and noise. For linear systems it can be shown that the change in
solution upon perturbation of initial data can be estimated by a condition number, k.
For non-linear systems, it is possible to define upper and lower bounds which reduce
to the condition number k under linear approximation.
2.5.1 Theory
2.5.1.1 Linear Systems
Simple matrix theory can be used to investigate the linear system
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Ax = b
	 (108)
with nonsingular A E L(r), and determine the effect of perturbations in A and b on
x. Let the perturbation of this system be a matrix B E L(R) which is close to A in that
IA II IIB -All < 1	 (109)
Then we can show that B is also nonsingular and that for b ^ 0, the solutions
= A 1b, y=B'c satisfy the estimate
Ix*...y*I	 K(A)	 [lB_Al + lb-cu	 (110)
rx*u	 1 - ic(A)BA/IAI
	
141	 IlbII j
where
K(A) = 141 14'lI	 (111)
is the condition number of A, i.e. the relative error in x can be ic times the relative
error in A and b and in this way ic quantifies the sensitivity of the linear system. It
should be noted that the condition number is norm-dependent. There are several matrix
norms which are generally used. The most common of these are the Frobenius norm
(F-norm)
lifl
	
1411, 
= lEE IaI2I	 (112)[i_i j-i	 j
and the p-norms
Wl,
141p =	 ____
	
x*O lXllp	 (113)
Any two condition numbers ica(A) and ,c8(A) are equivalent in that there exists constants
c1 and c2 for which
c1iç(A) ^ ic1(A) ^ C2Ka(A)	 (114)
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2.5.1.2 Non-Linear Systems
For non-linear systems ic does not exist and it is necessary to define other quantities
which describe the sensitivity of the system. These quantities are the greatest lower
bound and the least upper bound or Lipschitz norm.
For X and Y which are real normed linear spaces and L(X, Y) the space of bounded
linear operators from X into Y. For any mapping F: D X Y and closed subset
C CD, we introduce the greatest lower bound
(F,C) = sup{t e [O,00); IFx-FyI ^ tx-y Vx,y e C)	 (115)
and the least upper bound or Lipschitz norm
v(F,C) = inf(t e [0, co];UFx- FyI ^ tIx- y Vx,y € C)	 (116)
This suggests the following definition of the condition number for complex systems
ic(F,C) = 
v(F,C/(F,C)	 (1 0 < p(FC),v(F,C) <	 (117)
otherwise
(Rheinboldt, 1976)
2.6 Results
2.6.0 Introduction
Two systems will be examined. These illustrate the principle of top-down analysis in
that each is an increasingly detailed version of the same system. The simplifications are
based upon the data which can be collected. In examining a system in such a manner
we are trying to match what should be measured with what can be measured. By using
the fermentation data as our simplification criteria we can obtain initial results which
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can then be used to determine what are the important areas of the system which should
be further investigated. In this way, this type of analysis can be used to direct the
analysis required for pathway engineering.
2.6.1 The two-step system
This system is illustrated in Figure 2.4. It shows the TOL meta-cleavage pathway
simplified to two steps, involving the compounds benzoate, catechol, pyruvate and
acetaldehyde. This simplification was initially chosen because of the ease of availability
of these compounds for use as standards and because methods for analysis of these
compounds were easy to develop.
Following the procedure for establishing and validating a system model as outlined
above:
The stoichiometric reaction matrix is
-1, 0,
	
0,	 1,
R=
	
0,	 1,
1, -1,
1, 0, -1, 0, 0
0, -1, 0, 1, 0
-1, 0, 0, 0, 1
-1, 1, 0, 0, 0
(118)
We can partition this matrix, separating the net conversion rates and the metabolic
reaction rates to yield the m x r matrix N'
1-i, 0,	 1,	 ol
N' = J 0,	 1, 0,	 l	 (119)lo,	 1,	 0, -ii
[1, -1, -1, ii
and from this we can isolate the simplified reaction matrix, N involving only the non-
exchanged compound, X4
N = [1, -1, -1, 1]	 (120)
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Figure 2.5 Predicted variation of catechol levels () and pathway flux (•) with
increasing benzoate concentration for lumped system.
Because of the simplicity of this system, the results of some of the validation tests are
obvious, but it is good practice to carry them out routinely. It is obvious that the system
is a linearly independent one as it comprises only one equation. This can be tested by
calculating the rank of the matrices R and N (see Appendix A for a defmition of rank
and some other concepts in matrix algebra).
rank(R) = 4 = m as required
rank(N) 1 = m' as required
The number of degrees of freedom = r-m' = 3. This indicates that the system is
consistent and that it is necessary to measure three of the system components or rates
to determine the state of the system.
Partitioning the matrix N' to separate the measured rates from the calculated rates and
applying the test for observability, we find rank((N')m) = 4 r so that 4 linearly
independent reaction relations are required to determine the v 1 ,...v4 reaction rates if the
criterion of observability is to be fulfilled.Having established the independence,
consistency and observability of the system it is now necessary to calculate the steady
state of the system and to investigate the existence and stability of the steady state
resulting from a perturbation of this system. To do this we use Michaelis-Menten
kinetic parameters obtained from the literature (see Table 2.1) to calculate the pseudo-
steady state value of X4. This value is X4 = 2.57 mmol.
Table 2.1: Kinetic parameters for lumped system.
Reaction	 k1	 Km	 K2	K12	 K21
(s')	 (mM)
v 1	 00	 15
v2
	70	 8
50	 3
v4	1.5	 4	 6	 3	 9
To simulate the system about this operating point we use a power-law expression where
the coefficients and exponents are calculated from the kinetic parameters using the
subroutine KinParam and for this system the power-law expression for the change in
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the pool of catechol is:
dX4/dt = -22.09 x[4]° 63x[6]° 42x[7]° 57 + 10.08 x[ 1 ]°59x[2]°°°2x[3]°°°'x[5]°x[8]°°°2 In
This expression, the rate of change of the pool of catechol (X 4) is dependent on the
concentration of the lumped enzyme catalysing the first forwards reaction x[5] to the
power of almost 1 and the concentration of the lumped enzyme catalysing the first
backwards reaction (471) to the power of 0.57. This situation would be unlikely in
mechanistic terms if E1 were an actual enzyme and would warrent a review of the model
assumptions or the kinetic data but is not unfeasible when the enzyme is a result of the
lumping together of several enzymic steps.
Using this expression the profiles for the non-exchangeable intermediates and fluxes
which occur as a result of changes in the exchangeable parameters can be calculated.
Figure 2.5 shows how X4 and V4 change with varying X1 (input benzoate concentration).
In this example the input benzoate concentration is varied from 5 mmol to 15 mmol (the
operating point about which the system is modelled is at 10 mmol). Over this range it
can be seen that the catechol concentration increases from just over 6 mmol to 7 mmol.
The flux to catechol is also shown and this increases from approximately 0.5 mmol/hr
to 1.3 mmol/hr over the range examined. The approximation is exact with respect to the
Michaelis-Menten approximation at the operating point and is accurate to over 98% even
at the edges of the range (data not shown for the lumped system, see Figure 2.13 for
results for the full system). Similar profiles can be obtained for any of the exchangeable
parameters i.e. the input, output and enzyme concentrations.
The flux and concentration control coefficients are found using the coefficients g1 and
hg and the matrices L and M from Eqn.(37). The concentration control coefficients are
found from the expression
3InX8y	 (1)
8lnX1
	3y
and the flux control coefficients from
amy
-g L
ôlnX1
(2)
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These coefficients are shown in Figure 2.6 which shows which components of the
system have the greatest effect on the level of the intermediate X 4 (catechol), and on the
fluxes which go to increase and decrease its concentration, V 4 and V. The results are
what would be expected from examination of the profiles in Figure 2.5 and also from
the physiology of the system. The greatest controlling element in the system is the first
lumped enzyme (comprising the effects of the first two enzymes in the pathway). This
has a flux control coefficient of 1.57 and a concentration control coefficient of 1.58.
Increasing the concentration of the second lumped enzyme in the pathway has a negative
effect on both the flux to catechol and the concentration of catechol, as can be seen
from the flux control coefficient of -0.52 and the concentration control coefficient of -
0.91.
The linear form of the power-law expression can be used to optimize the system using
standard linear optimization techniques. A very large amount of data is generated by this
technique, as a full set of optimal system parameters is generated for each objective
function tested. Because of this, the most convenient way of displaying the data is by
a density plot or by a 3-D plot. Figure 2.7a shows the optimal state of the system values
when each of the intermediate and enzyme concentrations is minimized in turn and
Figure 2.7b shows the optima achieved when these concentrations are maximized.
Figures 2.8a and 2.9b show the optima achieved when the system fluxes are minimized
and maximized, respectively. Examining the predicted system parameters for the
maximization or minimization of the system concentrations, it can be seen that they
correspond with the system control coefficients. For example, to maximize or minimize
the catechol concentration, X 4, it is necessary to maximize or minimize the concentration
of the first enzyme in the system which reflects its high control coefficients, which is
a predictable and physically reasonable result.
For flux optimization, it is the benzoate concentration which has the greatest effect.
Because A is a lxi matrix the condition number ic is automatically 1 and the system is
well-conditioned. This indicates that small errors in the input data will not cause a great
error in the results.
2.6.2 The Full Pathway
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This is the full pathway as shown in Figure 2.2. Applying the above tests to the TOL
meta-cleavage pathway shown in Figure 2.2 and described by the reaction matrix R,
above the following results were obtained:
In this set rank (N) = 7 = m'. This indicates that there are no dependent reactions in the
set so that the reaction set is a basis and N = N (K = I) and m0 = m'.
The number of degrees of freedom in the system is dr = 18 - 7 = 11 and the system is
conceptually realistic.
Table 2.2: Kinetic parameters for the TOL meta-cleavage pathway.
E	 k1	 K1	 K12	 K21
v1
	 600	 210	 7.62	 75	 -	 -
v2	12	 210	 0.05	 62	 -	 -
v3	1400	 200	 7	 200(a)	 -	 -
v4	 25	 195	 0.13	 89	 -	 -
v5	128	 180	 0.71	 30(b)	 -	 -
v6	105	 185	 0.57	 55	 -	 -
v7	120	 210	 0.57	 2(c)	 -	 -
v8
	5	 210	 0.02	 11	 -	 -
v9
	6000(d)	 100	 600	 20(d)	 -	 -
v10	 100	 100	 1	 18	 -	 -
v11	 51(d)	 195	 0.26	 15(d)	 -	 -
v12	 6	 195	 0.03	 23	 -	 -
v13	 120(d)	 230	 0.52	 30(d)	 -	 -
v14	 25	 230	 0.11	 21	 -	 -
100	 128	 0.78	 53	 -	 -
v16	 95	 128	 0.74	 34	 47	 32
v17	 80(e)	 250	 0.32	 100(e)	 -	 -
v18	 65	 250	 0.26	 74	 49	 62
The check for observability is that the number of rates which must be measured to
completely determine the system is equal to the number of degrees of freedom and in
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this case the number is 11. The rank of the matrix Ntm is 18 which is sufficient for
observability.
The steady state which will be examined is simulated by choosing realistic kinetic
parameters and metabolite concentrations of the same order of magnitude as those
obtained from the literature (see Table 2.2). Michaelis-Menten kinetics are assumed to
be valid and the simulated steady state is determined by solving the set of simultaneous
rate equations to obtain the results in Table 2.3.
To show the existence of a single steady state upon perturbation the Jacobian of the
system N. v is calculated and shown to be invertible. The eigenvalues of this matrix are
listed in Table 2.4. These are all negative, indicating the stability of the steady state.
To simulate the TOL meta-cleavage pathway using biochemical systems theory, the
pathway is written as shown in Figure 2.2(b) so that each of compounds affecting the
system is denoted by X 1 . X 1 to X4 are the exchangeable metabolites, X 5
 to X11 are the
non-exchangeable metabolites and X 12 to X29 are the enzymes of the pathway. Using
Eqn.s (30) and (31) the parameters a 1 , B1, g1j and h1 can be calculated from the kinetic
parameters in Table 2.2 to give a power-law model for the system given in Table 2.3.
Table 2.3: Power-law approximation for the TOL pathway
dX 5/dt = -1.797 x50 '°9x130889x2201 ' + 0.192 x10713x60°°'x120x230°°'
,1V IA - 1 A -ii o	 0.959	 0.999	 0.001	 1	 0.030 0.00003	 0.999	 0.00003uut - It.IL7 X6	 x14	 x23	 + J..OJh x5	x7	x13	 x
AV IA - A A 1 Q	 0.975 0.999 0.0003 0.00003UA'7(Lt - --t.i.tzo X.	 X15	 X20	 X	 +
0.034 0.831 0.055
	
0.037	 0.866	 0.052	 0.0809.22 x4 x6 x8
 x10 x14 x21 x25
	
0.596	 0.921	 0.078
	
0949 0.001	 0.972	 0.027dX8/dt = -0.545 x8 x16 x25	 + 43.113 x7 x9 x15 x26
0.556	 0.041	 0.944	 0.055
	
0.050	 0.972	 0.027dX9/dt = -1.928 x9 x1., x	 + 0.544 x8 x10 x16 x27
0.034	 0.628	 0.892.., 0.052	 0.055dX 1ddt = -0.337 x4 x10 x18	 21 X27	 +
1 795	 0.0003 0.048	 0.021	 0.973	 0.0003	 0.025x7	x9	x11	 x 1	 20	 x
0.007 0.006	 0.611	 0.991	 0.0080.752	 0.971	 0.028dX11/dt = -0.230 x 11	 x19 x28	 + 0.323 x2	x3 x10 x18 x29
Because there is no lumping of enzymes in this case, the dependencies of the rate of
change of the metabolite pools upon the concentrations of the enzymes are all
approximately first order i.e. to the power of 1.
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Table 2.4: Eigenvalues of System Jacobian
-9292.25, -3070.91, -7.931, -0.070, -18.736, -19.872
Solving the linear system of Eqn.(33) gives a solution of the form in Eqn.(37) so that
we obtain the two matrices containing the system sensitivities L and M. As expected,
most of these sensitivities are relatively small indicating that many of the system
components have little effect on each other or on the fluxes. A list of the largest
positive and negative sensitivities is given in Table 2.6. The system flux and
concentration control coefficients are illustrated more clearly in Figures 2.9 and 2.10
respectively.
Table 2.5: List of highest and lowest system sensitivities:
[i,j]	 lnVj	 [i, J]
	
lnX1/	 [i,j]	 lnXj
lnX	 1na	 lnX
[5,13]	 -5.806	 [8,9]	 -24.14	 [9,17]	 -19.96
[7,8]	 -1.353	 [9,9]	 -23.53	 [9,18]	 -2.59
[8,19]	 -1.267	 [7,9]	 -23.48	 [10,18]
	
-1.622
[7,13]
	
1.891	 [6,9]	 -20.36	 [5,1]	 6.537
[5,1]	 5.379	 [5,12]	 9.151
[5,12]	 6.531	 [9,13]
	
15.26
By varying the input metabolite concentration, profiles of the intermediate metabolite
concentrations and fluxes can be obtained and these are shown in Figures 2.11 and
2.12. The power-law approximation is exact at the operating point, but will be a poor
approximation at regions far from the operating point. This is illustrated in Figure 2.13
which shows how the power-law approximation deviates from the behaviour resulting
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Figure 2.10: Concentration control coefficients for the full system. These show that the
highest are C <5 <1 , C' 5 E1 , C <9E1 and C' 9 . This indicates that it is the first two enzymes
in the pathway which exert the greatest control and the metabolites which are most
affected are X5 and X9 (cis-diol and oxalocrotonate).
10
U
C
0
C-)
a,
4-
a,
a,
E
0
4-
C
SemialdehydE
Oxalocrotona
(enol)
Oxalocrotona
(keto)
'	 Dienoate
I
0.01 1
Flux to cis-diol
to catechol
1000
	 cis-Diol
Catechol
100
Oxovalerate
Benzoate Conc. (mM)
Figure 2.11: Predicted concentration profiles with changing input concentration.
600
550
500
450
. 400
0
4-
'3
: 350
a,
300
- - - - - -
- - - - - - — - -
— - - - - - - -
- - - -
C\J	 CD CD 0 C'J	 (0 CD 0
cJ	 C'J	 CJ	 CJ	 C')	 C')	 C')	 C')	 C')
Benzoate Conc. (mM)
Flux to semialdehyd
- - - - - - Flux to
oxalocrotonate
(enol)
Fluxto
oxalocrotonate
(keto)
Flux to dienoate
Figure 2.12: Predicted flux profiles with changing input concentration.

from Michaelis-Menten kinetics. It can be seen here that the predicted values of the
parameters vary in their deviations from the Michaelis-Menten values. It can be seen
that the deviation at either end of the range for cis-diol (X5) is quite small whereas those
for oxalocrotonate (X8), (X io) and (X11 ) reach values of up to 15% at the lower end of
the range.
Examining the sensitivity of the power-law system, the condition number (calculated
using the F-norm) is 124.5. This is a measure of the relative error in x as a result of
the relative error in A and b.
The results of the optimization of the system fluxes and concentrations are shown in
Figure 2.14 and Figure 2.15. These are again displayed as 3-D surface plots and as
density plots in order to show patterns of enzyme and intermediate concentrations.
2.7 Discussion
There are three issues to be examined, following from the results above: the behaviour
of the two-step system, the behaviour of the full system and how the two compare.
The flux control coefficients of the two-step system indicate that the initial benzoate
concentration and the activity of the first enzyme, the dioxygenase, have the strongest
positive influence on the flux V4, the flux which goes to increase the pool of catechol.
The flux which goes to decrease this catechol pool, V4, is affected by the backwards
first reaction and by the forwards second reaction. Not surprisingly, the same patterns
are shown for the concentration control coefficients for catechol, although the
coefficients differ quantitively.
Looking at the system parameters obtained when optimizing the concentrations of the
intermediates and enzymes in the pathway, it can be seen that the system is quite
insensitive to some parameters, for example, X 2 , X3 and E4 (pyruvate, acetaldehyde and
the lumped set of backward reactions). To maximize benzoate it is necessary that the
activity of the dioxygenase be kept low. To maximize the catechol concentration, the
dioxygenase activity should be as high as possible. The results for flux optimization are
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slightly trivial: to maximize V4, the initial benzoate concentration should be maximized,
to minimize V4, all of the system concentrations should be minimized. This is an
indication that to obtain meaningful flux optimization results, it is necessary to further
define the system.
The results obtained for the full TOL pathway are as expected for such a system. The
concentrations of most of the metabolites in the pathway vary little on changing the
input concentration. Only X5 and X9 show a significant change, increasing steadily with
increasing benzoate concentration. While this would have been predicted for X 5 (being
the second metabolite in the pathway and therefore directly affected by input levels)
the profile for X9 is more interesting as it is a result of the branched loop in the
pathway.
Most of the rates increase gradually with increasing metabolite concentration, the
exception being the flux to X5 which rises significantly. Looking at the profiles of the
concentrations and rates it is already possible to identify the bottlenecks in the pathway
in qualitative terms. The increase in both the concentration of X5 and the flux through
it, followed by the lack of change in the variables immediately after it indicate that the
first and second reactions in the pathway play a large part in controlling the rate
through the pathway. The increase in the concentration of X9 without a significant
increase in its rate of formation indicates that this is another bottleneck.
While these profiles can indicate where in the pathway such bottlenecks occur, they do
not quantify the extent of the control exerted or identify the rate and concentration
controlling species. For this information we must examine the system sensitivities.
Table 5 lists the highest and lowest of the sensitivities of the dependent metabolites with
respect to the independent metabolites, the sensitivities of the fluxes to the metabolite
concentrations and the sensitivities of the metabolite concentrations to the rate constants.
From the flux sensitivities we see that the first flux in the pathway is under the most
control, in that it is the most sensitive to changes in the input concentration, and in the
activities of enzymes catalyzing the first and second reactions in the pathway. The first
enzyme in the pathway is the most rate-controlling although all of its control is exerted
on the first flux in the pathway. The second enzyme in the pathway has a significant
controlling effect on several of the pathway fluxes and may be more important in that
respect.
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Looking at the concentration control coefficients, we see that X9 is under the most
control being strongly influenced by changes in the levels of X 1 and enzymes X 13 , X17,
X18 and to a lesser extent X21 . This is due to its position just before the branch point in
the system.
Again the levels of the input concentration and the first and second enzymes in the
pathway are seen to have a large effect on the concentration of X5.
The sensitivity information on the rate constants points to the rate constant for the X9
step in the pathway as having the greatest negative effect on several of the pathway
intermediates.
One of the more notable points about the system sensitivities is that the concentration
sensitivities are quite high. This is of interest in a system where many of the
metabolites are toxic to the cell as it indicates that changes made to the system in an
effort to improve the throughput flux may instead cause an increase in the
concentrations of toxic intermediates, impairing or killing the cell.
The initial benzoate concentration has a strong positive controlling influence on all of
the dependent system parameters as has the activity of the dioxygenase, B1 . This is
evident from their control coefficients and is in agreement with the results obtained
from the lumped two-step system. E2 has a strong positive influence on all of the
intermediate concentrations except that of benzoate. It can be seen from the density plot
in Figure 2.11 that the enzyme following each intermediate has a negative control
coefficient with respect to the concentration of that intermediate. The intermediate X9,
oxalocrotonate, displays a more complex pattern of control than the others and is
affected both positively and negatively by several of the system components.
The flux control coefficients are more straightforward. All fluxes are negatively affected
by the following enzyme, but to varying degrees: the flux to X 9 is the most strongly
affected by its degrading enzyme, followed by the first flux in the pathway, and all the
others are of a similar order of magnitude. The concentrations of benzoate and the cis-
diol have the greatest effect on VI.
Examining the optimization patterns of the metabolites in the pathway, the following
trends appear. To minimize the concentration of each component in the pathway it is
necessary to reduce the levels of X5 and X6 (the cis-diol and the semialdehyde) as much
as possible. For minimization of )Q, X7, and X8 , the enzymes E1 to E1 should be
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minimized except for the enzyme which degrades the compound in question.
To maximize the system fluxes, E 1 , E2, and E3 should in general be most active, X5
should be high and X6 low. The reverse holds for minimizing the fluxes. It should be
noted that the conditions for minimizing and maximizing V 1 are identical to those for
maximizing and minimizing V..1 respectively as is physically reasonable.
As an example, two objective functions have been chosen for optimization. The first
is the maximization of V.. 1 , the rate of degradation of benzoate; the second is the
minimization of X 11 , the toxic by- product, formate. The results for the maximization
of benzoate degradation indicate that the strategy should be to: (a) increase the benzoate
concentration in the cell by increasing the rate of transport into the cell and by
increasing the cell's tolerance to high benzoate concentrations; (b) minimize the
concentrations of the end-products, and (c) over-express the levels of the enzymes
catalyzing the forward reactions in the pathway. The minimization of the by-product
formate (X4) at constant benzoate concentration indicates that the end- product
concentrations should be minimized. Also the level of enzyme X 20 should be decreased
while that of X should be increased. This result indicates that increasing the level of
all of the enzymes in the pathway simultaneously will not necessarily result in increased
flux or improved performance. The positive rate-controlling enzymes must be identified
as above, and then cloned and over-expressed individually.
This program proposes a structured way of examining the behaviour of metabolic
pathways. Data can be either from in vitro kinetic data or in vivo fermentation data so
that it is of use in preliminary studies and fermentation design as well as fermentation
studies and process optimization. It has the advantage of examining processes at a basic
metabolic level so that it provides direction for genetic engineering programs.
The sensitivity analysis pinpoints the rate-controlling steps and shows where efforts
should be focused on removing bottlenecks so that yields can be improved. The
optimization routine indicates the set of operating parameters required for optimum
performance of the system as well as giving upper and lower bounds for productivity
and metabolite levels.
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3. MATERIALS AND METHODS
3.0 Introduction
The models in the previous chapter demand that a broad range of analytical techniques
be employed to yield the appropriate data. The primary requirement is that the pathway
intermediate concentrations be measured over a period of time to determine the transient
concentrations. This lead to several issues: firstly the fermentation must provide
sufficient density of cells to carry the plasmid encoding the pathway and these cells
must be of an appropriate metabolic state to express the enzymes of the pathway and
to supply the necessary cofactors for the pathway reactions. The levels of these enzymes
is dependent upon the copy number of the plasmid as well as the strength of the
pathway promoter. The rate at which the degradation of the pathway substrate proceeds
will be dependent on the substrate concentration as well as the enzyme levels so it is
desirable to have initial levels as high as possible without causing damage to the cell.
The analyses which must be performed on the system can be divided into two types:
those which will measure global fermentation parameters which are bulk properties of
the system and those which will measure pathway parameters which are specific to the
pathway of interest. Into this first group fall such parameters as pH, temperature,
dissolved oxygen concentration, CER, OUR, biomass, total carbon and total nitrogen
whereas the second group refers to specific metabolite concentrations and enzyme
activities.
Initial shake flask experiments were used for media optimization. The final fermentation
protocols was chosen on the basis of initial experiments as described in Section 4.1.
3.1 Strains
The strain used is Escherichia coli JM107 which has been transformed with a number
of different plasmids. The first of these is pQR15O. This plasmid is a derivative of
pBGS18 into which has been inserted the meta-cleavage pathway of the TOL plasmid
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Figure 3.1: The construction of the plasmid pQR 150 and the gene order of the plasmids
pQR185 and pQR 186.
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Figure 3.2: Miniprep of pQR 150 showing presence of plasrnid. Number 2 shows two bands
for the Xba Hindlil digest in lane 5 as expected.
from Pseudomonas putida (see Figure 3.1) with the natural promoter replaced by the
tac promoter. Presence of the plasmid was confirmed initially by DNA mini-prep and
gel (see Figure 3.2), where the presence of two bands in lane 5 indicates the correct
conformation, and subsequently by catechol dioxygenase activity, that is, colonies
containing the plasmid will convert colourless catechol solutions into bright yellow
coloured 2-hydroxymuconic semialdehyde.
The other plasmids studied, pQR185 and pQR186 were truncations of this pathway. The
gene orders for these plasmids are also shown in Figure 3.1.
Cultures were plated out on M9 minimal media agar plates (see below) and incubated
at 37°C until growth was apparent (approximately 12-18 hours). Plates were then stored
at 4°C and subcultured every 10 days. Stock cultures were stored in a 1:1
glycerol:media mixture at -80°C.
3.2 Media
Two types of media were used: one complex (LB) and one defined (M9). LB media
was composed of: tryptone (20 gIl), yeast extract (10 gIl), NaCI (10 gIl), with glucose
(30 g/l) as carbon source.
M9 media of the following formulation was used: Na2HPO4 (6 gIl), KH2PO4
 (3 gIl),
NaC1 (0.5 g/l), NH4C1 (6 gIl). This was stored as a 10 times concentration stock
solution for shake flask cultures and freshly made up for 1.5 1 fermentations. To this
was added CaC12 (10 mM) and MgSO4 (100 mM), stored separately as a 100 times
stock solution. Agar (1.5 %) was added for making up slopes and plates.
This media was supplemented either with thiamine or with 0.1 % yeast extract. Positive
pressure for retention of plasmid-bearing cells was exerted by the addition of 25 mgIl
kanamycin and the meta-cleavage pathway was induced by the addition of IPTG. Both
of these were sterile filtered through a 0.4 m filter (Gelman Sciences, Ann Arbor, MI,
USA) and added after sterilisation.
The carbon sources used were glucose (10 g/l), glycerol (10 g/l) and benzoic acid (2-20
mM). 1 Mm IPTG was used for induction of the tac operon of the meta-cleavage
pathway.
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Yeast extract was obtained from Difco, E.Moseley, Surrey. All other chemicals were
obtained from Sigma Chemicals mc, Poole, Dorset, U.K. A range of substrates was
supplied to the pathway. The primary substrates were benzoic acid and sodium
benzoate. Also used were p-toluic acid (4-methyl benzoate) and m-toluic acid (3-methyl
benzoate). When difficulties in dissolving the substrates occurred, 1 % ethanol was used
to solubiize them before adding to the medium.
3.3 Fermentation
3.3.1 Shake Flask Fermentations
Agar plates were prepared from stock cultures and incubated for one day at 37°C after
which colonies were tested for presence of the plasmid with catechol. These plates were
used to prepare overnight cultures in M9 medium, 1 ml of which was used to inoculate
the lOOml shake flask cultures. These were incubated for 12 hours at 37°C and 200 rpm
in an orbital shaker.
3.3.2 Batch Fermentations
Batch fermentations were carried out in a 2 L LH fermenter (LH Engineering, Reading,
Berkshire). The fermenter configuration process overview is outlined in Figure 3.3. A
combination pH electrode and a polarographic oxygen electrode, both manufactured by
Ingold, were used to measure pH and dissolved oxygen tension, respectively.
Temperature was also measured and off-gas analysis of CO2, 02 and N2 was carried out
by a VG MM 8-80 mass spectrometer. Temperature was controlled at 37°C and pH was
controlled at 7.00 by the addition of 2 M NaOH using TCS controllers (Worthing, UK).
DOT was kept above 40% by controlling the agitation rate. Data was acquired and
logged by either of two data acquisition systems: the first was a DEC PDP 11-73
operating the Bio-i (Biotechnology Computer Systems) and the second was RT-DAS
(Real Time Data Acquisition Systems). Two methods were used to control foaming: one
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was the addition of 0.5 mill PPG, the other, used to avoid the interference of PPG with
analysis was the use of a glass wool trap between the fermenter and the outlet ifiter as
shown in Figure 3.3.
Before sterilisation, the pH probe was calibrated to pHs 7 and 4 using standard buffers.
The DOT probe was calibrated to 100% air saturation by bubbling air through the
medium, and to 0% by bubbling nitrogen through and waiting for the reading to
stabiise. Having calibrated the probes, all inlet and outlet lines except the gas outlet
were clamped shut and all sterilisable connecter ends and electrical connections covered
with cotton wool and aluminium foil. The fermenter was then filled with 1.5 1 of
medium and the clamps closed loosely. The assembled fermenter was then sterilised by
autoclaving at 14 1°C for 20 minutes. The base addition cylinder was similarly sterilised.
On cooling the necessary attachments were made to the stirrer, pH, DOT and
temperature controllers and the heating and cooling fingers. The NaOH addition
cylinder was filled with 2 M NaOH and the stericonnectors joined aseptically. The
controllers were then switched on to allow the fermenter to reach a temperature of 37°C
and a pH of 7. The DOT probe was then re-calibrated to 0 % and 100 % by bubbling
nitrogen and air through, respectively. The air inlet was attached to a compressed air
supply and the air outlet to a mass spectrometer line.
A 1 ml overnight culture was used to inoculate a 150 ml shake flask culture in an
inoculation flask. This was added to the fermenter at mid-exponential phase of growth.
Just after inoculation, kanamycin was sterile filtered and added to a concentration of 25
mg/i. The initial stirrer speed was 400 rpm and the initial air flow rate 0.5 vvm. DOT
was kept above 40 % by manually controlling first the stirrer speed (up to a maximum
of 1000 rpm) and then the air flow rate.
Samples were taken hourly and the temperature immediately reduced to 4°C by
immersion in ice to minimize metabolic activity during sample processing.
Several fermentation and feeding regimes were used, as described below:
(i) Batch fermentation: M9 + 10 gIl glycerol + 10 mM benzoate
-pathway not induced
(ii) as in (i) but induced at t=0 with IPTG
(fli) Fed-batch: M9 + 10 g/l glycerol
-feed of benzoate + glycerol at stationary phase, pathway not induced
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(iv) as in (iii) but induced with IPTG upon addition of benzoate.
3.4 Analyses
3.4.1 Spectrophotometric Measurements
Spectrophotometric measurements were carried out on the whole broth at 560 nm to
measure the optical density (O.D.) and on the supernatant at 320 nm to measure the
concentration of hydroxymuconic semi-aldehyde. Samples were also scanned from 210
to 700 nm. The spectrophotometer used was a Beckman DU-700. A deionised water
blank was used to zero the readings. Samples were diluted to fall within the linear range
of the instrument.
3.4.2 Measurement of Biomass
1.5 ml eppendorfs were dried for at least 24 hr and weighed before analysis. 3 x I ml
of sample was placed in these dried, pre-weighed eppendorfs and spun down for 2
minutes at 10,000 rpm in a Beckman microcentrifuge. The supernatant was taken off
and retained, a second aliquot was added to each eppendorf and spun down again.
Supematant was again retained for analysis and the biomass was washed with lml
deionized water, resuspended and spun down. This washing process was repeated. The
eppendorfs with biomass were dried in a 100°C oven for 24 hours and then weighed.
The supernatant was stored at -20°C before analysis.
3.4.3 Presence of Plasmid
Presence of the plasmid and activity of the pathway enzymes was monitored by placing
catechol into a small amount of the fermentation broth. A bright yellow colour indicated
the presence of an active catechol-2,3-dioxygenase.
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3.4.4 Assays
Formate, pyruvate and glycerol were assayed using commercially available kits
(Boehringer-Mannheim, Lewes, E.Sussex).
3.4.5 Total Organic Carbon
Total organic carbon content of the broth and supernatant was measured by a Shimadzu
TOC-5050. This instrument works by introducing an aliquot of sample into a total
carbon combustion tube which is filled with oxidation catalyst and heated to 680°C.
Carrier gas is supplied into the combustion tube at a controlled rate and this carriers the
CO2 resulting from the combustion of the total carbon in the sample into an inorganic
carbon reaction vessel and then it is cooled and dried by a humidifier. It is then sent
through a halogen scrubber into a sample cell set in a non-dispersive infrared gas
analyzer (NDIR) where CO2 is detected. The NDIR outputs a detection signal which
generates a peak whose area is calculated by a data processor.
Both broth and supematant were diluted 1:10 to fall within the optimum range of the
instrument. Calibration curves were obtained by using potassium hydrogen phthalate in
concentrations of 0.1 0.5, and 1 C g/l as standard for total carbon and sodium hydrogen
carbonate and sodium carbonate in concentrations of 0.1, 0.5 and 1 C g/l as standard
for inorganic carbon. The sample was sparged with nitrogen for 1 minute before 4
washes of the system were carried out. Three repeat injections were routinely made
with a maximum of 5 if a coefficient of variance of 2 % was not initially achieved.
3.4.6 Total Nitrogen
Total nitrogen was measured using a LECO nitrogen analyzer. This instrument analyses
nitrogen in three phases: purge, burn and analyse. In the purge phase, the encapsulated
sample is placed in the loading head and purged of any atmospheric gases that have
entered during sample loading. The ballast volume and gas lines are also purged.
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During burn phase the sample is dropped into an 850°C furnace and flushed with pure
oxygen. The products of combustion, CO2, H20, N2 and NO are passed through a
thermoelectric cooler to remove most of the water and collected in the ballast volume.
In the analyse phase, a piston on the ballast is forced down and 10cc of the sample is
collected through the loop of the doser valve. The sample is swept through hot copper
to remove oxygen and to convert NO to N2, then through Lecosorb and Anhydrone to
remove CO2 and H20 respectively. The N2 remaining is measured by a thermal
conductivity cell which is based on a Wheatstone bridge which is balanced with helium.
Readings are given to 0.001 % with an accuracy of +1- 0.003 %, when the instrument
is operating in its optimal range of detection. This is in the range 0.01 g- 1.0 g
nitrogen. For amounts below this, the accuracy will decrease (to +1- 2 % for amounts
of 1 mg or below). This means that there is an optimum accuracy which can be
obtained with dilute samples by concentrating (e.g. by evaporation).
At least three air blanks measurements were made before each use, until the readings
were within +1- 0.003 % of each other. EDTA was used as a standard.
3.4.7 Capillary Zone Electrophoresis
3.4.7.0 Introduction
Capillary zone electrophoresis (CZE) is an analytical technique which separates
components in a mixture using electrophoresis, then measures the absorbance of the
components by IJV spectrophotometry. The result is a quantitative output similar to a
chromatogram called an electropherogram, but obtained by means of a different
separation principle.
3.4.7.1 Principle of Operation
The configuration of a typical CZE system is shown in Figure 3.4. It consists of a
silica-coated capillary, whose inner diameter can range from 20-200 m though it is
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of intermediates.
typically 50 or 75 m inner diameter and ranging from 7 to 100 cm in length, which
is filled with buffer and each end of which is immersed in buffer. After injecting an
amount of sample, a high voltage, up to 30 kV is applied across the capillary and this
causes the electrophoretic movement of the buffer as a whole and of the sample past a
detector window where a UV detector monitors the absorbance and the results are
logged.
The process that drives the separation is electroosmosis. This occurs because of the
surface charge properties of the ionizable silanol groups of the fused silica capillaries
which are in contact with the buffer. When a voltage is applied across the capillary the
wall becomes negatively charged to a degree which is controlled by the pH of the
buffer. This negatively charged wall attracts positive ions from the buffer, creating an
electrical double layer (see Figure 3.5), so that when a voltage is applied across the
capillary, cations in the solution move towards the cathode, in a process known as
electroosmotic flow. The electroosmotic flow is defined by the equation
V = __00	 47th
where € is the dielectric constant, j is the viscosity and is the zeta potential. The zeta
potential is related to the inverse of the charge per unit surface area, the number of
valence electrons and the square root of the electrolyte concentration. Since it is an
inverse relationship, increasing the concentration of the electrolyte decreases the
electroosmotic flow.
In CZE, when the voltage is applied across the capillary, the components in the sample
begin to separate into bands according to their electrophoretic mobility , which is
defined by
= q
I1ep	 6itqR
where q is the net charge, R is the Stokes radius and is the viscosity. That is, the rate
at which a compound will move is dependent upon its charge: mass ratio where the net
charge is usually dependent on the pH of the buffer.
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3.4.7.2 CZE Parameters
Analysis was carried out on a Beckman P/ACE 2000, controlled by System Gold
software. the capillaries used were 50 urn i.d and 50 cm length to detector (57 cm
overall). The analysis parameters were entered as a method and sample table on System
Gold. The method and sample table format and the system parameters are shown in
Figure 3.6. The buffers used were as follows: borate 50 mM pH 7.5, phthalate 10 mM,
pH 8.2.
3.4.7.3 Media
There will be always be a background caused by the media components. This may vary
over the course of a fermentation as media components are utilized by the
microorganism. For this reason it is preferable to be able to identify this changing
background rather than simply subtract the initial baseline from all subsequent
electropherograms. An electropherogram of M9 media whose formulation is given in
Section 3.2, identifying the contribution from the individual media components is shown
in Figure 3.7.
3.4.7.4 Standards
The compounds which were available in pure form and which could be used as
standards were: benzoate, catechol, pyruvate, formate, acetaldehyde, cis-diol and
oxalocrotonate. The wavelength at which each compound showed maximum absorbance
was determined by spectrophometric scanning and this determined what wavelength was
used in the CZE UV detector. The separation of benzoate, catechol, cis-diol and
oxalocrotonate in M9 media was obtained using a borate buffer system and is shown
in Figure 3.8 where all compounds are at 10 mM concentration. Calibration curves
were obtained by running standards at concentrations of 1 mM, 5 mM and 10 mM.
The separation of pyruvate, formate and acetaldehyde was carried out using a phthalate
buffer. Calibration curves were obtained by running concentrations of 1, 5 and 10 mM.
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3.4.7.5 Effect of Changing Composition
Over the course of a fermentation the ionic composition of the samples taken will
change. This is due to the utilisation of media components by the cells, the excretion
of metabolites such as organic acids by the cells, the presence of proteins and other
polypeptides from cell lysis, and the degradation of benzoate and the production of
pathway intermediates by the TOL meta-cleavage pathway. This change in ionic
composition will cause a shift in the migration times of the sample components as seen
in Figure 3.9. As the benzoate peak is easily identifiable throughout the fermentation,
this peak is used as a marker and all other peaks are assigned with respect to their
distance from the benzoate peak.
3.4.7.6 Effect of Antifoam
The antifoam agent used in these experiments was PPG. PPG acts as a surfactant and
so breaks down the foam formed by the culture. The effect of addition of PPG to a
fermentation on the CZE analysis is quite noticeable because of its surfactant nature.
This is complicated by the fact that it is difficult to relate the amount of PPG remaining
in a sample after the sample has been stored and processed, with that originally in the
fermentation broth. Only if a colloidal emulsion can be maintained in the sample
throughout processing and up to the time of analysis, can the PPG concentration be
assumed to be equal.
Figure 3.10 shows the effect of adding 0.5 ml!! PPG to M9 medium, when the PPG is
evenly suspended and the sample is analysed immediately, and when the sample has
been allowed to stand for 1 hr and has been centrifuged at 10,000 rpm for 10 minutes.
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4. FERMENTATION
4.0 Introduction
The purpose of the fermentation in this case is to provide sufficient information to
enable the calculation of the fluxes and of the control coefficients of the meta-cleavage
pathway. As these control coefficients will be calculated on the basis of transient
intermediate concentrations, it is necessary that the pathway produces and excretes to
the medium intermediates in concentrations great enough for analysis. To do this, it is
first necessary to define the system in terms of the pathways to be considered, the
cellular environment of the pathway in terms of the host organism, and the process
environment in which the pathway will operate. It is this last consideration which will
be examined in this chapter which will define the fermentation conditions and determine
the concentrations of the pathway intermediates.
The pathway engineering objective is to maximize the flux through the pathway i.e.
maximize the rate of degradation of benzoate. Without attempting to alter the pathway
by genetic means there are many process characteristics which can be optimized. These
fall into the broad categories of media, substrate feed and fermentation protocol.
The first requirement of the medium is that it provides sufficient carbon and nitrogen
for the required cell density. It must also provide salts and trace elements. Complex
media such as nutrient broth and LB media will usually result in higher growth rates
as amino acids and peptides are being supplied and the cell does not need to synthesize
them. However the cell may also use the amino acids as a carbon source so that it is
difficult to perform material balances. Minimal media overcomes this problem by
supplying only defined components to the cell. This also has advantages in that it
provides a low noise background for analysis. Choice of carbon source can greatly
influence the growth characteristics of the cell. One of the most common carbon sources
used is glucose. This is very easily and rapidly metabolised by E.coli, but causes the
production of acetate which represses growth.
Under the heading of fermentation protocol comes the issues of whether to run in batch,
fed-batch or continuous culture, fermentation volume, size of inoculum, point of
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induction, point of substrate feed. These issues are primarily decided on the basis of the
purpose of the fermentation and what is to be gained from it.
The stage in the fermentation at which the pathway substrate is introduced is also
crucial: whether it is at the stage of inoculation, at the beginning, middle or end of
logarithmic growth, or at the beginning of stationary phase will have different effects
on the cell physiology. It must also be decided whether the substrate is to be pulse or
continuously fed to the culture. A pulse feed will expose the cells to higher
concentrations of the toxic substrate but may increase the rate of degradation.
All of the above considerations must be taken into account when deciding on
fermentation conditions and were used to guide initial experiments.
4.1 Choice of Media
The choice of media was guided by the following considerations: it must give good,
rapid growth of E.coli JM1O7 and it must allow for easy analysis. The M9 minimal
media described in Section 3.2 had been used in the development of the strain and this
was the basic media which was chosen for use as it had historically given good growth
of JM1O7 and because it was a defined media which would simplify the analysis as well
as carbon balancing.
One possible carbon source for use was benzoate as this is degraded to form pyruvate
which is then passed to the central carbon metabolism. This would have had the effect
of linking cell growth directly to the TOL pathway performance. To examine its
performance as a carbon source a series of shake flask experiments were conducted, the
results of which can be seen in Table 4.1. This shows that benzoate cannot act as a sole
carbon source for the growth of E.coli JM1O7 pQR15O.
This indicated that an additional carbon source was necessary for growth of the
organism with benzoate supplied as a substrate for the pathway. Of the candidates for
this carbon source (glucose, lactose, galactose, glycerol) glycerol was chosen.
Because benzoate is toxic to E.coli (benzoic acid is a commonly used preservative and
anti-bacterial agent) it was also necessary to determine what is the allowable
concentration for growth of E. coil. For subsequent analysis it was necessary to use the
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highest possible concentration of benzoate that allows growth of the cells. In Table 4.1
it can be seen that at concentrations of above 10 mM , benzoate has a marked negative
effect on the cell densities achieved. On the basis of these cultures a working
concentration of 10 mM benzoate was decided upon.
Table 4.1: Shake-flask fermentations to examine effects of benzoate toxicity
Media
M9+ lOg/i glucose
M9 + lOg/i glucose + 1 mM benzoate
M9 + lOg/i glucose + 2 mM benzoate
M9 + lOg/i glucose + 5 mM benzoate
M9 + lOg/i glucose + 10 mM benzoate
M9 + 10 mM benzoate
Optical Density
(after 12 hours)
1.8
1.509
1.497
1.052
0.873
no growth
Initial fermentations run with M9 media and 10 g/l glycerol demonstrated poor growth
and a long lag phase. Both of these problems were eliminated by the addition of 0.1 %
yeast extract as is illustrated in Figure 4.1. This concentration of yeast extract is
sufficiently small to have a negligible effect on the CZE analysis (see Figure 3.8).
4.2 Effect of Benzoate and Plasmid Induction
The purpose of the initial fermentations was to determine the effect of 10 mM benzoate
and of plasmid induction on the growth of the plasmid-containing organism in a 2 1
batch culture. To achieve this, 4 fermentations were carried out, the results of which
can be seen in Figures 4.2-4.4. The negative effect caused by the metabolic burden of
plasmid expression can be seen from the CER, OUR and dry weight profiles. While
this expression is not fatal to the cells it has the effect of reducing the cell growth by
over half. In the presence of benzoate as substrate, this effect is counteracted somewhat
by the advantage of being able to convert benzoate to pyruvate, which can then enter
the central carbon pathway. The toxicity of benzoate is less evident in the induced cells
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as it is converted to a carbon source but since the effects are not necessarily additive
it is difficult to determine to what extent the contributions to the negative effects on cell
growth come from benzoate toxicity, plasmid induction and the toxicity of the pathway
intermediates. The RQ profiles shown in Figure 4.4 also vary depending on the
substrate and pathway induction conditions, although because of the extent of the noise
in the data the trends are less obvious. However it can be seen that the lowest RQ
values occur when the pathway is induced and supplied with substrate.
From the above information, the optimum fermentation protocol was defined. The
negative effect of plasmid induction upon growth suggested that the cells be exposed
to these conditions at the end of the exponential growth phase and just before stationary
phase. The toxic effects of benzoate were minimized by ensuring that the pathway was
fully induced before its addition.
The same initial fermentations were carried out for strains bearing the plasmids pQR 185
and pQR186 (see Figure 3.1 for the pathways encoded by these plasmids). The effect
of the substrate p-toluic acid was also examined. This substrate is degraded solely via
the dehydrogenase branch of the pathway, whereas benzoate is degraded by both
branches (although primarily via the dehydrogenase).
The effects of substrate and plasmid induction on the growth of pQR185 can be seen
in Figure 4.5. Induction of the pathway enzymes places a metabolic load on the
organism which causes reduced growth rates and a lower final cell density. The addition
of the pathway substrate benzoate seems to change this growth pattern, however. Both
substrates give higher initial growth rates than are obtained when the pathway is
induced in their absence: in the case of benzoate as substrate growth is higher over the
first 6 hours and then tails off, for p-toluic acid, the increase in growth occurs between
5 and 13 hours. In both cases, the final cell density is lower that the density achieved
with both M9 and M9 with IPTG. This is most likely due to the damaging effect of
these substrates on the cell membranes, thus reducing their viability.
The increased initial growth rate effect is also evident from the CER and OUR profiles
shown in Figures 4.6 (a) and (b). It can be seen from these that the CER and OUR of
E.coli pQR185 when the pathway is induced and supplied with benzoate are higher by
a factor of two at some points than when no benzoate is supplied and the pathway not
induced. These high values for CER and OUR do not occur when p-toluic acid is used
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Figure 4.3: This figure shows the variation in the CER (a) and OUR (b) of the strain
E.coli JM1O7 pQR15O with plasmid induction and.presence of 10mM benzoate. The
effects of benzoate toxicity is not as marked on the CER profile as on the growth profiles
.The OUR of the culture whan the pathway is induced and supplied with benzoate is
higher that would be expected from the biomass levels because of the oxygen
requirements (1 mole of 02 for eveiy mole of benzoate degraded).
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as a pathway substrate. In this case, values for CER and OUR are lower than those
obtained when no substrate is supplied. Values of CER and OUR are lowest for the
strain when the pathway is induced but no substrate is supplied.
Looking at the effect of fermentation conditions on the growth of pQR 186 in Figure
4.7, similar trends are evident. The presence of benzoate at a concentration of 10 mM
when the pathway is not induced causes a higher growth rate between 7 and 12 hours
but a lower final cell density than when benzoate is absent. Induction of the pathway
enzymes in the presence of benzoate has a further negative effect on cell growth and
final cell density. This is due to both the metabolic load placed on the cell by the
expression of the pathway enzymes and the toxic effects of the pathway intermediates.
The use of p-toluic acid as pathway substrate has a much more damaging effect on the
cell. There is almost no growth until after 14 hours and the final cell density is
significantly lower than each of the other cases. The CER and OUR profiles in Figures
4.8 (a) and (b) correspond well with the growth trends. All of the CER and OUR traces
show the same pattern of rising gradually to a highest point and then falling off
suddenly. What differs is the length of time over which this occurs and the maximum
CER or OUR value achieved. The greatest CER and OUR values (31.5 and 45.2 mM!
lh respectively) occurred during the growth of E.coli pQR 186 on benzoate without the
pathway being induced. After a 6 hour lag phase there was an increase over the
following 9 hours until the values dropped sharply. The time course was similar when
the pathway was induced and supplied with benzoate but the CER and OUR values were
lower, the maxima being 14.8 and 20.2 mM/lh respectively. When p-toluic acid is
supplied as a substrate to the induced pathway, the CER and OUR begins to rise only
after 15 hours, reaching maxima of 27.5 and 35.1 mM/lh respectively at 28.5 hours and
then dropping off. The lowest CER and OUR values correspond with the highest final
cell density achieved and occur when growing the strain on M9 without inducing the
pathway or supplying it with substrate.
There is a lot of noise in the on-line fermentation and gas analysis data as can be seen
in the CER and OUR profiles shown in Figures 4.2 to 4.8. The existence of out-lying
points in the gas analysis data was also a problem.
There were several causes for these outlying points in the data and these varied
depending on whether the data acquisition system was Bio-i or RT-DAS. The first was
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resulting from presence of pathway substrate and pathway induction by IPTG.
the interface between the mass spectrophotometer and the data acquisition system which
returned sporadic values of -9999 due to signal interruption. These occurred irrespective
of what data acquisition system was used. The second type of error was in the
positioning of the decimal point which occurred when using RT-DAS. An example is
shown in Table 4.2. The out-hers generated by this kind of error were much more
difficult to identify and eradicate than the first type, which were dealt with by a writing
an Excel macro. Setting an upper limit will eradicate some erroneous points but it is
generally not possible to set a lower limit. Also, as with any computer-based data
acquisition system there were a number of crashes during the fermentations and these
left "holes" in the profile data. While these can in most cases be easily removed when
analysing data historically, they can be a serious problem if data is to be used in on-line
control or decision-maldng and must be recognised if spurious results are to be avoided.
Table 4.2: Off-gas analysis data, showing the different errors which can occur
(underlined)
Time	 CER	 OUR	 RQ
(hours)	 (mMIlh)	 (mM/lh)
	
4.700287	 43.014	 76.537	 0.562
	4.840843	 Q	 Q
	4.940843	 40.601	 75.535	 0.5375
	4.990843	 40.375	 75.831	 0.5324
	
5.040843	 -9999	 -9999
	
5.090843	 46.311	 82.103	 0.564
	
5.140843	 46.224	 82.709	 0.5588
	
5. 190843	 46.2	 82.361	 0.5609
	5.240843	 37.035	 773.51	 0.0478
	
5.290843	 36.657	 765.76	 0.0478
	
5.340843	 36.657	 765.76	 0.0478
	
5.390843	 36.657	 765.76	 0.0478
	
5.440843	 46.704	 76.842	 0.6077
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Sodium
Calcium
Magnesium
Chlorine
Iron
All others
1
0.5
0.5
0.5
0.2
0.3 approx.
The presence of questionable measurements in the data can be seen in the RQ profiles
in Figure 4.4. Because the RQ is a quotient of the CER and the OUR it is very
sensitive and any fluctuations in these data sets are magnified. Because of this it is
difficult to identify trends.
4.3 Optical Density and Dry Weight Correlations
Throughout the range of the fermentations on pQR15O, pQR185 and pQR186, optical
density (O.D.) was a reliable indicator of biomass, even though the yellow compound
hydroxy-muconic semialdehyde was produced in fermentations where the pathway was
expressed. The correlation is shown in Figure 4.9. This shows the optical density as a
function of the dry weight obtained throughout the time courses of 15 fermentations.
This gives a linear fit with a coefficient of determination (R2) of 0.91. The different
symbol sets in this figure represent data from different fermentations. It can be seen that
the different data sets have slightly different correlations. The result of this is that the
individual data sets provide a better correlation (with an R2 of approximately 0.97) for
a particular set of fermentation conditions than does the overall correlation, which
should be used in the absence of an individual correlation.
Table 4.3: Elemental analysis of E.coli
Element	 % of dry weight	 Element	 % of dry weight
Carbon	 50
Oxygen	 20
Nitrogen	 14
Hydrogen	 8
Phosphorus 3
Sulfur	 1
Potassium	 1
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Figure 4.10: Correlation of biomass measured by dry weight with that measured
by total carbon
This indicates that this correlation can be used to provide a rapid estimate of biomass
for any fermentation of E. coil JM1O7 on M9 irrespective of any plasmid that it may be
carrying and whether or not the pathway is expressed.
4.4 Results of Total Organic Carbon Analysis
Total organic carbon analysis was performed on the whole broth and on the supernatant
from centrifuged samples. Total organic carbon is obtained by measuring the total
carbon and the total inorganic carbon and subtracting the two. The difference in carbon
content between the broth and the supernatant has previously been used as an estimator
of the biomass. An attempt was made to correlate the dry weight measured by carbon
analysis and that measured by spinning down, drying and weighing cells in eppendorfs.
To do this, the elemental analysis of E.coli shown in Table 4.3 (Bailey and 011is, 1986)
which gives the percentage of carbon present in an E.coli cell was used together with
the difference between the total carbon in the broth and the supernatant to give the
biomass.
Plotting the total carbon in the biomass (biomass.c) against the dry weight over 15
fermentations (see Figure 4.10), we find a much poorer correlation that obtained for the
optical density. A linear regression gives an R2 value of 0001. The scatter obtained
in these measurements was not reflected in repeatability of analysis of individual
samples, all of which showed a coefficient of variance of less than 2% over three
measurements. The repeatability was not noticeably worse in outlying points than in
points which gave the predicted result so that it was unclear whether these deviations
could be attributed to measurement error or whether they were reflections of what was
happening in the culture. These total carbon measurements are later used in carbon
balancing and can be used in on-line flux analysis. For this reason it is crucial to be
able to decide whether they are accurate measurements of the state of the culture, and
when a data point falls out of the region which is physiologically reasonable. To isolate
possible reasons for this variance and more closely identify its occurrence, the total
carbon data was looked at in more detail.
A problem with analysis of the errors in this data is that there is no perfectly correct
set of data with which to compare our results, so that the scatter in Figure 4.10 may
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be due to errors in the dry weight data as well as any present in the total carbon data.
For this reason it is instructive to use the dry weight:optical density correlations and the
Carbon emitted as CO2
 (C O2):Total Carbon in broth cFCb correlations to aid in
identifying where the error lies. For example, Figure 4.1 la shows the profiles of the
optical density, the biomass as measured by dry weight (d.w.) and the biomass as
measured by total carbon (biomass TC) over the time course of a fermentation of E. coil
JM1O7 pQR15O growing on M9/0. 1 % yeast extract media. It is seen that after 10 hours
there is a peak in the O.D. and biomass1. profiles which does not occur in the d.w.
profile. This is reflected in how these measurements correlate with each other in Figure
4.1 lb such that O.D. :biomass .rc gives a better correlation as reflected in the coefficient
of determination, R2 , than does d.w. :biomass.rc. This indicates that some of the error
may be in the dry weight measurements rather than in the total carbon measurements.
However, looking at how the carbon emitted as CO2 corresponds with the decrease in
total carbon in the broth in Figure 4.1 ic, it can be seen that there is an outlying point
which corresponds to the 10 hour data in Figure 4.1 la, signifying that the principal
proportion of the error resides in the total carbon data. If this data point were to be
considered as an outlier, then the R2 for the d.w. :biomass1. improves to 0.966 and the
CCO2:TCb 	 changes to 0.981.
One feature of the biomass as predicted by total carbon measurements is the notable
fluctuations in the data in the early stages of the fermentation, up to mid-log phase.
Because the biomass values being measured here are low, any experimental errors such
as those from dilution and the retention of media components by the biomass to be
weighed will be disproportionately reflected. This can be seen in Figures 4.12 and 4.13
which show the growth of strains containing the plasmids pQR 185 and pQR 186 growing
on M9/0. 1 % yeast extract media. In Figure 4.12, while there is a lot of scatter initially,
this ceases once the biomass reaches 1 g/l. A correlation using all data points gives an
R2 of 0.84 whereas if only those data points over 0.75 g/l d. w. improves the correlation
slightly giving an R2 of 0.88 but the slope is not greatly affected, changing from 1.03
to 1.05.
In Figure 4.13, it can be seen that the biomass data corresponds with the biomassd.w.
quite well except for one outlier at 8 hours. This outlier results from the TC b data
and is also present when comparing the carbon emitted as CO2 with the total carbon in
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the broth. If this point is regarded as lying outside the confidence limits of the data, the
R2 value for the d.w. :biomass 1. correlation improve from 0.75 to 0.94 and the R2 value
for CCO2:CTØ becomes 0.96.
It should be noted that in this case and in other cases where outliers occurred in the
biomassTC data, the variance was in the measurements of total carbon in the broth and
not in those of total carbon in the supernatant. This suggests that continuing metabolic
activity which may have occurred during handling and analysis of the sample may be
one reason for spurious results.
Despite the variability in the d.w. :biomass 1. correlations, the C 2 :TCb correlation
was, over all of the fermentations considered, quite good with a minimum R2 of 0.80.
The carbon emitted as CO2 is calculated from the cumulative CER using numerical
integration. Because the data is sampled every 3 minutes, the errors introduced by this
method are small. However, hardware or software malfunctions may have a significant
effect depending on the CER levels being measured. The slopes of the regression lines
are in general greater than one, indicating that there is a difference in the calibration
of the two measurement systems, the mass spectrometer pumps and the total carbon
calibration.
As mentioned above, further metabolism during sample preparation and analysis can
introduce errors not only because the production of CO 2 and its subsequent sparging
will cause an under-estimation of the total carbon present in the culture but also further
metabolism will effect a change in the pH of the sample and this will alter the
equilibrium of CO2 in the sample. Another source of error could arise from inadequate
or variable purging and this will result in an over-estimation of the total carbon present.
The total carbon data can be used along with the CER data to perform a carbon balance
over the system. This carbon balance can be used to provide estimates of the carbon
flux to by-products and of the carbon source concentrations in the fermentation. This
method and the results from the fermentations described above are outlined and
discussed in Section 5.1.1.
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4.4 Total Nitrogen Data
Total nitrogen data was collected to monitor the nitrogen consumption of the culture
over the course of the fermentation. It is theoretically possible to use this as an
indicator of dry weight, but the accuracy is significantly worse than that obtained by
total carbon measurements or by weighing. Also, because of the low levels of nitrogen
present in the fermentation broths studied (typically 0.01 %), it is necessary to
concentrate samples by evaporation in order to obtain reasonable results. This also
removes any time advantage as the analysis is the same as that for centrifuging, drying
and weighing cells.
Total nitrogen measurements can however be used as a measure of the total protein
content of a stationary culture. This data can be used to monitor protein production as
in, for example, the expression of the enzymes for a pathway.
4.5 Metabolite Concentrations
Measurements of specific metabolites were carried out by several means. Glycerol was
measured by commercial enzyme assay kits. Pyruvate, acetaldehyde and formate were
assayed by CZE with back-up analysis carried out by enzymic assay kits. Benzoate,
catechol, dienoate and oxalocrotonate were measured by CZE and hydroxymuconic
semialdehyde was assayed spectrophometrically. All of the above methods are described
in Section 3.4.
Analyses were carried out on the broth supernatant and also on the sonicant supernatant
in order to detect differences between intra- and extra-cellular levels of the metabolites.
Figure 4.14 shows the measured levels of hydroxymuconic semialdehyde from the broth
supematant and the sonicant supernatant. It can be seen that there is no significant
difference in the levels except at the 24-hour point where concentrations are higher in
the broth supernatant than in the sonicant supernatant. This is most probably caused by
the absorbance of the compounds onto the products of cell lysis which will be much
more prevalent after 24 hours than during the growth stage of the fermentation. These
results (which were similar for the other intermediates measured) indicate that the
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Figure 4.15: This figure shows the Concentrations of the pathway intermediates over the
time course of the stationary phase of a fermentation.
extracellular intermediate concentrations can be used as a good approximation of the
intracellular intermediate concentrations. The reason this leakage of the pathway
intermediates occurs may be due to the damaged cell membrane caused by the toxic
effects of benzoate. E.coli may also actively secrete the pathway intermediates to
minimise their toxic effect.
Because E.coli JM1O7 has no pathways for aromatic degradation, the pathway
intermediates were only measured for those fermentations where pathway substrate was
added and the pathway induced. The profiles of the intermediates benzoate, cis-diol,
catechol, hydroxymuconic semialdehyde and oxalocrotonate are given in Figure 4.15.
those for pyruvate, formate and acetaldehyde are shown in Figure 4.16. The profiles
in Figure 4.15 show the benzoate concentration decreasing at first rapidly, then
levelling off to a concentration of 2.5 mmol. This effect may be attributed to a decrease
in enzyme viability or perhaps to deactivation of the pathway enzymes by feed-back
repression of intermediates. Similarly the other pathway intermediates build-up quickly
at first and then level off to a steady concentration.
It is these concentration profiles which will be used to calculate the control coefficients
of the pathway in Section 5.2.
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5. FLUX AND METABOLIC CONTROL ANALYSIS
5.0 Introduction
In Chapter 2 it was demonstrated how predictions for the metabolic engineering of a
particular reaction pathway in a cell could be made on the basis of in vitro kinetic
parameters using techniques described in Chapter 1. Chapters 3 and 4 then described
the experiments and analytical techniques necessary to provide the data for the
verification of these predictions. This chapter will show how such data can be used for
the identification of rate-limiting enzymes by the calculation of flux control coefficients.
In doing this other issues which have been raised by Chapter 4 are addressed: for
example, what is the most appropriate "framework" which should be used to display
and interpret fermentation data, and how can data from on-line, bulk measurements
such as gas analysis be brought together with that from off-line, specific pathway data,
such as intermediate metabolite concentration measurements so that a useful analysis of
it can be made. A summary of the analyses performed on the data from the
fermentations described in Chapter 4 is shown in Figure 5.1.
This approach is an attempt to deal with the large amounts of data of different types
which are generated by a fermentation. Data can be categorised in a number of ways.
Firstly, it can be on- or off-line. On-line data is typically gathered at quite short time
intervals, every 3 minutes in the case of the mass spectrometer gas analysis in this
study. Because of the continuous nature of the signal, noise and out-hers will be more
evident. On-line data analysis tends by its nature to be rapid, so that it is reasonably
certain that what is being measured is that which is being experienced by the cells. For
off-line data, samples are generally taken at 30 or 60 minute intervals, with the results
of the analysis being available anything from immediately in the case of O.D. to 8
hours later for dry weights. Because of possible delay between sampling and analysis
it is necessary to minimize any changes which could occur in the sample from chemical
biodegradation and biological metabolism. (This is normally done by reducing the
temperature to at least 4°C, as described in Section 3.4.4.)
A distinction can also be made between measurements of bulk or lumped variables and
those of specific variables, since each requires different treatment. In this context, bulk
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variables can be defined as those variables which have several input or output points
in the physiological pathways or which are an agglomeration of more than one
component of the system. Examples of lumped variables are total carbon, total nitrogen,
CO2 evolved and 02 taken up and biomass. Examples of specific variable measurements
are those of specific pathway substrates or intermediates, glycerol or glucose
concentration, production of specific organic acids and the concentration of any
products of interest.
Because of the difficulties of dealing with data which differs both in the time-frame in
which it is taken and in the extent to which it is lumped, many of the models described
in Section 1.3.1 restrict themselves to just one type. For example, in the fermentation
models of Papoutsalds (Papoutsakis et al, 1986), bulk measurements of biomass and
CO2 are used, whereas in the structured model of Bacillus subtilis developed by
Backman (Backman et al, 1989), concentrations of each of the pathway metabolites
were required. In practical terms, however, both types of measurements are routinely
carried out so that it is necessary to have a modelling framework which is flexible
enough to be capable of incorporating different forms of data.
The framework outlined in this chapter for flux and metabolic control analysis is based
upon specific (such as pathway intermediates) and bulk (such as CO2 and biomass)
system concentration measurements. It uses a graphical programming system called
LabVIEW for data handling and flux analysis and the Mathematica based program
InVivo (described in Section 2.3) for the calculation of control coefficients. Because of
the modular nature of the LabView environment, it is possible to use whole existing
pathway modules, to link pathway modules in different ways and to create new
pathways. Data can then be fed in to calculate the fluxes through the system. The
program (or Virtual Instrument, in Lab View terminology) Carbon Fluxes uses lumped
data (biomass, total carbon, CO 2) along with specific metabolite data (benzoate
concentration) to provide estimates of carbon flux to by-products and carbon source
concentration. The program pQR15O calculates the system fluxes for the case where a
pathway which feeds into the central carbon pathways is introduced into a
microorganism. This program illustrates the capability of the programming environment
to combine new pathways with those existing.
The system fluxes calculated in this way are used for the calculation of the control
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coefficients as described in the second part of the chapter.
The program Central Carbon examines the fluxes through the central carbon metabolism
of E.coli HB1O1 growing aerobically on glucose and producing a mixture of organic
acids, and how these fluxes are altered in a mutant, deficient in the enzymes for acetate
production.
The second part of this chapter describes the calculation of the control coefficients for
the TOL pathway from transient fermentation data. This requires a slightly different
programming approach, which is described in Section 2.3 and this is explained in detail
in this chapter. With improvements in graphical user interfaces and the development of
software which can be run on several platforms it will be possible to combine these two
approaches.
5.1 Flux Analysis
5.1.0 Introduction
The analysis of the fluxes through the metabolic pathways of an organism is a technique
which can be used to process fermentation data, identify control points in a pathway
and, as described below, increase fermentation productivity. By measuring the inputs
and outputs from a pathway of interest, we can calculate the fluxes through the steps
in the pathway for different fermentation conditions. An analysis technique of this kind
can be used in several ways:
1) In the case of an already established process, flux analysis can determine what
proportion of the carbon flux is being directed towards the product of interest and
examine the effect upon this of changes in fermentation conditions. It may identify a
need for additional analysis of by-products.
2) Where a process is at the development stage, the identification of control points and
overflows to waste by-products can be used to direct genetic engineering efforts, either
to overcome the regulatory mechanism or to eliminate the flow to by-product.
3) It can be used in a predictive way, for examining the effect upon the system fluxes
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of the addition of new pathways to an existing system. For example, it would be
possible to determine the increased demand for reducing equivalents and the subsequent
changes in central carbon metabolism occurring as a result of a new pathway.
4) A flux analysis system forms a useful and intelligent framework upon which to
"hang" fermentation data, that is, a wide range of fermentation parameters, from
overall off-gas analysis to individual secondary metabolite concentrations can be
correlated and presented using this technique, and mass balances carried out.
5.1.1 Method
Setting up the pathway:
There are three initial steps which must be followed for the flux analysis of a process:
1) Identify the important metabolic pathways or groups of metabolic pathways in the
process of interest.
2) Write down all of the compounds which are or will be analysed in the process.
3) Using 1) and 2) as a basis for simplification, write down the metabolic pathway for
the system. This step in itself is extremely instructive, as it may identify by-products
which require analysis.
There are a range of pathway modules already constructed in the software, and these
should be reviewed before programming any new pathways as novel pathways can often
be constructed by altering those already present.
5.1.2 Construction of the pathway modules
In LabVIEW, because it is designed primarily as an instrumentation tool, the program
modules which handle the data, describe the pathways and output the date are known
as virtual instruments (VIs). A Lab VIEW VI consists of a front panel, a block diagram
and an icon/connector. The front panel is the user interface, the block diagram is the
VI source code and the icon/connector is the calling interface. A block diagram contains
inputloutput, computational and sub VI components, which are represented by icons and
interconnected by lines directing the flow of data. SubVI components call other VIs,
passing data through their icon/connectors. Thus there is a hierarchy of VIs which is
ifiustrated in Figure 5.2. The CCM (Central Carbon Metabolism) VI is the controlling
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VI in this case (more complex systems could have additional VIs such as secondary
metabolite or protein production) and it contains several sub-VIs which can be grouped
into three types according to their function: data reading and manipulation, pathway
blocks and data output. This group of subVls had a further set of subVls: the data
reading VI, READ DATA, uses a LabVIEW-supplied subVl which reads data from
disk into an array, the FLUX VI has a subVl called calc mu for specific growth
calculation, a flux calculator and a difference calculator. The pathway modules have as
their subVls a set of stoichiometric reactions, 1> 1, 1->2, 2->!, 1->3, and so on.
These are linked together to construct the metabolic pathways.
The data reading and manipulation VIs are READ DATA, and FLUX dp/dx.. Their
function is to read in a file of metabolite and biomass concentration data (in text format)
and to convert this to input and output fluxes. The FLUX dp/dx. VI contains three
sub VIs: DATA F'MT for converting the concentration array to an array of
concentration differences, a sub-VI for calculation of specific growth rate called caic
mu, and FLUX CALC, which uses the specific growth rates and the concentration
differences to calculate the fluxes. Fluxes are calculated by multiplying the throughput
(mmol metabolite produced or consumed per g biomass produced) by the specific
growth rate.
This flux data array is then broken up so that the appropriate sets of input and output
fluxes are sent to each pathway sub-VI. It should be noted that while in physiological
terms some of the fluxes are inputs (e.g. glucose) and some are outputs (biomass,
acetate etc.), in data computational terms, all the data fed to the program can be called
inputs. This distinction between physiological inputs and outputs and data inputs and
outputs is quite important and care must be taken not to confuse the two.
5.1.3 Meta-Cleavage Pathway
The representation of the TOL meta-cleavage pathway as expressed in E.coli using the
Pathway Builder program is shown in Figure 5.3 (full documentation and listings are
given in Appendix D). This pathway has benzoate as its sole flux input and pyruvate,
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acetaldehyde and formate as its flux outputs, as E.coli has no native mechanisms for
degrading aromatics. Two parameters are required for the calculation of the fluxes in
this pathway. In this case, the chosen parameters are the benzoate and formate
concentrations. From these, the pyruvate and acetaldehyde fluxes are calculated and are
then passed on to the central carbon metabolism VIs.
There are two central carbon metabolism VIs: one for glucogenesis and the glycolysis
of glycerol to acetyl C0A, GLYC(glycerol), and the other for the TCA cycle, TCA.
GLYC(glycerol) has as its inputs: glycerol, lactate, acetate, ethanol, pyruvate and
acetaldehyde fluxes and differential biomass i.e. biomass 1 -biomass . The biosynthesis
stoichiometries are entered on the front panel and the defaults are those for E. coli. The
output fluxes are those for glucose-6-phosphate, pyruvate, acetyl CoA and the flux of
PEP to oxaloacetate. The last two act as inputs to the TCA VI.
The TCA VI calculates the fluxes in the TCA cycle. Its inputs are the acetyl CoA and
PEP to oxaloacetate fluxes from the GLYC(glycerol) VI, the succinate flux and
differential biomass. Again, the biomass stoichiometries are entered on the front panel
and can be altered from it. The outputs are the oxaloacetate flux and the oxaloacetate
requirement from PEP to make up for use of the TCA cycle intermediates for biomass
synthesis (this last flux is passed to the GLYC VI to calculate the PEP to oxaloacetate
flux). The fluxes calculated are then plotted directly onto the front panel as well as
being stored as a spreadsheet file.
5.1.3.1 Results
The metabolite concentration profiles which occur during the growth of E.coli pQR185
on M9/IPTG/benzoate are shown in Figure 5.5. In this case the acetate levels can be
calculated from the carbon flux to by-products as acetate is the only organic acid
produced in detectable quantities by E.coli JM1O7 [Turner et a!, 1994]. The benzoate
concentration decreases rapidly for the first 5 hours and then remains steady due to the
inactivation of pathway enzymes by the pathway intermediates (in particular that of
catechol-2,3-dioxygenase by hydroxymuconic semialdehyde). The growth rate was low
for this fermentation due to the inhibitory effect of benzoate and the metabolic load of
plasmid expression and the final cell density was 1.4 g/l.
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The metabolite fluxes for the system are shown in Figure 5.6. Because of the initial
small changes in biomass as compared to glycerol uptake, the initial fluxes to G6P and
pyruvate are very high but quickly drop.
The specific growth rate (jz) shows a substantial variability throughout the course of the
fermentation. This is characteristic of specific growth rates calculated from dry weight
measurements because of inaccuracies in the measurements and is particularly evident
at the lower end of the scale as in this case. The variation in will cause a variation
in each of the calculated fluxes as flux is defined as the product of throughput and .
However this variation is not as evident in the other fluxes. The calculation of the
specific growth rate could be improved by using the O.D. as a measure of biomass
rather than the dry weight. It can be seen that when dry weight increases at 9 hours
there is a corresponding increase in and in the flux from PEP to oxaloacetate to make
up for the loss to the TCA cycle from the supply of precursors for biosynthesis. The
trend in the flux from PEP to oxaloacetate follows that of the specific growth rate, but
it is offset by one time point as the growth rate at one point provides the estimate for
the flux to oxaloacetate needed at the next time point.
The fluxes to pyruvate and to acetaldehyde are significantly greater than the other fluxes
in the system. It is a build-up of these metabolites which causes overflow to by-
products, in this case, acetate. Pyruvate is also supplied to the central carbon
metabolism from the TOL pathway causing high levels of intracellular pyruvate which
may account for the high production of acetate seen in Figure 5.10. These relatively
high pyruvate and acetyl CoA fluxes with the corresponding over-production of acetate
indicate that there is a bottleneck occurring at this point.
5.1.3 Production of Organic Acids
We wish to perform a flux analysis to study the effect of blocking the pathway to
acetate in E.coli K-12. This was achieved by using a strain which carried deletions in
the genes ack and pta, encoding the enzymes acetate kinase and phospho-transacetylase
respectively. In addition, an attempt was made to reroute the carbon flux to ethanol by
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Figure 5.7: Schematic of central carbon pathway used for flux analysis, showing outputs to biomass,
CO2 and byproducts.
introducing a plasmid carrying the genes for alcohol dehydrogenase. This strain
produces a range of organic acids during aerobic growth on glucose, one of which is
acetate.
The experiments carried out were aerobic fermentations on complex media (LB) with
glucose as carbon source. Samples were taken at 30 minute intervals and were analysed
for biomass, glucose, and the following organic acids: pyruvate, acetate, formate,
succinate, lactate [L.Regan, M.S.Thesis, 1990, Diaz-Ricci et al, 1991].
From the above information it is possible to draw out a metabolic pathway. The outputs
to biomass are calculated as mmol of intermediate used per g of biomass produced.
These figures are calculated from the monomeric composition of E. coil (Dawes and
Large, 1973).
The data must be entered in the following order:
time (hrs)	 metabolites	 (mmol)	 biomass (gil)
The order of the metabolites will determine which numbers are used in the case loops
when the appropriate data columns are cut out for the different pathway blocks (see
documentation in Appendix D). The VI CCC then calculates the intermediate fluxes of
the system and outputs a user-determined selection of these by means of the sub-VI
PLOT FLUX.
Three cases are considered below: the first is the wild type (K-12), the second is the
mutant TA3476 which is deficient in pta and ack, the third is the same mutant bearing
a plasmid bearing the "pet" operon which expresses the enzymes pyruvate
decarboxylase and alcohol dehydrogenase.
5.1.5.1 Results
Figure 5.8 (a) shows the metabolite concentrations for the wild type K-12 growing on
glucose. Here, the primary organic acids produced are lactate, acetate and succinate.
Examining the fluxes and specific growth rate z in (b), it can be seen that the initial
pyruvate flux is low, the specific growth rate reaches a maximum at 2.5 hours and
afterwards decreases. At this point the pyruvate flux starts to increase, corresponding
to the increasing organic acid levels in (a). The oxaloacetate flux is high initially and
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decreases as glucose utilisation increases and specific growth rises. It reaches a
minimum at 3 hours and then begins to rise, after which time it follows the pyruvate
flux trend. This can be explained by the fact that when glucose utilisation is low, the
cell is utilising the TCA cycle. As this increases and the cell is generating enough ATP
from glycolysis, the TCA cycle is disconnected and the cell produces organic acids to
maintain the redox balance. As above, the flux from PEP to oxaloacetate follows the
specific growth rate but offset by one data point in response to the requirement of
precursors for biomass synthesis from TCA intermediates.
Comparing the performance of the ackipta deficient mutant TA3476 shown in Figure
5.9, the most significant difference is in the excretion of pyruvate at 4 hours. This
occurs as a result of the very large pyruvate flux seen in Figure 5.9(b) at 2.5 hours.
This apparently acts as an inducer for the excretion of pyruvate and also for the
expression of an alternative pathway for the production of acetate. The specific growth
rate of this strain is lower than that for the wild type and reaches a maximum at 4.5
hours before decreasing. The rest of the system fluxes are comparable to those for the
wild type and follow the same trend.
In Figure 5.10 it can be seen that the effect of including the pet operon (encoding
enzymes for ethanol biosynthesis) in this mutant is to utilise these high levels of
pyruvate in the production of ethanol and prevent the expression of the alternative
acetate pathway. This strain produces more ethanol than either the mutant without the
plasmid or the wild type. The succinic acid production is also higher. The pyruvate flux
in Figure 5.10(b) is the lowest for any of the strains, showing the efficacy of this
technique of rerouting the carbon flux. The oxaloacetate flux rises as succinate is
excreted and then drops sharply. The specific growth rate is very low however as is the
final dry weight. This indicates that just preventing the production of acetate will not
necessarily lead to higher growth rates or biomass. In this case the metabolic load
incurred by bearing the plasmid out-weighed the advantages of reducing the production
of acetate.
The above examples illustrate how flux analysis can be used to draw conclusions about
the physiology of a system from the measurement of external parameters once the
reaction pathways are known. Because of the way that internal fluxes determine the
external fluxes it can also be used as part of a control strategy. For example in Figure
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5.9, the increased pyruvate flux causes the production of organic acids and this could
be used as the basis of a control strategy.
There are several advantages to using graphical programming language in this kind of
analysis. The first is the ease with which new pathways can be constructed and existing
pathways altered. This is crucial when working with microorganisms whose reaction
pathways may differ with a change in media or carbon source, as well as with the
introduction of a plasmid bearing non-native pathways (as in the case of E.coli
pQR15O). Also it is intuitively easier to work with graphical reaction elements (as
opposed to stoichiometric reaction matrices) and errors can be more easily detected.
Finally it is essential that software for this kind of analysis can be interfaced to
fermentation and analytical instrumentation, so that on-line analysis can be performed.
This is easily done in LabView which contains application-specific libraries for data
acquisition, VXI, OPIB and serial instrument control, data analysis and data storage so
that a range of Vi's can be constructed for the development of a complete on-line
system for flux analysis.
5.2 Calculation of Control Coefficients
The previous section has dealt with the calculation of the fluxes through a metabolic
system and has described how some of the regulatory characteristics of the system can
be identified from a flux analysis. This method is limited, however, in that it requires
qualitative judgements to be made about the importance of any individual enzymic
reaction based upon observing all of the fluxes in the system. What is needed is a
quantitative measurement of how influential each external concentration or enzyme level
is in regulating the system such as is provided by the flux and concentration control
coefficients described in Section 1.2.1. These have been calculated for the TOL
pathway in a simplified and full form using kinetic data in Section 2.6 and these figures
can be verified by calculation of the control coefficients using the transient
concentration data obtained for the system as described in Section 4.6. The calculation
of these coefficients using transient concentration data is based on the method developed
by Delgado and Liao [1990, 1992] described in Section 2.4. The program InVivo
described in Section 2.4 and listed and documented in Appendix D is used to calculate
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the flux control coefficients from the stoichiometric matrix and the concentration data.
In this section the two systems based on the TOL pathway are analysed: the first is the
simplified two-step system shown in Figure 2.7, the second is the system shown in
Figure 5.16.
Table 5.1: Data required for calculation of control coefficients of lumped system.
Time	 Benz	 Pyr	 Acet	 C'chol
(hours)	 (mM)	 (mM)	 (mM)	 (mM)
0
	
10
	
0
	
0
	
0
2
	
7.7
	
0.65
	
0.65
	
0.01
3
	
6.98
	
0.83
	
0.83
	
0.02
4
	
5.66
	
0.71
	
0.71
	
0.02
5
	
4.62
	
0.69
	
0.69
	
0.02
6
	
4.36
	
1.04
	
1.04
	
0.01
7
	
4.40
	
1.05
	
1.05
	
0.015
8
	
4.37
	
1.07
	
1.07
	
0.01
9
	
4.47
	
1.09
	
1.09
	
0.11
5.2.1 The two-step system
This system (shown in Figure 2.4) lumps the TOL pathway into two reaction steps: one
from benzoate to catechol, the other from catechol to pyruvate and acetaldehyde.
Because of the ease of obtaining and analysing these compounds, lumping the system
in this way allowed for a rapid control analysis of the pathway. This method allows
the calculation of a control coefficient for each section of the pathway. Depending on
this result it can be decided what refining of the lumping system is required: for
example, if the overall control coefficient for a section of the pathway is negligible, it
may not be necessary to investigate this part of the pathway further whereas a high
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control coefficient for a lumped pathway indicates that additional data should be
obtained to determine exactly where the controlling effect lies.
The data required for input to InVivo.m is shown in Table 5.1. It consists of
concentration data for benzoate, catechol, pyruvate and acetaldehyde over a time period
of 8 hours. The stoichiometric matrix for the lumped system is the same as that used
in Section 2.6 and the number of non-exchangeable metabolites and the number of time
points is also required as input. 'U' and 'M' are parameters required for the NAG
subroutine CO5NBF as described in Appendix D.
5.2.1.1 Results
The flux control coefficients for this lumped system are shown in Figure 5.11. In this
figure it can be seen that the control resides primarily in the first two enzymes in the
pathway. To determine how this control coefficient is partitioned among these two
enzymes it is necessary to monitor the cis-diol concentration. In addition, the control
coefficient for the second part of the pathway is not insignificant. This indicates that
useful information can be gained by further refining the analysis of this part of the
pathway by the measurement of more intermediate concentrations.
1 T	 0.963
0.8
0.7
E0.5
C) 0.4
gO.2
0.1
Lumped Enzyme
Figure 5.11: Control coefficients for the two-step system.
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5.2.2 The Refined System
The results from the previous section indicate that the lumped step with the greatest
control coefficient should be refined. This requires analysis of the cis-diol so that
control coefficients can be assigned to the first two enzymic reactions in the TOL
pathway. The refinement of the second lumped step is of less importance, as the control
coefficient is smaller but it is of interest to see where the control lies. The additional
metabolites in the pathway which were analysed were cis-diol, hydroxymuconic
semialdehyde, oxalocrotonate and formate (see Section 3.4 and 4.5). This resulted in
the more refined (but still lumped) system which is shown in Figure 5.12 with its
stoichiometric matrix. The data from the intermediate concentration profiles in Figure
4.15 is used as input to InVivo.m (using the same format as shown for the two-step
system in Table 5.1) along with the stoichiometric matrix in the same way as for the
two-step lumped system. The results for the set of data in Figure 4.15 are shown in
Figure 5.13. These are presented as a bar chart with the appropriate reactions
underneath.
5.2.2.1 Results
The flux control coefficients are presented in Figure 5.13 and in Table 5.2. These
indicate that the control over the pathway resides primarily in the first and second
enzymes in the pathway. There is also a small control coefficient of 0.106 for 4-
hydroxymuconic semialdehyde hydrolase. The control coefficient for the last 4 lumped
enzymes in the pathway is small enough to indicate that it may not be necessary to
make the necessary intermediate measurements to further refine the analysis of this part
of the pathway. The sum of these control coefficients is 1.109 which is greater than the
value of 1.0 predicted by the flux control coefficient summation theorem (see Section
1.2.1).
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Table 5.2: Control coefficients for full system.
Enzyme	 Control Coefficient
toluate-1 ,2-dioxygenase 	 0.508
1 ,2-dihydroxycyclohexa-3 ,5-diene- 	 0.463
carboxylate dehydrogenase
catechol 2,3-dioxygenase 	 0.002
4-hydroxymuconic semialdehyde	 0.106
hydrolase
Lumped enzymes [40T,40D,OEH,
	 0.03
HOA]
5.3 Discussion
The agreement between the lumped and the refined system is very good proving that
this lumping technique can be used as a method of top-down analysis. This is useful
when analysing large systems where a system may be lumped intelligently using
available physiological and regulatory data. This will have the effect of high-lighting
key areas in the system which are of regulatory importance. Lumping will also be
necessary in cases where it may be difficult to assay certain metabolites. In this case
a control coefficient can be used to determine the importance of refining the system as
compared to the time and cost of developing an assay for the metabolite(s) in question.
There are some differences between the system control coefficients as calculated from
kinetic parameters and those from the transient concentration data. There are three
significant flux control coefficients in Figure 2.9. Two of these are from the two first
enzymes, TO and DCHDH, which are the rate controlling enzymes in Figure 5.13,
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although the figures are higher. The third is for the enzyme 40T which is a part of the
lumped enzyme ES in Figure 5.13 and which shows no significant control coefficient
when measured using concentration data. However, the high control coefficient for OT
was attributed to the functioning of the hydrolase branch of the pathway (see Figure
1.18). This is active on degradation products of benzoate in vitro but in vivo the
dehydrogenase branch is used preferentially which is confirmed by the low levels of
formate detected. Because of this the pathway is essentially operating as a linear
pathway and the control resides in the first two enzymes.
There are several reasons why the control coefficients obtained from concentration data
differ from those calculated from the kinetic data in Section 2.6.2. The first is that the
kinetic parameters obtained in vitro are not an accurate reflection of the reaction
kinetics in vivo. One cause of this is the deactivation of the pathway enzymes by the
build-up of pathway intermediates. This will cause a change in the kinetics of the
affected enzymes such as catechol-2,3-dioxygenase as the reaction proceeds and this
effect has not been included in the modelling of the system in Chapter 2.
5.3 Conclusion
The modelling techniques in Chapter 2 were found to provide good qualitative
predictions for the system flux control coefficients, once the difference between enzyme
reaction kinetics in vitro and in vivo had been noted and accounted for. There is poor
agreement in quantitative terms but this does not detract from the use of this approach
to indicate areas of reguLatory importance in large systems.
The results for the TOL system were as expected for such a pathway. With benzoate
as substrate, it functioned in an essentially linear mode and the control resided in the
first two enzymes. This indicates that the first step in engineering this pathway should
be to increase the expression of TO. There is however a flux control coefficient of
0.106 for HMSD. This is significant because when the first enzyme in the pathway TO
was over-expressed, there was a three-fold increase in the concentration of
hydroxymuconic semialdehyde. This indicates that in the engineered pathway there may
be a shift in the control features and a recalculation of the control coefficients might
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implicate HMSD. This is particularly important because of the deactivation of catechol
2,3-dioxygenase by hydroxymuconic semialdehyde and leads to the consideration of
non-genetic methods for flux maximization, such as the continuous removal of
hydroxymuconic semialdehyde so as to keep the equilibrium on the right hand side of
the forward reaction.
Secretion was not an issue in this study because of the similarity of the intra- and extra-
cellular intermediate concentrations. This would not have been the case if the pathway
had been studied in its native host Pseudomonas putida, firstly because membrane
damage due to pathway intermediates would not have occurred and secondly because
the function of the pathway in Pseudomonas is to supply the central carbon pathway and
benzoate can be used as a sole carbon source. A similar study of the TOL pathway in
Pseudomonas would require that the effect of secretion be taken into account. In
addition there are several other pathways in Pseudomonas which degrade TOL pathway
intermediates such as catechol (see Section 1.3.1) and the effect of these pathways
would have to be included in the model. For these reasons, a control study of the TOL
pathway in a host other than E.coli would not be expected to give similar results.
A vital feature of this type of analysis software is its ease of use and its compatibility
with fermentation and analytical instrument. This has been addressed by using a
graphical programming language to provide a front end and perform a flux analysis.
With the interfacing of this to instrumentation and to the control analysis software, this
provides a complete on-line system for flux and metabolic control analysis.
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6.0 CONCLUSIONS AND FUTURE WORK
In this work a systematic approach has been applied to the metabolic pathway analysis
of the TOL pathway. This approach consists of modelling the system using kinetic data
to predict the rate-limiting enzymes, using transient fermentation data for the
verification of the predictive results and then altering the pathway genetically for
improved performance. To do this successfully requires a knowledge of the physiology
of the system and a systematic approach to collecting and interpreting data from the
system.
The software written in this study for the predictive modelling of the TOL pathway was
based on a power-law approximation from biochemical systems theory and metabolic
control theory and can be used for the control analysis of any metabolic system for
which kinetic data is available.
A control analysis using this software indicated that the first two reaction steps in the
pathway were the rate-controlling enzymes. Sensitivity analysis showed that the
metabolites in the pathway most sensitive to perturbations were cis-diol and
oxalocrotonate. Because the system was now approximated by a power-law formalism,
it was also possible to apply linear optimization techniques to determine the set of
system parameters necessary to maximize or minimize a particular system variable,
such as a flux or concentration.
To verify the results obtained from a power-law approximation using kinetic data,
control coefficients were calculated from transient concentration data. This required the
development of analytical techniques for measurement of the concentration of the
pathway intermediates. The principal analytical technique used was capillary zone
electrophoresis, where the separation is by electrophoresis and the detection by
spectrometry. Initially, only benzoate, catechol, pyruvate, formate and acetaldehyde
could be measured so the pathway was simplified by lumping it into two reaction steps.
When analysis methods were developed for oxalocrotonate and cis-diol, measurements
could be made of 7 of the 9 metabolites involved in the TOL lower pathway,
throughout the stationary phase of batch fermentations.
Calculation of the flux control coefficients for both the simplified and more defined
pathway showed that the bulk of the control resided in the first two reaction steps. This
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analysis attributed no particular sensitivity to oxalocrotonate, as had been indicated from
the analysis of the kinetic data. This may have been due to the dehydrogenase branch
of the pathway being inactive with the benzoate substrate. This would make the pathway
strictly linear. The use of substrates which have different affinities for the
dehydrogenase and hydratase branches and calculation of the resulting control
coefficients would indicate if this were the case.
The use of the top-down analysis allowed rapid identification of the areas of the
pathway which were not rate-controlling. This is especially important when dealing with
large systems where it may be difficult to analyze every metabolite.
A systematic approach to data gathering and manipulation is also essential when dealing
with large systems. This is the principal aim of the flux analysis software described in
Chapter 5 which can be linked to instrumentation to provide an on-line analysis of a
fermentation where the metabolic system of interest can be easily programmed by
means of graphical elements.
The future work indicated by this project falls into two areas. The first is concerned
with the TOL pathway. While several of the individual enzymes have been individually
cloned and over-expressed, their effects on the control coefficients of the system have
not yet been investigated. It is also interesting to consider the effect on the pathway of
using different host organisms, in particular, the parent Pseudomonas strain. This would
require incorporating mechanisms for secretion into the model as intra- and extra-
cellular levels of the metabolites will differ.
The second area for future work is in the development of the model and software. A
robust and user-friendly graphical interface has been developed using the LabView
environment and this could be extended and used for on-line flux analysis.
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APPENDICES
APPENDIX A: NOMENCLATURE
A =
b=
f=
G,H =
k =
K=
L =
m =
m' =
m0 =
M=
N=
N'	 =
NR =
n	 =
q	 =
R =
S	 =
S=
vi	=
v_i	=
p	=
=
Pt01	 =
Xi	=
yl	 =
matrix of power-law exponents, [a] = g - h 	 (m' x n)
matrix of constraints for optimization
vector of power-law coefficients, b, = in B 1/a,	 (m' x 1)
objective function
matrices of power-law exponents, analogous to kinetic orders
rate constant
link matrix defined by N = KNR where NR is a basis set of N (m' x in0)
matrix of system metabolite sensitivities,	 ( m' x n)
[L1 ] = inX1/ lnX
number of metabolites in system
number of non-exchangable metabolites
number of basis rows of N
matrix of rate constant sensitivities
	 ( m' x in'	 )
partition of N' to exclude exchangable compounds	 (m' x r)
partition of R to exclude stoichiometry of net conversion
rates	 (mxr)
matrix of the linearly independent basis set of N
	
(m0 x r)
number of variables affecting system
order of reaction
metabolic reaction matrix 	 (m x r+m-m')
columns of active set
sensitivity
net flux going to increase X. This is an group of fluxes rather than a
reaction rate.
net flux going to decrease X1
vector of reaction rates	 (r x 1)
vector of net conversion rates 	 ( m x 1)
system rate vector	 (r+m-m' x 1)
concentration of metabolite i
lnX,
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a1 ,131 	 =
=
x=
p. =
umax =
Km =
k1	 =
t_1x 	 -
A=
r	 =
B	 =
q=
b=
7	 =
F	 =
J=
E-
-
r=
7	 =
V	 =
B=
C=
dX/dt =
power-law coefficients, analagous to rate constants
increment
Lagrange multiplier
specific growth rate (hr')
maximum specific growth rate (hr')
Michaelis-Menten parameter (mM)
Michaelis-Menten parameter (hrt)
Control coefficient = dlnX/dlnY
Stoichiometric matrix
no. of reactions in system
matrix of atomic coefficients
no. of atomic species in system
vector of atomic species
degree of reductance of compound
covariance matrix
flux matrix
elasticity = ôlnEI3nS
steady state control matrix
transition time for a steady state established from rest
flux
matrix of C
matrix of e
the rate of change of the concentration of the pool of the metabolite X.
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APPENDIX B: Some Bits of Matrix Algebra You May Have Forgotten:
It may be of use to be reminded of some common concepts in matrix algebra
A set of vectors {a1 ,. . . ,a.}in Rm is linearly independent if
Ea1a,=O 1 a i =... =a=O
Otherwise a non-trivial combination of a 1 ,... ,a,, is zero and (a 1 ,... ,aj is said to be
linearly dependent.
A subspace of Rm
 is a subset that is also a vector space. The set of all linear
combinations of a1 ,.. .,a € Re,, is a subset referred to as the span of (a 1 ,... ,a}, i.e.
span(a1,...,a} = (	 13 a1	€ R}
I
Two important subspaces associated with a matrix A in R are the range and the null
space.
The range of A is defined by
R(A) = fy eR tm y = A x for some x € R "}
and the null space of A by
N(A) = {x E R't Ax = 0)
If A = [a1 ,...,aJ then
R(A) = span(a1,...a)
The rank of a matrix A is defined by
204
rank(A) = dim[R(A)]
An alternative definition of rank: A matrix A is said to have rank r if it contains at least
one r-rowed square sub matrix with a non-zero determinant whith the determinant of any
square submatrix having r+ 1 or more rows, possibly contained in A, is zero.
It should be noted that for any A R, dim[N(A)] + rank(A) n, and that rank(A)
= rank(AT) so that the rank of a matrix equals the maximal number of independent
rows or columns.
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T
[A.] = (Cl)
APPENDIX C
C.1 Number of reactions required to determine system:
(Niranjan and San 1989)
If we divide the m compounds into s external variables and p internal variables, where
the external variables are those which are exchanged by the system and the internal
variables are those which are internal to the system, we can partition A into two
subsystems
T
= flint
	 (C2)
Using a quasi-steady state assumption on the internals (that is, assuming that they are
non-accumulating) we have
[A]x = 0	 (C3)
Subjecting Eqn. Cl to the q elemental balances we can reduce it to
=
	 (C4)
where	 is an (s-q) x r matrix. Dividing the right hand side of this equation into two
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parts we can rewrite it as
1T 01 F xl	 Fs_q_ilIn,	 I	 (C5)I4ex_jII'I
	 [ 0 JIj1ei
Similarly Eqn. C3 becomes
[A o]
	
=
Here,	 represents the fluxes of the externals that are externally measured.
If the r reactions are independent (or the system has been reduced to ensure this) then
the coefficient matrix in Eqn. C6 has linearly independent columns and its rank is r +
1. Because of this it follows that
r +1 = s-q +p
(Cl)
is a necessary and sufficient condition to solve the system uniquely for any values of
the s - q - 1 experimentally determined external fluxes [Tsai and Lee 1988].
When r= r, 1 = 0 and the only relation among the s external metabolites is that
derived from the elemental balances.
C.2 flux-Oriented Theory - a Treatment of Substrate Cycling:
(Crabtree and Newshohne, 1985)
Using the product rule for series reactions
F
= Tç1 (1+ C/f) = a
£2 	 FSj( = T(3)(1+C/f) = b	 (C8)
£2 	 F
s1
 =f,(-C/J) = c
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Using the power-law formalism we can express the reaction rates as
v1 = k[S]0[P]l[X]c
v2 =	 (C9)
V3 =
In steady state v 1 =v2 =v3 =J so that substituting into Eqn. 8 the expressions for [S] and
[P] we have
J = k[X]
	 (dO)
where
E1 E2 F
J	 s1(,s,(,)rQ(l ^C/J)
S( 
=	 E1 £3	 £	
(Cli)
( SS10 - sS (F) r(S)( l i-C/f) + sr(C/J)
We can use this expression to derive the conditions under which cycling will increase
the sensitivity of the flux to the regulator X, as follows:
For zero cycling (C equals zero)
F
-	 Sj(g)Sj(p)Tç
	
E1 E3	 £3 F
	
S1(S1(p)	 (C 12)
£3 F
= S1(gT
F
-
For infinite cycling (C equals oo )
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£3	 C
Sgp) > r(F) (C18)
E1
 E3
 p
-	 S1( S1(1
	 (C 13)
	
E1 c	 £3
Si( r() - Sj(p) r(5)
F E
-	
- (s	 - T(,)S,(p)	 (C 14)
	
Ei	 E3F
S1( T(p) - S .(p) T(g
All the terms in this expression are positive except 5 i(s) (since this represents an
inhibition) and, replacing this by its' absolute value SEI i(S) , we obtain
—H1	 F E
- (S ( + T(g,)Sj(p)	 (C 15)
c	 £3
S1(g r() + Sj(p) r(S)
For cycling to increase sensitivity we require p> 1
£3—H1	 F	 —H1 c	 H3
S1(p) [ i(s) +	 -	 T(p) + Sj(p) r) > 0	 (C 16)
—H1 E
S [5 ( -	 > 0	 (C 17)
SEll(s) > 0 so that our condition for cycling to increase the sensitivity of the flux to X is
That is, if the sensitivity of the reaction catalyzed by E3 to P is greater than the
sensitivity of the reverse cycle to P.
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C.3 Model Differential System:
(Reder, 1988)
dx = Nv(x;p.)	 (C19)
where	 = external parameter vector
x = concentration vector
v = reaction rate vector
N = stoichiometric matrix
At a steady state designated u°
N v(u°;°) = 0
(C20)
and we assume that (NR Dv L) is invertible.
Defining the steady state flux function J
J (x;i) = V (o(x;tL):tL)
(C21)
so that J associates with every couple (x;tt) the rate vector corresponding to the steady
state a(,c;).
We can define the rate vector V in a similar way
V (x;,L) = { v(;) ; x e (x) }
(C22)
There exists a simple steady state control matrix r such that
= F D,v
(C23)
Do = I +rDv
(C24)
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Similarly there exists a simple steady state flux control matrix C such that
DJ=CDv
(C25)
DxJ = C Dxv
(C26)
F and C can be obtained from the expressions
F = -L (NR D,(v L)'NR
(C27)
C = I - Dv L (Nk
 D v L)'NR
(C28)
äa.	 äv (C29)= [t(o0;10)]
at	 äv[J(O;)O)]1	 (C30)cii = [(0O;)O)]
where X is a parameter that acts on v only at point (&';X°)
C.4 Proof for Linear System
(Westerhoff and Chen, 1984)
E1	 E2 E3
AS1S2P
the above theorems can be written as
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CE1+Ci'2+Ci=0	 (87)
cES: + c4 + CE E = 0	 (88)
CE E + Ce + cE = 0	 (89)
c:+c+c=o	
(90)
S2
cE1 +CE2 +C=O	 (91)
S1 E1	 S1E2
CE1 S1 + CE2 ES1 + C € = -1	 (92)
CE + c€ + CE = - i 	 (93)
c : €' + C 4: +	 = 0	 (94)
C.5 Theorems of Metabolic Control
These give a set of relationships between the control coefficients and the elasticities
which can be developed into what are frequently called the theorems of metabolic
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control. We will state these theorems below. Their physical significance will be
discussed in Section 1.2.3.
1 .Flux Control Summation Theorem:
(60)
(from the product of row 1 of B and column 1 of A)
2.Flux Control Connectivity theorem:
c.E=o
	 (61)
(from the product of row 1 of B and columns 2 to n of A)
3. Concentration-Control Coefficient Summation Theorem:
(62)
(from the product of rows 2 to n of B and column 1 of A)
4.Concentration-Control Coefficient Connectivity Theorem:
I,
€ =
	 jk	 (63)i-i
(from the product of rows 2 to n of B and columns 2 to n of A)
Derivation of Control Theorems from Biochemical Systems Theory:
We can obtain a set of results which is similar to the above but more general from
biochemical systems theory. Referring back to Eqn. 11 but considering a system with
no external variables i.e. n =0 we can write
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y = Mb
	 (64)
M=A'
	 (65)
and since
MA=I
	 (66)
E MU aJk = öjk
_Ji	 i=kl,
i*kJ
(67)
Summation and use of Eqn. 28 yields
[ S(Xk, aJ) + S(Xk, l3)] = 0
	 (68)
This is a general constraint but can be expressed in terms of the control coefficients
defined in Eqn. 46 if we consider an unbranched system with homogenous rate
equations as before. In this way we obtain the concentration-control coefficient
summation theorem
= 0
	 (69)
where
CE = SXk,af or S(Xk,PJ	 (70)
Substitution of Eqn. 28 into Eqn. 70 yields
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'I
E S(X1J3J)afk =	 (71)f-i
n
[S(X31)g1
 - S(XI, 13J) hfk ] = 81k	 (72)i-i
'I
E [S(X1,a1) &1k + S(X,, P) hfk I = - 1k
	
(73)
i-i
Again for the special case defined above this reduces to the concentration-control
coefficient connectivity theorem.
CE4 = ik
	 (74)
In order to derive the flux control summation and connectivity theorems we must defme
a sensitivity with respect to flux similar to that in Eqn. 47 but using the parameters of
biochemical systems theory. We can write a flux Vk through a pool X 1, as
Vk=Xf1*	 (75)
so that the sensitivity can be written as
S(Vx1)	 aLnVk= _____ = 1k +
	
gS(XJ,a 1)	 (76)
aLna1	 j-1
n
= c3LnVk = E g,S(X 1)	 (77)aLn	 i-i
Summing these terms,
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[S(V,tx) + S(Vk,13 1)J = 1	 g[ S(X,a 1) + S(X,,13,) 1
	
1	
(78)
i-i	 i-i f-i
so that, when as before we assume the special case of an unbranched system whose rate
laws are homogenous with respect to the system enzymes, we find that this expression
simplifies to the flux control summation theorem.
(79)
We can obtain a general flux control connectivity theorem as follows,
[S(V,,cc 1)g + S(Vk,Pa) h ]	 (80)
Il	 fl	 *
=	 +	 gS(X1,ag, + [ 4S(X1,p1)]h,,,)
i-i	 f-i	 f-i
I'
=	 - E
	
3) a
ë-1 f	 (51)
=	
- E gA[E S(X,, i) a]
f-i	 i-i
= gk4 -	 g[ôj ] = 0
Again, simplifying to the above special case, we obtain,
C4 = 0	 (82)
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C.6 Control coefficients for different reaction mechanisms:
Irreversible Inhibition
CL =
J
Competitive Inhibition
reversible reaction
j i( an 
.-K1 +	 +CE, 
= 7jj)10
 1\ 	 K,	 K)
irreversible reaction
j( aj" 
.-KJ1 +CE 
= :ki4;i)1. 0 	 K,)
Uncompetitive Inhibition
irreversible reaction
j	 11 i\ -K,K( +CE, 
=	 jiij)1.; [SJ	 K,)
Noncompetitive Inhibition
reversible reaction
j i / afl	 ____________CE, 
=	
-Ks.	
K,	 K,,)
( 
1 + [Sfl
irreversible reaction
I	 ifaiCE, =
	
-K
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APPENDIX D
D. 1 Instructions for using Meta on Sun Sparc:
1. Log in to user account:
2. Open windows environment:
machinename login: "username"
password: "password"
1 machinename% openwin
3. Open a cmdtool window by moving the cursor to an unused (grey) area of the
screen, clicking on the right mouse button and choosing Command Tool from the
Programs sub-menu.
4. In this window, we will log in to the machine suppporting Mathematica and
set up the graphics connections as follows:
machinename % xhost bernadette
machinename % riogin bernadette
1 bernadette % setenv DISPLAY machinename:O.O
5. To enter the Mathematica programme: 2 bernadette % math
6. There are demo programs which simulate the behaviour of the TOL meta-cleavage
pathway which can be run.
To run a simulation of the TOL pathway on varying the input benzoate concentration:
In[1]:= <<Meta/Demo.m
In[2]:= <<MetalSimDemo.m
In [3] : = PL[IC, aa, ext, int, enzime]
To run an optimization of the TOL pathway:
In[1]: <<Meta/Demo.m
In[2]: <<MetalOptDemo.m
In[3]: = Opt[k, aa, int, ext, enzime, c]
Descriptions of these subroutines, the input data required and the output parameters
returned are given in the Figures D. 1 and D.2 and in the following documentation.
Notation conventions: All references to functions or variables actually used in
Mathematica are denoted by bold face.
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D.2 Documentation of MetaSim.m:
Subroutine PL:
Purpose: This subroutine calculates the concentrations of the system parameters which
result from varying one of the external metabolite concentrations as predicted by the
power-law formalism. The calculations are made over a range, xmin to xmax, about
an operating point xmean.
Parameters: [k, aa, int, ext , enzj
k: k is the matrix of kinetic parameters. Each row corresponds to the reaction of the
same column number in the stoichiometric matrix. The kinetic parameters are normally
those for one and two substrate Michaelis-Menten reactions, k 1 and K., and k1 , k2, K12,
K21 , and Km respectively. The choice of rate expression can however be changed by
altering the expressions f[x, e] in RateExp.
aa: aa is the stoichiometric matrix, containing the relationships between the metabolites
in the system. It has dimensions m x r+(m-m0) where m is the total number of
parameters, r is the number of reactions and mo is the number of dependent
parameters. The coefficients of [aa]1 are as follows: +a if a moles of i are produced
by reaction j, -a if a moles of i are consumed by reaction j, and zero if i does not take
part in reaction j. The metabolites are numbered with the independent metabolites first,
followed by the dependent metabolites.
mt: mt is the array of independent metabolite concentrations. It is entered in
the form { {x[l], concj},..., {x[i], 	 concx, conc,.j ,..., {x[m-mJ,
conc,..j }.
ext: ext is the array of dependent metabolite concentrations. It is entered in the form
{ {x[m-m0+l], conc, mo+i}, {x[m-m0+2], conc, 10+2} ,..., (x[m], conc,j }.
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enz: enz is the array of enzyme concentrations. It is entered in the form { {e[1],
concEl}, {e[2], conc} ,. •., {e[r], concEj
 }.
Description:
1. The function gi assembles pairs of points for the graphical element Line from a list
of data in the form X, Yli, Y21 ,. . . ,Y1.
2. The function Ii attactes the label xl to the line of data points constructed from listi.
3. The values for the variable parameter xi, the operating point xmean and the range
xmin to xinax are read from ext.
4. The number of dependent metabolites mo is calculated from the dimensions of hit.
5. The number of components, ncomp and the number of reactions, nrcn are calculated
from the stoichiometric matrix aa.
6. The arrays xx and ee which will contain metabolite and enzyme concentrations
respectively are constructed.
7. depi, which gives the value of the variable parameter xi at the operating point
xmean, to be used in KinParam for calculating the power-law coefficents, is taken
from ext.
5. These concentration arrays, cint, cext and cenz are constructed.
6. The range of x parameters which will be varied is calculated in listxi.
7. Headings for the concentration and flux data lists are constructed in xresult and
vresult respectively.
8. The subroutine Findroot is called to calculate the steady state of the system using
the kinetic parameters.
9. The subroutine KinParam is called to calculate the power-law parameters of the
system.
10. The stream str is opened to the file molsol.r
11. The concentrations of the internal variables at the operating point output, the array
of rates v, the matrix go-ho and b are written to the file.
12. The stream str is closed.
13. The iterative loop which runs through the values xmin to xmax is entered and depi
is used instead of ext with the current value of xi inserted.
14. The subroutine SSCaIc is called to calculate the power-law linear system.
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15. The results arrays vresult and xresult are built up from the arrays vpl and
pivalues.
16. These arrays are transformed into pairs of points xplot and vplot by the functions
gi and fi, for plotting.
17. ploti and plot2 are the graphical outputs of vplot and xplot respectively.
D.3 Documentation of MetaOpt.m:
Subroutine Opt
Purpose: This subroutine calculates the optimal set of system parameters for an
objective function c. The system is approximated by a power-law model whose
parameters are calculated from the kinetic parameters of the system. The system can
then be expressed in linear terms so that linear optimization techniques can be applied.
The linear optimization technique used is from a NAG subroutine EO4MBF. This
minimizes the objective function
f(x) = cTx
subject to the equality and inequality constraints
Ax b
x<b1
x>b2
These constraints are collected together into an upper bound and a lower bound so that
<A'x < ba,pp.r
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Parameters: [k, aa, int, ext , enz, c]
k: k is the matrix of kinetic parameters. Each row corresponds to the reaction of the
same column number in the stoichiometric matrix. The kinetic parameters are normally
those for one and two substrate Michaelis-Menten reactions, k 1 and Km, and k1 , k2, K12,
K21 , and K. respectively. The choice of rate expression can however be changed by
altering the expressions f[x, el in RateExp.
aa: aa is the stoichiometric matrix, containing the relationships between the metabolites
in the system. It has dimensions m x r+(m-m0 where m is the total number of
parameters, r is the number of reactions and mo is the number of dependent
parameters. The coefficients of [aa] are as follows: +cr if a moles of i are produced
by reaction j, -a if a moles of i are consumed by reaction j, and zero if i does not take
part in reaction j. The metabolites are numbered with the independent metabolites first,
followed by the dependent metabolites.
int: tnt is the array of independent metabolite concentrations. It is entered in
the form { {x[1], conc 1 }, {x[2], concx2} ,..., {x[m-mJ, conc,	 } }.
ext: ext is the array of dependent metabolite concentrations. It is entered in the form
{ {x[m-m0+1], concxmmo+i}, {x[m-m0+2], COflCXm..mo +2} ,..., {x[m], COflCm} }.
enz: enz is the array of enzyme concentrations. It is entered in the form ( {e[1],
COflCE1}, {e[2], conc} ,..., {e[r], conc} }.
C: C is the objective function of the optimization problem as defined in Eqn.D1 above.
For example, if it is required to minimize X 1, then c=O, i n.e. p, c1 =l, i=p.
Description:
1. The number of dependent metabolites mo is calculated from the dimensions of hit.
2. The number of components, ncomp and the number of reactions, nrcn are calculated
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from the stoichiometric matrix aa.
3. The arrays xx and ee which will contain metabolite and enzyme concentrations
respectively are constructed.
4. depi, which is used in KinParam is taken from ext.
5. These concentration arrays, cint, cext and cenz are constructed.
6. The subroutine Findroot is called to calculate the steady state of the system using
the kinetic parameters.
7. The subroutine KinParam is called to calculate the power-law parameters of the
system.
8. The subroutine SSCaIc is called to calculate the power-law linear system.
9. The initial guess for the numerical algorithm mit is the (feasible) operating point.
10. The matrix of the equality contraints, aout, is calculated from the power-law
parameters go and ho.
11. lower is the array of the lower bounds.
12. upper is the array of the upper bounds.
The next six lines of code open a data file called modelsol.r and write into it the data
required for the optimization algorithm
13. The stream sIr is opened to the file molsol.r
14. The objective function c, the matrix aout, the upper and lower bounds bupper and
blower and the initial guess mit are written to the file.
15. The stream str is closed.
The next five lines of code read in the Fortran program which calls the numerical
algorithm EO4MBF and enter the dimensions of the problem.
16. The Fortran program tstopt.f is read in as a list of characters, forprog.
17. The dimensions of the system mo and ncomp+ nrcn are entered in the appropriate
place in the list at positions 200 and 216.
18. A stream to the file tstoptl.f, stri is opened.
19. All of the characters in the amended list forprog are joined together and written to
the file tstoptl.f via the stream stri, which is then closed.
20. This file is then compiled on the f77 compiler
21. The executable file a.out is run.
The next four lines read in the optimization results from the file optsoLr
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22. The results file optsol.r is read as a list of word-delineated strings into the array
results.
23.The enzyme and intermediate concentration data required is in the fourth column in
positions 6 to 5+nrcn+ncomp and this is pulled out into xstring.
24. This string is then converted into a list of numbers, ylist, and plotted as a barchart.
Subroutine Findroot
Purpose: The subroutine Findroot calculates the steady state of a system of
metabolic equations. The values of the dependent variables are calculated from
the rate expressions and the values of the independent variables. The set of
reactions must be linearly independent and the number of independent reactions
must equal the number of dependent variables so that the system is not under- or
over-determined.
Parameters: [k, aa, int, ext , enz]
k: k is the matrix of kinetic parameters. Each row corresponds to the reaction of the
same column number in the stoichiometric matrix. The kinetic parameters are normally
those for one and two substrate Michaelis-Menten reactions, k 1 and and k1 , k2, K12,
K21 , and iç respectively. The choice of rate expression can however be changed by
altering the expressions f[x, e] in RateExp.
aa: aa is the stoichiometric matrix, containing the relationships between the metabolites
in the system. It has dimensions m x r+(m-m 0) where m is the total number of
parameters, r is the number of reactions and mo is the number of dependent
parameters. The coefficients of [aa] 1 are as follows: +a if a moles of i are produced
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by reaction j, -a if a moles of i are consumed by reaction j, and zero if i does not take
part in reaction j. The metabolites are numbered with the independent metabolites first,
followed by the dependent metabolites.
hit: hit is the array of independent metabolite concentrations. It is entered in
the form { {x[1], conc, 1 }, {x[2], concx2 } ,..., {x[m-m0], COflCmmo} L
ext: ext is the array of dependent metabolite concentrations. It is entered in the form
( {x[m-m + 1], COflCyj04j}, {x[m-m0+2], conc, mo+2} ,..., {x[m], conc,cj }.
enz: enz is the array of enzyme concentrations. It is entered in the form { {e[l],
concEl}, {e[21, conc} ,..., (e[r], conc} }.
Description:
1. The number of dependent metabolites mo is calculated from the dimensions of .
2. The arrays xx and ee which will contain metabolite and enzyme concentrations
respectively are constructed.
3. These concentration arrays, cint, cext and cenz are constructed.
4. The subroutine RateExp is called to calculate the reduced stoichiometric matrix n
and the array of reaction rate expressions v.
5. The system steady state balance equations eqns are calculated from n.y.
6. The rule eval is defined. This enables x[i] to be evaluated as conc1.
7. Applying this rule to cext and cenz evaluates x[i] and e[i] numerically as
concx, and conc in all following expressions.
8. The rule hi enables the Mathematica subroutine FindRoot to be applied to a
list of initial guesses.
9. Applying this rule and the subroutine FindRoot to eqns and the initial
guesses cint yields the steady state solution in the form { x[m-mo+ 11 ->
conc,. 01 ,..., x[m] -> conc,, }
10. The values of the reaction rates are obtained by using these values in v to obtain
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vval.
11. Clearing e and x removes the numerical value and allows them to be evaluated
symbolically.
Subroutine KinParam
Purpose: The purpose of this subroutine is to calculate the power-law parameters of a
system from a steady state operating point and the system rate expressions. The
power-law coefficients describe the behaviour of the system about the operating point
according to the equation
	
dX/dz =	 - V..,
	
=	
-	
i =
g and h1 are evaluated from the following equations:
= (1nv,0)/a(1nX1) (,daX1)(X,dv,)
h	 aan v /a(Inxp = Cay ..,d3X )(X1dv )
and the parameters a, and tI from
cc1 = ,0I X;
I,
13 , = v,oHXj"f-i
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Parameters:
aa: aa is the stoichiometric matrix, containing the relationships between the metabolites
in the system. It has dimensions m x r+(m-m 0) where m is the total number of
parameters, r is the number of reactions and mo is the number of dependent
parameters. The coefficients of [aa]1 are as follows: +a if a moles of i are produced
by reaction j, -a if a moles of i are consumed by reaction j, and zero if i does not take
part in reaction j. The metabolites are numbered with the independent metabolites first,
followed by the dependent metabolites.
hit: hit is the array of independent metabolite concentrations. It is entered in
the form { {x[1], conc 1 }, {x[2], conc 2} ,. •., {x[m-m0], concxm } I.
ext: ext is the array of dependent metabolite concentrations. It is entered in the form
{ {x(m-m0 +
 1], concxmmo+i }, {x[m-m0+2], conc, mo+2} ,. •., {x[m], concxm} L
enz: enz is the array of enzyme concentrations. It is entered in the form { {e[1],
conc 1}, {e[2], conc} ,. •., {e[r], conc} }.
The following two input parameters are calculated by RateExp
U: fl is the reduced stoichiometric matrix.
v: v is the array of rate expressions corresponding to the r system reactions.
output: output is the set of steady state values of the dependent variables, output is
calculated by the subroutine Findroot.
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Description:
1. The rule vform uses the reduced stoichiometric matrix n with the array of reaction
rate expressions to calculate the arrays of aggregated fluxes V and V 1 . V. is the sum
of the fluxes which go to increase the pool of X and V.., is the sum of the fluxes which
go to decrease the pool of X.
2.. The number of dependent metabolites mo is calculated from the dimensions of bit.
3. The arrays xx and eec which will contain metabolite and enzyme concentrations
respectively are constructed.
4. These concentration arrays, cint, cext and cenz are constructed.
5. xall constructs a full list of the system parameters, which includes independent
metabolites, dependent metabolites, and enzymes. The enzymes are renamed as x[m+ 1]
x[m+r] for ease in numerical computation.
6. vminus is V.1 , i= 1 ,..., m, the array of aggregated fluxes which go to decrease the
pool of X.
7. vplus is V1, i = 1 ,..., m0 the array of aggregated fluxes which go to increase the pool
of X.
8. g is the matrix of power-law coefficients calculated from Eqn.D5 above.
9. h is the matrix of power-law coefficients calculated from Eqn.D6 above.
The next 6 lines insert numerical values for those of x[iJ and e[iJ in the
expressions for g, h, vptus, vminus and xall.
10. Numerical values for the independent metabolite and enzymes concentrations are
entered in all expressions.
11. Numerical values for dependent metabolite concentrations are entered in g.
12. Numerical values for dependent metabolite concentrations are entered in h.
13. Numerical values for dependent metabolite concentrations are entered in vplus.
14. Numerical values for dependent metabolite concentrations are entered in vminus.
15. The power-law parameters c, (alpha) are calculated from Eqn.D7 above.
16. The power-law parameters (beta) are calculated from Eqn.D8 above.
17. The output array b = aI(3 is calculated.
18. Clearing all values of x removes the numerical values and allows them to be
evaluated symbolically.
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Subroutine SSCaIc
Purpose: The subroutine SSCaIc calculates values for the steady state that is reached
when the system is perturbed from its original operating point, using a power-law
model and coefficients as its model. The system is linear in logarithmic coordinates and
can be described by the equation
Ay = b
where A = - h, b = cj f3 and y = Ln x. The solution is obtained by partitioning
the matrix A into an m0 x m0 matrix al and an m0 x m-m0 +r matrix a2 and the vector
of system parameters y into [y':y"]. The solution is of the form
= mb + ly"
where m = [al]' and 1 = -[al] 1 a2. Both metabolite concentrations in logarithmic form
(ypi) and rates (vpl) are calculated.
Parameters:
aa: aa is the stoichiometric matrix, containing the relationships between the metabolites
in the system. It has dimensions m x r+ (m-m 0) where m is the total number of
parameters, r is the number of reactions and mo is the number of dependent
parameters. The coefficients of [aa] are as follows: +a if a moles of i are produced
by reaction j, -a if a moles of i are consumed by reaction j, and zero if i does not take
part in reaction j . The metabolites are numbered with the independent metabolites first,
followed by the dependent metabolites.
hit: mt is the array of independent metabolite concentrations. It is entered in
the form { {x[1], conc 1 }, {x[2], conc 2 } ,. •., {x[m-m0], concx,} }.
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ext: ext is the array of dependent metabolite concentrations. It is entered in the form
( {x[m-m0+1], conc,.,+1}, {x[m-m0+2], conc, +2} ,..., {x[m], conc,j ).
enz: enz is the array of enzyme concentrations. It is entered in the form { {e[1],
conc 1}, {e[2], conc} ,..., {e[r], conc} }.
The following two input parameters are calculated by RateExp
is the reduced stoichiometric matrix.
v: v is the array of rate expressions corresponding to the r system reactions.
output: output is the set of steady state values of the dependent variables, output is
calculated by the subroutine Findroot.
go: go is the m0 x m+r matrix of power-law coefficients defined by Eqn.D5 and used
in the linear expression above to model the system.
ho: ho is the m0 x m+r matrix of power-law coefficients defined by Eqn.D6 and used
in the linear expression above to model the system.
b: b=alpha/beta where alpha and beta are the power-law coefficients defined by
Eqn.s D7 and D8 and used in the linear expression above to model the system.
go, ho and b are calculated by KinParam.
Description:
1. The number of dependent metabolites mo is calculated from the dimensions of mt.
2. The arrays xx and eee which will contain metabolite and enzyme concentrations
respectively are constructed.
3. These concentration arrays, cint, cext and cenz are constructed.
4. The matrix a = go - ho to be used in the linear description of the system Ay = b
is calculated.
5 and 6. The m0
 x r matrix a is partitioned into an m0 x m0 matrix al and an m, x
m-m0+r matrix a2.
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7. x2 is the list of independent parameters, including the enzyme concentrations.
8. y2 is the natural log of x2.
9. Applying this rule to cext and cenz evaluates x[i] and e[i] numerically as
conc, and conc 1 in all following expressions.
10. The matrices m and 1 defined in Eqn.Dl0 above are calculated.
11. plvalues, the array of logarithmic values of the internal system parameters as
predicted by a power-law model, is calculated.
12. ypl, the array of logarithmic values of all of the system parameters as predicted by
a power-law model, is calculated.
13. vpl, the array of logarithmic values of the system fluxes as predicted by a power-
law model, is calculated.
14. Clearing all values of x removes the numerical values and allows them to be
evaluated symbolically.
D.4 Documentation of InVivo.m
Purpose: This subroutine calculates the flux control coefficients for a metabolic pathway
based upon transient metabolite concentrations. This is done by calculating correlation
coefficients a in the following expression:
, ( x [t=t) - x[t=t0]) =	 j = l,...,p
The flux control coefficients can then be calculated from the relationship:
C = aAJ
This program uses a NAG subroutine CO4NCF for the regression analysis.
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Parameters:
aa: aa is the stoichiometric matrix, containing the relationships between the metabolites
in the system. It has dimensions m x r+(m-m0) where m is the total number of
parameters, r is the number of reactions and mo is the number of dependent
parameters. The coefficients of [aa] are as follows: +a if a moles of i are produced
by reaction j, -a if a moles of i are consumed by reaction j, and zero if i does not take
part in reaction j. The metabolites are numbered with the independent metabolites first,
followed by the dependent metabolites.
mo: mo is the number of dependent metabolites.
Description:
1. The number of components ncomp is calculated from the dimensions of the
stoichiometric matrix aa.
2. The reduced stoichiometric matrix a (ncomp x nrcn) is extracted from aa.
3. The transient concentration data is read in as a series of columns of time and
concentration data.
4. The columns for time and benzoic acid concentration are extracted as xstringl and
xstr'ing2 and are converted into the expressions time and benz respectively.
The next five lines of code read in the Fortran program which calls the numerical
algorithm CO4NCF and enter the dimensions of the problem.
5. The Fortran program invivot.f is read in as a list of characters, forprog.
6. The dimensions of the system ncomp and the number of time parameters are entered
in the appropriate place in the list at positions 164 and 171.
7. A stream to the file invivol.f, stri is opened.
8. All of the characters in the amended list forprog are joined together and written to
the file invivol.f via the stream stri, which is then closed.
9. This file is then compiled on the f77 compiler
10. The executable file a.out is run.
The next four lines read in the optimization results from the file invivo.r
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11. The results file invivo.r is read as a list of word-delineated strings into the array
results.
12. The corriation coefficients required are in the second column in positions 7 to
6+ncomp and this is pulled out into xstring.
13. This string is then converted into a list of numbers, alpha.
14. The system flux ji is calculated from the changing benzoate concentration and an
nrcn x nrcn diagonal matrix j = [ji] is constructed.
15. The set of correlation coefficients coeffs is calculated from the expression D12
above and plotted as a barchart.
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D.5 Program Listings
MetaSim. m
BeginPackage["ModelSolve3"]
RateExp: :usage = "does rate expressions"
Findroot: :usage	 "finds roots"
KinParam: :usage = "calculates BST kinetic parameters"
SSCa1c: :usage	 "calculate steady state parameters"
PL::usage = "plots changing s.s. with changing input parameters"
Begin[" 'Private"]
RateExp[aa_, k, moj : =
Block[{i ncomp, nrcn, f, enzyme, nll},
fleomp = Length[aa];
flrcn = Length[Transpose[aa]] - (ncomp - mo);
Xx = Table[x[i], {i, Length[aa]}];
Ce = Table[e[i], {i, nrcn}];
Pos[xJ := üi; x > 0;
POs[xj : -X I; x <= 0;
r Map[ Drop[# , -(ncomp-mo)]&, aa];
fl = DropEr, (ncomp-mo)];
t{k1_, k2, {x_}, {e_}] := ki e x / (k2 + x);
1t(kl_, k2_, k3, k4_, k5_}, {xl, x2_}, {e_}] := ki e I
(1 + k5Ixl + k4/x2 + (k5 k3 + k2 k4)/ (2 xl x2));
236
nil = Map[List, Map[90S , Transpose[r], {2}].xx] I. List[Plus[x_, yJ]
-> List[x, y];(*note: try List[Plus[z,J1 -> List[z] *)
enzyme = Map[List, ee];
v = Thread[ f[k, nil, enzyme]];
I
Findroot[k_, aa, int_, ext_, enzj
Biock[{hi, z },
mo = Length[int];
xx = Table[x[i], {i, Jfingth[aa]}];
ee = Tabie[e[i], {i, Leflgth[TraSP0Se[aa]F(Length[aaFm0) }];
cenz = Transpose[{ee, Transpose[enzj[[2]]}];
cext = Transpose[{Tal(e[XX , Length[ext}], Transpose[ext}[[2}])];
cint = Transpose[{Ta1 e[XX , -Length[int]], Transpose[intj [[2]])];
xext = Transpose[cext][[l]]
RateExp[aa, k, mo];
eqns = n.v;
eval[zJ = Map[Apply[Set , #]&, z];
hi[eqn, {Iin }] = FindRoot[eqn, un];
eval[cext] ;eval[cenz];
output = hi[eqns, cint);
vval = v/.output;
Clear[x] ;Clear[e];
I
KinParam[aa_, int_, ext, enzj =
Biock[{z },
vform[r_, vv_, e_] : Transpose[Map[pos, Transpose[r], {-l}]].vv/.
e[z] -> x[z+Length[aa]];
mo = Length[int];
xx	 Table[x[i], {i, Length[aa}}];
eee	 Table[x[i], {i, Length[aa] + 1, Length[Transpose[aa]] + mo}];
cenz	 Transpose[{eee, Transpose[enz] [[2]] }];
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cext	 Transpose[{Take[xx, Length[e Xtll, Transpose[ext] [[2]]}];
cint = Transpose[{Take[xx, -Length (int]], Transpose[int] [[2]])];
xall	 =	 Union [Tran spose[cext] [[1]], Transpose[cint] [[1J],
Transpose[cenz] [[1]]];
vminus = vform[n, v, e];
vplus = vform[-n, v, e];
g = Transpose[ Table[ (x[i]/vplus[[iIl) D[ vplus[[j]], x[i] 1, {i,
Length[aa]+Length[v]}, {j, mo}]];
h = Transpose[ Table[ (x[i]/vminus[[i]]) D[ vminus[[j]], x[i] ], {i,
Length[aa]+Length[v]}, {j, mo}]];
eval[cext]; eval[cenzJ;
go = g I. output;
ho = h I. output;
xo = xall I. output;
vpluso = vplus I. output;
vminuso = vminus I. output;
alpha = Table [vpluso[[j]] Product[ x[i]A_gO[[J,i]J, {i, Length[xall]}],
{j , mo}]/.output.;
beta = Table [vminuso[[j]] Product[ x[i]A_ho[[j,i]], {i, Length[xall]} I
{j , mo}]/.output;
b = LogE beta/alpha];
Clear[x]
]
SSCa1c[aa_, int, ext_, enzJ : =
Block[{a2, i },
mo = Length[int];
xx = Table[x [i], {i, Length[aa]}];
eee = Table[x[i}, {i, Length[aa] +1, Lerlgth[Transpose[aa]] + mo}J;
cenz = Transpose[{eee, Transpose[enz] [[211)];
cext = Transpose[{Take[xx, Length[e%t]], Transpose[ext] [[2]])];
Cint = Transpose[{Take[xx, -Length[iilt]I, Transpose[intj [[2]]}};
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a = go - ho;
a! = Transpose[Table[Transpose[a][[i]], {i, Length[aa]-mo+1,
Length[aa]}J];
a2 = Transpose[Join[Tab1e[Transpose[a [[i]], {i, Length[aa]-mo}],
Table[Transpose[a][[iJ], {i, Length[aa] + 1, Length[xall]}]]];
x2 = Join[ Table[ xalI[[i]], {i, Length[aa]-mo} ], Table[ xall[[i]], (i,
Length[aa]+ 1, Length[xall]}]];
y2 = Log[x2];
eval[cext] ;eval[cenz];
m = Inverse[al]; 1 = -Inverse[al].a2;
pivalues = m.b + l.y2;
temp = Transpose[cint};
temp[[2]] = Exp[plvalues];
eval[Transpose[temp]];
ypi = Log[xall];
vpl = Log[alpha] + go.ypl;
Clear[x]
I
PL[k_, aa, ext_?(MemberQ[#, {xi_, xmean_, xmin_, xmax_}]&), int_, enzJ : =
Block[{i },
gi[xindepi_, listxij : = Line[Thread[List[listxi, Drop[xindepi, 1]]]];
fi[Line[IistlJ, xlJ : ={Line[listl](* ,
 Text[xl, Last[listl}, {O, _1}]*)};
{ xi, xmean, xmin, xmax} = Flatten[Cases[ext, {xl_, x2_, x3_, x4}],
1];
mo = Length[int];
ncomp = Length[aa];
nrcn = Length[Transpose[aa]] - (ncomp-mo);
xx = Table[x[i], {i, Length[aa]}];
ee = Table[e[i], {i, Length [Transpose[aa]J-(Length[aa]-mo)}J;
depi = extl.{xi, xmean, xmin, xmax} -> (xi, xmean};
cenz = Transpose[{ee, Transpose[enz [[2]]}];
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cext	 Transpose[{Take[XX, Length [dep 1]], Transpose[deP 1] [[2]])];
cint	 Transpose[{Take[XX, -Length[int]], Transpose[int][[2]]}]
listxi = Table[i, {i, xmin, xmax}];
xresult = {Transpose[iflt][[11]};
vlist = Table[rateV[i], {i, mo}]
vresult = {vlist};
Findroot[k, aa, int, depi, enz];
KinParam[aa, int, dep 1, enz];
str = OpenWrite["mOdsol.r"];
Write[str, output, v, go-ho, b]; Close[str];
Do[ depi = ext/.{xi, xmean, xmin, xmax) -> {xi, listxi[[j]]};
SSCa1c[aa, int, depi, enz];
vresult = Append[vresult, vpl];
xresult = Append[xresult, pivalues],
{j , Length[listxi]} 1;
xplot = Thread[fi [Map[gi[#, listxij &, N[Transpose[xresult]J],
Log[Transpose[int][[1]]]]];
vplot = Thread[fi [Map[gi[#, listxi] &, N[Transpose[vresult]J], vlist]];
plot2 = Show [Graphics[xplot], Axes -> Automatic, AxesLabel -> {FontForm[
"Conc.X[1] (mM)", {"Times", 10)], FontForm[" Log X[i] (mM)", {"Times", 10)] },
AxesOrigin -> {20.0, 0.0), Defaultfont -> {"Times-Italic", 8)];
plotl = Show[Graphics[vplot], Axes -> Automatic, AxesLabel -> {FontForm[
"Conc.X[1] (mM)", {"Times", 10}], FontForm["Flux V[i]", {"Times", 10)] ),
AxesOrigin -> {20.0, 5.85), DefaultFont -> {"Times-Italic", 8)1;
Show[GraphicsArray[{ {plot2}, {plot 1])]]
]
(*Opt[k ,
 aa_, ext_, int, enz_, coptj : =
Findroot[k, aa, int, ext, enz];
KinParam[aa, int, ext, enz];
SSCa1c[aa, int, ext, enz];
str = OpenWrite["opt.d"];
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Write[str , copt, Prepend[F1atten [go-ho bit], Append[b, bit]];
Close[str] ; *)
End[ I
EndPackagefl
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MetaOpt.m
BeginPackage[" Opt'", "Graphics' Graphics"]
Opt: :usage = "finds optimal set of system parameters for a given objective function."
RateExp: :usage = "does rate expressions"
Findroot: :usage = "finds roots"
KinParam::usage = "calculates BST kinetic parameters"
SSCa1c: :usage = "calculate steady state parameters"
Begin[" 'Private"]
RateExp[aa, k_, moJ : =
Block[{i, ncomp, nrcn, f, enzyme, nhl},
ncomp = Length[aa];
nrcn = Length[Transpose[aa]] - (ncomp - mo);
xx = Table[x[i], {i, Length[aa]}];
ee = Table[e[i], {i, nrcn}};
pos[xJ:O/;x >0;
pos[xJ:-x/;x <=0;
r = Map[ Drop[# , -(ncomp-mo)1&, aa];
n = Drop[r, (ncomp-mo)];
f[k1, k2_}, {x}, {e_}J : ki e x / (k2 + x);
f[{kl_, k2_, k3_, k4_, k5}, {xl_, x2_}, {e_}] := ki e /
(1 + k5/x 1 + k4/x2 + (1(5 k3 + k2 k4)/ (2 xl x2));
nil = Map[List, Map[pos, Transpose[rJ, {2}].xxJ I. List[PIUSEX_, yJ]
-> List[x, y];(*note: try List[Plus[z]] -> List[z] *)
enzyme = Map[List, ec];
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v = Thread[ f[k, nil, enzyme] J;
]
Findroot[k_, aa, int_, ext, enzJ
Block[{hi, z
mo = Length[int];
xx = Table[x[i], {i, Length[aa]}];
ee = Table[e[i], {i, Leflgth[Traflspose[aa]]_(Length[aa]_mo)}];
cenz = Transpose[{ee, Transpose[enz][[2]]}J;
cext = Transpose[ {Take[XX , Length [ext]], Transpose[ext]{[2]] }];
cint = Trarlspose[{Take[ XX , -Length [int]], Transpose[int] [[2]])];
xext = Transpose[cext][[l]]
RateExp[aa, k, mo];
eqns = n.v;
eval[zJ = Map[Apply [Set , #]&, z];
hi[eqn_, {Iin_}] : = FindRoot[eqn, un];
eval[cext] ;eval[cenzl;
output = hi[eqns, cint];
vval = v/.output
Clear[xJ ; Clear[e];
]
KinParam[aa_, i, ext_, enzj : =
Block[{z },
vform[r_, w, eJ	 Transpose[Map[pos, Transpose[r], {-J}]].vv/.
e[zJ -> x[z+Length[aa]];
mo = Length[int];
xx = Tabie[x[i], {i, Length[aa]}];
eec = Table[x[i], {i, Length[aa]+ 1, Length[Transpose[aa]] + mo}];
cenz = Transpose[{eee, Transpose[enz]{[2]] }];
cext = Transpose[ {Take[xx, Length [ext]], Transpose[ext] [[2]])];
cint = Transpose[{Take[xx , -Length[int]], Transpose[intJ[[2]}}];
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xall	 =	 Union [Transpose[cext] [ [ 1 1],	 Transpose[cint] [[1]],
Transpose[cenz] [[1]]];
vminus = vform[n, v, e];
vplus = vform[-n, v, e];
g = Transpose[ Table[ (x[i]/vplus[[jfl) D[ vplus[[j]}, x[i] ], {i,
Length[aa]+Length[v]}, {j, mo} 1];
h = Transpose[ Table[ (x[i]/vminus[[j]]) D[ vminus[[j]], x[i] ], {i,
Length[aa]+Length[v]}, 
'j , mo}]];
eval[cext]; eval[cenz];
go = g I. output;
ho = h I. output;
xo = xall I. output;
vpluso = vplus I. output;
vminuso = vminus I. output;
alpha = Table [vpluso[[j]] Produet[ x[i]Ago[[j,i]], {i, Length[xall]}],
Li, mo)]l.output;
beta = Table [vminuso[[j]] Product[ x[i]Aho[[j,i]], {i, Length[xall]}],
Li, mo}]/.output;
b = LogE beta/alpha 1;
Clear[x]
]
SSCa1c[aa, int_, ext_, enzj : =
Block[{a2, i },
mo = Length{int];
xx = Table[x[i}, {i, Length[aa]}];
eee = Table[x[i], {i, Length[aa]+1, Length[Transpose[aa]] + mo)];
cenz = Transpose[{eee, Transpose[enz] [[2]])];
cext = Transpose[{Take[xx, Length [ext]], Transpose[ext] [[2]])];
cint = Transpose[ {Take[xx, -Length[i nt]], Transpose[int] [[2]])];
a = go - ho;
a 1 = Transpose[Table[Transpose[a] [[i]], (i, Length[aa]-mo + 1,
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Length[aa]]];
a2 = Transpose[Join[Table[Transpose[a] [[i]], {i, Length[aa]-mo}],
Table[Transpose[a][[i]], {i, Length[aa] + 1, Length[xall]}]]];
x2 = Join[ Table[ xalI [[i]], {i, Length[aa]-mo} ], Table[ xall[[i]], {i,
Length[aa]+1, Length[xaIl]} 1];
y2 = Log[x2];
eval[cext] ; eval[cenz];
m	 Inverse[al]; 1 = -Inverse[al].a2;
pivalues = m.b + l.y2;
temp = Transpose[cint];
temp[[2]] = Exp[plvalues];
eval[Transpose[temp]];
ypi = Log[xall];
vpl = Log[alpha] + goyp1;
Clear[x]
I
Opt[k_, aa, int_, ext, enz_, cJ : =
Block[{i },
mo = Length[int];
ncomp Length[aa];
nrcn = Length[Transpose[aa]] - (ncomp-mo);
xx = Table[x[i}, {i, Length[aafl];
ee = Table[e[i], {i, Length[Transpose[aa]]-(Length [aa]-mo) }];
depi = ext;
cenz = Transpose[{ee, Transpose[enz][[2}fl];
cext = Transpose[ {Take[xx, Length[dep 1]], Transpose[dep 1] [[2]] }];
cint = Transpose[ {Take[xx, -Length [int]], Transpose[int] [[2]] }];
Findroot[k, aa, int, depi, enz];
KinParam[aa, int, depi, enz];
SSCa1c[aa, int, depi, enz];
mit = Join[ Log[Transpose[cext][[2]]], pivalues,
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Log[Transpose[cenz][[2]]] ];
aout = Flatten[go - ho];
lower = Table[-100., {i, ncomp+nrCfl)]
upper = Table[ 1 O . , U, ncomp+nrcn}];
str = OpenWrite["modsol.r"];
Write[str, Prepend[Append[c, s], s]];
Write[str , Prepend[Append[aout, s], s]];
Write[str , Prepend[Append[Join[lower, b], s], s]];
Write[str, Prepend[Append [Join [upper , b], s], s]];
Write[str, Prepend[Append[init, s], s]]; Close[str];
Run["f77 tstoptl.f -inag"];
Run["a.out"];
results = ReadList["optsol.r", Word, RecordLists -> True];
resi = Take[results, {6, (5+nrcn+ncomp)}J;
xstring = Map[Part[#, 4]&, resi];
strm = StringToStream[StringJoin[ Flatten[Transpose [{xstring, Table[H
, {i, ncomp + nrcn}]}]] 11;
ylist = ReadList[strm, Number];
BarChart[ N[ Exp[ Flatten[Transpose[{init, ylist)]]] ] ]
]
End[]
EndPackage[]
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InVivo.m
InVivo[aa_, moj:
Block[{i, aiph, xstring},
ncomp = Length[aa];
a = Transpose[Drop[Transpose[aa], -(ncomp-mo)]];
data	 ReadList["invivol .d", Word, RecordLists -> True];
xstringl = Map[Part[#, 2J&, Take[data, {4, 10)1];
xstring2	 Map[Part[#, 1]&, Take[data, {4, 10}I];
benz = ToExpression[xstringl];
time = ToExpression[xstring2];
forprog = ReadList["invivot. f", Character];
forprog[[ 164]] = ToString[(Length [aa] + 2)];
forprog[[171]] = ToString[(Length[time] +2)1;
forprog[[821]] = "invivol.d";
stri = OpenWrite["invivol .f"];
WriteString[str 1, StringJoin[forprog]1 ; Close[strl];
Run["f77 invivol.f -inag"];
Run["a.out"];
aiph = ReadList["invivo.r", Word, RecordLists -> True];
xstring	 Map[Part[#, 2]&, Take[alph , {7, (6+Length[aa]))]];
alpha = ToExpression[xstring];
ji = (benz[[1]]_benz[[7]])/(time[[7]Ftime[[l]I);
j = DiagonalMatrix[Table[ji, {i, 1 Length[Transpose[a]]}]];
coeffs = alpha.a.j;
BarChart[coeffs]
]
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fulopt.f
* EO4MBF Example Program Text
* Mark 14 Revised. NAG Copyright 1989.
*	
.. Parameters
INTEGER	 NCLIN, NROWA, N, NCTOTL, LIWORK, LWORK
PARAMETER
(NCLIN=7,NROWA=NCLIN,N=29,NCTOTL=NCLIN+N,
+
LIWORK =2*N,LWORK =2*N*N + 6*N +N+4*NCLIN + NROWA)
INTEGER	 NIN, NOUT
PARAMETER	 (NIN = 7,NOUT = 8)
*	
..LocalScalars..
DOUBLE PRECISION OBJLP
INTEGER	 I, IFAIL, ITMAX, J, MSGLVL
LOGICAL	 LINOBJ
*	
..LocalArrays..
DOUBLE PRECISION A(NROWA,N), BL(NCTOTL), BU(NCTOTL),
+	 CLAMDA(NCTOTL), CVEC(N), WORK(LWORK), X(N)
INTEGER	 ISTATE(NCTOTL), IWORK(LIWORK)
*	
.. External Subroutines..
EXTERNAL	 EO4MBF, XO4ABF
OPEN(UNIT = 7, FILE = 'lucy/fulopLd')
OPEN(UNIT = 8, FILE = 'lucy/fulopt.r')
*	
.. Executable Statements
WRITE (NOUT,*) 'EO4MBF Example Program Results'
*	 Skip heading in data file
READ (NIN,*)
CALL XO4ABF(1 ,NOUT)
ITMAX =20
MSGLVL = 1
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LINOBJ = .TRUE.
READ (NIN,*) (CVEC(J),J=1,N)
READ (NIN,*) ((A(I,J),J=1,N),I=1,NCLIN)
READ (NIN,*) (BL(J),J=1,NCTOTL)
READ (NIN,*) (BU(J),J=1,NCTOTL)
READ (NIN,*) (X(J),J=1,N)
IFAIL=1
*
C	 A	 L	 L
EO4MBF(ITMAX,MSGLVL,N,NCLIN,NCTOTL,NROWA,A,BL,BU,CVECLINOW
+
X,ISTATE,OBJLP,CLAMDA,IWORK,LIWORK,WORK,LWORK,IFAIL)
*
STOP
END
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31, 49,	 62
MetData.m
BeginPackage["InputData3"]
InputData3::usage = "contains data"
aa = { {-i, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0,-i, 0, 0, O},
{ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0,-i, 0,-i, 0, 0),
{ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0,-i, 0, 0,-i, 0),
{ 0, 0, 0, 0, 0, 0, 0, 0, 1,-i, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,-i),
{ 1,-i, 0, 0, 0, 0, 0, 0, 0, 0,-i, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0},
{ 0, 1,-i, 0, 0, 0, 0, 0, 0, 0, 0,-i, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0),
{0,0, i,-i3O,0,0,0,-i, 1,0,0,-i, 1,0,0,0,0,0,0,0,0),
{ 0, 0, 0, 1,-i, 0, 0, 0, 0, 0, 0, 0, 0,-!, 1, 0, 0, 0, 0, 0, 0, 0),
{ 0, 0, 0, 0, 1,-i, 0, 0, 0, 0, 0, 0, 0, 0,-i, 1, 0, 0, 0, 0, 0, 0),
{0,0,0,0,0, 1,-i 3 O, 1,-i3O,0,0,0,0,-1, 1,0,0,0,0,0},
{0, 0,0,0,0,0, 1,-i 3 O, 0,0,0,0,0,0,0,-i, 1,0,0,0,0)	 };
I	 7.62,
2,	 0.20
50,	 3.0
100,	 2.0
6.00, 20
2.6,	 15
5.2, 30
7.8, 53
3.2, 100
2.6, 74,
1, 18
0.26, 15
0.03, 23
1
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{	 0.52, 30
(	 0.11, 21	 1
{	 0.78, 53
{	 0.32, 100
{	 0.26, 74,	 31,	 49,	 62	 }
mt = {{x[5], 20.), {x[6], 25.), {x[7], 33.), {x[8], 41.), {x[9], 32.), {x[10], 29),
(x[11], 30));
ext = {{x[l], 30., 20., 40.), {x[2], 15.), {x[31, 19.), {x[4], 30.));
enzime = {(e[ 1], 210.), {e[2], 210.), (e13}, 200.), {e[4J, 195.), {e[5], 180.), {e[6],
185.), {e[7], 210.), {e[8], 210.), {e[9], 100.}, {e[10], 100.), e[11], 195.), {e[12],
195.), {e[13}, 230.), {e[14], 230.), {e[15], 128.), {e[16], 128.), {e[17], 250.), {e[18],
250.) };
EndPackagefl
invivold
Transient Conc. Data for InVivo
7 4 'U' 'M'
Time Xl X2 X3 X4
0	 10	 0	 0	 0
5	 8	 0.1	 0.1	 0.08
10	 6	 0.2	 0.2	 0.5
15	 5	 0.4	 0.4	 1.0
20	 4	 0.5	 0.5	 1.4
25	 3.5	 0.7	 0.7	 1.6
30	 2.8	 1.0	 1.0	 2.0
1	 1	 1	 1
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roots.f
* CO5NBF Example Program Text
* Mark 14 Revised. NAG Copyright 1989.
*	
.. Parameters
INTEGER	 N, LWA
PARAMETER	 (N=1,LWA=(N*(3*N+ 13))/2)
INTEGER	 NOUT
PARAMETER	 (NOUT=8)
*	
.. Local Scalars..
DOUBLE PRECISION FNORM, TOL
INTEGER	 I, IFAIL, J
*	
..LocalArrays..
DOUBLE PRECISION FVEC(N), WA(LWA), X(N)
*	
.. External Functions..
DOUBLE PRECISION FO6EJF, XO2AJF
EXTERNAL	 FO6EJF, XO2AJF
*	
.. External Subroutines
EXTERNAL	 CO5NBF, FCN
*	
.. Intrinsic Functions
INTRINSIC	 SQRT
OPEN(UNIT = 8, FILE = 'Iucy/roots.r')
*	
.. Executable Statements
WRITE (NOUT,*) 'CO5NBF Example Program Results'
WRITE (NOUT,*)
*	 The following starting values provide a rough solution.
DO2OJ= 1,N
X(J) = 1.ODO
20 CONTINUE
TOL = SQRT(XO2AJFO)
IFAIL=1
*
CALL CO5NBF(FCN,N,X,FVEC,TOL,WA,LWA,IFAIL)
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*IF (IFAIL.EQ.0) THEN
FNORM = FO6EJF(N,FVEC,1)
WRITE (NOUT,99999) 'Final 2-norm of the residuals ',FNORM
WRITE (NOUT,*)
WRITE (NOUT,*) 'Final approximate solution'
WRITE (NOUT,*)
WRITE (NOUT,99998) (X(J),J=l,N)
ELSE
WRITE (NOUT,99997) 'IFAIL = ',IFAIL
IF (IFAIL.GT.1) THEN
WRITE (NOUT,*)
WRITE (N0UT,*) 'Approximate solution'
WRITE (NOUT,*)
WRITE (NOUT,99998) (X(I),I=1,N)
END IF
END IF
STOP
*
99999 FORMAT (1X,A,D12.4)
99998 FORMAT (1X,3F12.4)
99997 FORMAT (1X,A,I2)
END
*
SUBROUTINE FCN(N ,X ,FVEC ,IFLAG)
*	 Scalar Arguments
INTEGER	 IFLAG, N
*	
.. Array Arguments..
DOUBLE PRECISION FVEC(N), X(N)
*	
..LocalScalars..
*	
.. Executable Statements
FVEC(1) = 801.967 - 1000*X(4)/(3 + X(1)) - 1400.*X(4)I(8 + X(1))
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RETURN
END
tstopt.f
* EO4MBF Example Program Text
* Mark 14 Revised. NAG Copyright 1989.
*	
.. Parameters..
INTEGER	 NCLIN, NROWA, N, NCTOTL, LIWORK, LWORK, NALL
PARAMETER (NCLIN = , NROWA =NCLIN, N = ,NCTOTL =NCLIN+N
+
LIWORK=2*N,LWORK=2*N*N+6*N+N+4*NCLIN+NROWA,
+	 NALL=NROWA*N)
INTEGER	 MN, NOUT
PARAMETER	 (MN =7,NOUT = 8)
*	
.. Local Scalars..
DOUBLE PRECISION OBJLP
INTEGER	 I, IFAIL, ITMAX, J, MSGLVL
LOGICAL	 LINOBJ
*	
.. Local Arrays..
DOUBLE PRECISION A(NROWA,N), AA(NALL), BL(NCTOTL)
BU(NCTOTL),
+	 CLAMDA(NCTOTL), CVEC(N), WORK(LWORK), X(N)
INTEGER	 ISTATE(NCTOTL), IWORK(LIWORK)
CHARACTER Al, A2
*	
.. External Subroutines
EXTERNAL EO4MBF, XO4ABF
OPEN(UNIT = 7, FILE = 'modsol.r')
OPEN(UNIT = 8, FILE = 'optsol.r')
*	
.. Executable Statements..
WRITE (NOUT, *) 'EO4MBF Example Program Results'
*	 Skip heading in data file
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* READ (NIN,*)
CALL XO4ABF(l ,NOUT)
ITMAX =20
MSGLVL = 1
LINOBJ = .TRUE.
READ (NIN,*) Al, (CVEC(J),J=1,N), A2
READ (NIN,*) Al, (AA(J),J=l,NALL), A2
READ (NIN,*) Al, (BL(J),J=l,NCTOTL), A2
READ (NIN,*) Al, (BU(J),J=l,NCTOTL), A2
READ (NIN,*) Al, (X(J),J=l,N), A2
DO 201 = l,NCLIN
DO3OJ = l,N
A(I,J) = AA(J + 29*(I_1))
30 CONTINUE
20 CONTINUE
IFAIL=l
*
C	 A	 L	 L
EO4MBF(JTMAX , MSGLVL, N,NCLIN,NCFOTL,NROWA,A ,BL,BU, CVEC,LINOBJ,
+
X,ISTATE, OBJLP , CLAMDA ,IWORK, LI WORK ,WORK,LWORK,IFAIL)
*
STOP
END
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Appendix E: Carbon Balance for Calculation of By-Product Formation
By measuring the primary carbon-containing components in the fermentation system and
performing a balance over them, it is possible to calculate how much of the carbon feed
is being channelled into unwanted by-products. By using total carbon measurements,
the problem of analysing for specific by-products is avoided, although is necessary if
the balance is to be refined and if further physiological information is required.
The carbon balance is based on two conservation relationships:
	
Total Carbon b 	=	 + Cg iyccroi + Cb	 +
	
+	 aCb. + oC O2 +
From these two relationships, the two unknown quantities, Cg iyccmi and Cbyproducta can be
calculated using the expressions:
Cbyproóucis = 1/2 4TCbroth -	 - 1/2	 t%Cc02
	
ACgiyceroi =	 + ACco2 + ACbYPTO3UCIS -
In this case, glycerol concentration is easy to assay by other means (see 3.4.4).
However if the microorganism was growing on complex media this method would give
the uptake of carbon source. Also, it is only by a carbon balance such as this that the
carbon lost to byproducts can be calculated.
For cells operating under fully aerobic conditions where the TCA cycle is functional,
the following relationship should also hold on a molar basis:
glycerol = 1/3 aCO2
These relationships are examined below using the total carbon data described in Section
4.4. A Lab View interface, Carbon Fluxes has been written to calculate the results of
these balances (see Appendix E for documentation). This program calculates the carbon
fluxes and the specific growth of the organism and these are then displayed in strip
chart form if the data analysis is being performed on-line or on a graph for the analysis
of historic data.
Results
Using the above balance method, the build-up of byproducts was estimated for
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fermentations of E.coli pQR15O, E.co/i pQR185 and E.coli pQR185 under the different
fermentation conditions described in Section 3 and whose fermentation performance was
discussed in Section 4.3. The results obtained for E.coli pQR15O are shown in Figure
E. 1. In this figure it can be seen that the level of by-product formation is greatest when
the strain is grown on M9 without plasmid induction or presence of the substrate
benzoate, and least when the pathway is induced by IPTG and supplied with benzoate.
From these results the correlation between growth rate and by-product formation is very
high. The outliers in the Total Carbon data as discussed in Section 4.5 are reflected
here in the profile for growth on M9/IPTG and to a lesser extent in that for growth on
M9. The accumulation of by-products over the stationary phase is evident in the profiles
for growth on M9lbenzoate and on M9/benzoateflPTG.
The profiles for by-product formation during growth of E.coli pQR185, shown in
Figure E.2 are slightly different. While roughly the same final levels are reached, they
do not show the same correspondence with growth rate. For example, growth of the
strain on M9/benzoate/ IPTG results in higher by-product levels as compared to those
achieved during growth on M9 alone even though the final cell density achieved on M9
was higher than that for M9/benzoate/IPTG (this can be seen in Figure 4.4). However
the initial growth rate on M9/benzoate/IPTG is higher than that on M9 only so it is
probable that this is the cause for the by-product build-up. This indicates that, in this
case, it is the initial growth rate and not the final cell density which determines the by-
product levels and that by-product formation occurs primarily during exponential
growth.
Examining the profiles of by-product levels during growth of E.coli pQR186 in Figure
E.3, it can be seen that they correspond very closely to the growth profiles in Figure
4.7, in that by-product levels are initially higher during growth on M9/benzoate/IPTG
when the growth is higher but these are exceeded by the levels obtained during growth
on M9 after 14 hours. The highest by-product levels obtained for E.coli pQR 186 were
roughly half that of those for E.coli pQR15O and E.coli pQR185.
The purpose of the glycerol estimator in Eqn. 85 is to provide a rapid estimate of the
glycerol levels in the fermentation without the need for an additional assay. Because it
will contain all of the errors in the individual variables in the right hand side of Eqn.85
it will be less accurate than the enzyme assay described in Section 3.6. The actual and
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estimated glycerol profiles for growth of E.coli pQR 150 on M9 are shown in Figure
E.4. It can be seen that the estimate is initially good but deteriorates over the time
course of the fermentation as the errors accumulate. One probable source of error
which has been previously mentioned is a poor calibration of the mass spectrometer
pumps. This is illustrated in the plot of Figure 4.13 where the slope of the line is -1.29
where it ought to be -1.0. If this is corrected for then the estimate improves to that
shown in Figure E.5. Also shown in Figure E.5 is the glycerol estimate obtained from
Eqn.86 above.
Errors in this approximation can occur for several reasons: one is the previously
mentioned inaccuracies in the off-gas analysis, and another is the probability of glycerol
or intermediates being taken off via other pathways.
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Figure E.1: Accumulation of by-products during fermentation of E.coli pQR15O under different
fermentation conditions: M9 minimal media, M9 with IPTG for plasmid induction, M9 with IPTG
plus the pathway substrate benzoate (b) and M9 with benzoate but without plasmid induction.
6	 I	 I
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Figure E.2: Accumulation of by-products during fermentation of E.coli pQR 185 under different
fermentation conditions: M9 minimal media, M9 with IPTG for plasmid induction, M9 with IPTG
plus the pathway substrate benzoate (b) and M9 with IPTG plus the pathway substrate p-toluate
(p).
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Figure E.3: Accumulation of by-products during fermentation of E.coli pQR186 under different
fermentation conditions: M9 minimal media, M9 with IPTG plus the pathway substrate benzoate
(b) and M9 with IPTG plus the pathway substrate p-toluate (p).
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Figure E.4: Estimate of carbon source from total carbon data.
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Figure E.5: Estimate of carbon source from CO2 data.
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